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CHAPTER I 
 
 
INTRODUCTION 
 
 
Multidrug Resistance 
Living cells have long had machineries that protect them against toxic compounds 
present in the natural environment. The ability of some cells to gain resistance to new 
drugs is known as multidrug resistance.  In 1928, an antimicrobial drug, penicillin was 
first discovered. This drug was highly effective against a wide variety of harmful micro-
organisms (Fleming, 1980). Two decades later, penicillin resistance Staphylococcus 
aureus was discovered (Abraham & Chain, 1988).  
For decades, pathogenic bacteria have been successfully kept in check by the use 
of various antibiotics. During the 1980s and 1990s infectious diseases such as 
tuberculosis reemerged, causing a serious public health problem.  Alarming increases in 
antibiotic resistant bacteria were documented, including Methicillin-resistant 
Staphylococcus aureus (MRSA) from gram-positive bacteria as well as other dangerous 
bacteria such as Acinetobacter baumanii, Enterococcus faecium, Klebsiella pneumoniae, 
Pseudomonas aeurginosa and Enterobacter species (Taubes, 2008).  
The problem is not restricted to antimicrobials, since 40% of human cancer 
tumors develop resistance to chemotherapeutic drugs. To successfully fight the increasing 
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numbers of drug resistant bacteria and tumor cells, extensive knowledge of the molecular 
mechanism of drug resistance is required. 
 
Mechanisms of Resistance 
Microbes have both intrinsic (natural) and acquired resistance to antimicrobials. 
Intrinsic resistance has been associated with the presence of an outer membrane barrier in 
gram-negative bacteria. The outer membrane decreases the rate of transmembrane 
diffusion of lipophilic solutes by narrowing its porin and lowering the fluidity of the 
lipopolysaccharide leaflet. However, equilibration across the barrier is achieved very 
rapidly (Nikaido, 1985, 1989). Therefore, additional mechanisms are needed to explain 
the level of intrinsic resistance. The second type of resistance is known as acquired 
resistance. Bacteria are susceptible to antibacterial agents, and undergo changes either by 
chromosome mutation or by passing their genes that encodes for resistance from one 
bacterium to another very rapidly. Strains emerged that are less susceptible or not at all 
susceptible to antibacterial drugs (Silver & Phung, 1996). 
There are four primary mechanisms that give rise to multidrug resistance in 
bacteria, they include: (1) drug modification by enzymes of the targeted cell; (2) 
alteration of the cellular target through mutation or post-translational modification; (3) 
increased cell wall and outer membrane impermeability to drugs, that can be amplified by 
the loss of one or more porins; and (4) active efflux of drugs by membrane-bound 
multidrug efflux transporters.      
Drugs can be hydrolyzed before reaching their targets, such as β-lactam 
antibiotics (penicillins and cephalosporins) that are hydrolyzed by bacterial β-lactamase 
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(Nikaido & Normark, 1987). This enzyme family expands its substrate range by a series 
of point mutations at different sites within the gene, causing a change in the interaction 
between the enzyme and its substrate (Jacoby & Carreras, 1990). In turn, the cycle of 
natural protein engineering that occurs in β-lactamase in response to changing antibiotics 
provides an obstacle in designing new and improved drugs against resistant bacteria. It 
has also been shown that resistance to a few antibiotics occurs by the acquisition of a 
gene encoding a new target enzyme that has much lower affinity for the antibiotics than 
the normal enzyme.  This type of mechanism is known as target alteration (Maxwell, 
1992). 
Another mechanism of resistance depends on the malfunction in the transport of 
drugs, which depends on both the lipophilicity and the structure of the cell membrane 
(Hayes & Wolf, 1990). Thus, the permeability of drugs depends on the physiochemical 
properties of the membrane. It has been shown that hydrophobic antibiotics have a large 
effect on gram-positive bacteria compared to gram-negative bacteria due to a decrease in 
the diffusion rate of drugs across the outer membrane of gram-negative bacteria. This is 
attributed to the asymmetric structure of its lipid bilayer, where the outer and inner 
leaflets are comprised of lipopolysaccharide (LPS) and glycerophopholipids, 
respectively. The LPS layer its less fluidity and rigidity is thought to contribute to the 
ability of the outer membrane to exclude many hydrophobic antibiotics (Seydel, 
Labischinski, Kastowsky, & Brandenburg, 1993). Also, porin proteins have negatively 
and positively charged side chains at the lower and upper rim of the pore eyelet, which 
give rise to a transverse electric field. The electric field is suggested to separate polar and 
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non-polar solutes (Schulz, 1993; Weiss & Schulz, 1992). Consequently, the transverse 
field facilitates the permeation of hydrophilic compounds but expels hydrophobic ones. 
The fourth mechanism is the active efflux of drugs by membrane-bound 
multidrug transporters (Figure 1). These transporters or proteins are present in all 
organisms. In bacteria, their genes are located on the chromosome, or transmissible 
genetic elements, such as plasmids that can confer an increase in resistance to antibiotics. 
Thus, the proteins that can transport several compounds are associated with multidrug 
resistance (MDR). 
 
 
 
 
 
 
Figure 1: Schematic illustration of the main types of bacterial drug efflux pumps. Illustrated 
starting from the left, are: Staphylococcus aureus NorA, a member of the MFS superfamily; 
Escherichia coli EmrE, a member of the SMR superfamily; Vibrio parahaemolyticus NorM, a 
member of the MATE superfamily; Escherichia coli AcrAB-TolC, a member of the RND 
superfamily; and Lactococcus lactis LmrA, a member of the ABC superfamily (Kumar & 
Schweizer, 2005). 
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Multidrug Resistance Family 
Multidrug transporters are divided into two major classes depending on their 
energy source for drug efflux. ATP-binding cassette (ABC) multidrug transporters use 
ATP hydrolysis to extrude drugs out of the cell while secondary multidrug transporters 
utilize electrochemical gradients of protons or sodium ions to drive the extrusion of drugs 
from the cell. 
The functional unit of an ABC transporter contains two transmembrane domains 
(TMD) and two nucleotide ATP binding domains (NBD). The TMD’s and NBD’s can be 
expressed in a variety of arrangements. The four domains can be fused in a single 
polypeptide such as for P-glycoprotein (P-gp) (Aller et al., 2009) or can be expressed as 
half transporter with one TMD and one NBD.  Each half dimerizes in order to have a 
functional transporter such as LmrA from Lactococcus lactis (Federici et al., 2007), 
MsbA from E.coli (Ward, Reyes, Yu, Roth, & Chang, 2007), and Sav1866 from 
Staphylococcus aureus (Dawson & Locher, 2006).  
Dano was the first to suggest that the decrease in drug efficacy in multidrug 
resistance tumor cells is through active extrusion (Dano, 1973). Later, it was shown that 
the decrease in intracellular drug concentration is associated with the presence of a cell 
surface glycoprotein, known as P-glycoprotein (P-gp) (Juliano & Ling, 1976). It was 
recognized that Pgp is an ABC transporter protein that functions as an efflux pump (C. J. 
Chen et al., 1986). Diverse substrates are translocated by ABC transporters, ranging from 
chemotherapeutic drugs to naturally occurring chemical and biological compounds.  
Most bacterial multidrug efflux systems are sensitive to agents that dissipate the 
proton motive force (PMF), triggering the expulsion of toxic compounds from the cells in 
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a coupled exchange with protons. During metabolism, the bacterial cell extrudes protons 
to the exterior. The generation of ATP and flagella movement are linked to solute 
transport via the bacterial cytoplasmic membrane. The combined potential, concentration 
or osmotic effect of the proton and its electropositivity, contribute to the proton motive 
force (PMF) (McDonnell & Russell, 1999). 
 PMF is composed of a chemical proton gradient (ΔpH, inside alkaline) and an 
electrical potential (Δψ, inside negative). In order to explore the energy characteristics of 
secondary multidrug transporters, experimental studies used ionophores which can 
selectively dissipate ΔpH and Δψ (Ng et al., 1994). These experiments provide insights 
into the drug/proton ratio governing the export process. 
Secondary multidrug transporters are subdivided into four distinct families. The 
families include the major facilitator superfamily (MFS); the resistance nodulation-
division-family (RND); the multidrug and toxic extrusion family (MATE); and the small 
multidrug resistance family (SMR).  
The major facilitator superfamily is the largest and the most functionally diverse 
of the secondary multidrug transporters. Membrane proteins of this family are made of 12 
or 14 transmembrane segments (TMS). An example is EmrD from E.coli that is involved 
in the shock adaptive response. Expression of EmrD protects the cell against uncouplers 
such as CCCP (carbonyl cyanide m-chlorophenylhydrazone), which is a protonophore 
that inhibits the PMF and in turn arrests the growth of E.coli (Naroditskaya, Schlosser, 
Fang, & Lewis, 1993). EmrD is homologous to two other MFS multidrug transporters; 
LmrP from Lactococcus lactis (Mazurkiewicz, Driessen, & Konings, 2004) and MdfA 
from E.coli (Adler & Bibi, 2005).  
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The most intensively studied member of the resistance-nodulation-division 
protein family is AcrB from E.coli (Zgurskaya & Nikaido, 1999). The functional AcrB 
transporter is a trimer, consisting of AcrA that has a role in membrane fusion and TolC 
which is a pore-like molecule that spans the outer membrane (Koronakis, Sharff, 
Koronakis, Luisi, & Hughes, 2000). AcrB translocates drugs into the TolC pore through 
which they cross both the periplasm and outer membrane. Many antibiotic targets are 
located in the periplasmic space. Therefore, to confer reistance against a broad spectrum 
of antibiotics, active transport must not only pump them out of the cytoplasm but also 
across the outer membrane of gram-negative bacteria. 
The most recently identified secondary multidrug transporter family is MATE.  
The MATE family of transporters extrudes various drugs, especially cationic ones, 
through electroneutral exchange with protons. The first identified multidrug transporter 
of this family is from  Vibrio parahaemolyticus, and denoted NorM (Morita et al., 1998).  
In eukaryotes, a transporter of the MATE family known as MATE1 is responsible 
for the extrusion of organic cations, such as cationic drugs, some vitamins, and 
endogenous compounds such as choline and dopamine, thus is regarded as a multidrug or 
polyspecific exporter (Otsuka et al., 2005). When drugs reach the target cells upon 
absorption, they are then excreted from the kidney and liver (Pritchard & Miller, 1993). 
During this process, the drugs may pass through several cells using different transporter 
pathways (Inui, Masuda, & Saito, 2000; Tamai et al., 1999; Tsuji & Tamai, 1999; 
Ullrich, 1994). Final extrusion occurs at the brush border membranes of renal tubule cells 
and bile canaliculi.  
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 Finally, the smallest of the secondary multidrug resistance family is the small 
multidrug resistance (SMR) (Chung & Saier, 2001). Members of the SMR family are 
distinct from the other transporter families in demonstrating transport of lipophilic 
compounds, primarily quaternary ammonium compounds (QAC) and a variety of 
antibiotics (Heir, Sundheim, & Holck, 1999). The structural model is composed of a 
tightly packed four-helix bundle (Arkin, Russ, Lebendiker, & Schuldiner, 1996; Edwards 
& Turner, 1998; Paulsen, Brown, & Skurray, 1996). SMR proteins demonstrate drug 
efflux via electrochemical proton gradient analogous to MFS. Therefore, SMR proteins 
have been classified as a proton-dependent multidrug efflux system (Littlejohn et al., 
1992). One member of the SMR family is EmrE from Escherichia coli. 
 
Regulation of Multidrug Transporters 
All bacterial MDR transporters identified to date whose expression is under the 
control of a transcriptional regulatory protein are PMF-dependent exporters (Paulsen et 
al., 1996). Most of the MDR family of transporters belonging to the MFS and RND 
superfamilies are controlled by transcriptional regulatory proteins (see Table 1), such as 
the MDR gene regulator, BmrR (multidrug resistant regulator of B subtilis) (Ahmed, 
Borsch, Taylor, Vazquez-Laslop, & Neyfakh, 1994). 
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Multidrug
transporter(s)
Regulator Type
Blt BltR Activator
Blt, Bmr Mta Global activator
Bmr BmrR Activator
EmrB EmrR Repressor
QacA QacR Repressor
AcrB MarA Global activator
AcrB AcrR Repressor
AmrB AmrR Repressor
MexB MexR Repressor
MexD NfxB Repressor
MexF MexT Activator
MexZ MexX Repressor
MtrD MtrA Activator
MtrD MtrR Repressor
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Reported transcriptional regulators that control the expression of multidrug 
transporters in bacteria. Adapted from (Putman, Van Veen, Degener, & Konings, 2000). 
 
The expression of Staphylococcus aureus multidrug efflux gene qacA is regulated 
by the transcribed repressor protein QacR (Grkovic, Brown, Roberts, Paulsen, & Skurray, 
1998). However, members of the SMR family do not have their synthesis controlled at 
the transcriptional level. This could be a reflection of unknown physiological roles for the 
unregulated pumps in normal cellular metabolism (Grkovic, Brown, & Skurray, 2002). 
The small but continuous supply of these transporters can easily be controlled, either by 
low level production of the mRNA or by high turnover rates of the mRNA and/or the 
transport protein, without any additional regulatory controls. Understanding the 
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regulation of multidrug transporters may have an important role in the drug discovery 
process and for the development of combination therapies. Inhibition of these transporters 
may be achieved through targeting the regulatory networks that control expression. 
 
Phylogeny of the SMR Family 
SMR proteins are not all drug effluxers. This characteristic is a result of 
divergence of this family into three classes: small multidrug pumps (SMP) and 
suppressor of groEL mutation proteins (SUG) which is based in their conferred 
phenotype (Greener, Govezensky, & Zamir, 1993). The paired SMR (PSMR) protein 
group is a distinct group of SMR homologues. This group has been both identified and 
characterized based upon multidrug resistance and substrate transport. These SMR 
homologues are unique compared to the other subclass as they require co-expression of 
two separate SMR genes within the host bacterium. This group includes Escherichia coli 
YdgE and YdgF (Ninio, Rotem, & Schuldiner, 2001), Bacillus subtillis EbrA and EbrB 
(Kikukawa, Nara, Araiso, Miyauchi, & Kamo, 2006) YKKC and YKKD, and YvaE, 
YvdR and YvdS (Jack, Storms, Tchieu, Paulsen, & Saier, 2000) 
In all cases the genes of members from each subclass have been identified on a 
variety of plasmids and transposable elements that provide high level resistance to a wide 
range of antibiotics such as β-lactams (Sidhu, Langsrud, & Holck, 2001), cephalosporin 
(Miriagou, Tassios, Legakis, & Tzouvelekis, 2004), dihydrofolate inhibitors (Burnside & 
Groot Obbink, 1996) as well as other aminoglycosides (Jeljaszewicz, Mlynarczyk, & 
Mlynarczyk, 2000). The frequency of their occurrence with other drug resistance genes 
strongly suggests that there is a tight genetic link between antibiotics and SMR resistance 
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genes (Sidhu et al., 2001). The co-selection of antibiotic and antiseptic resistance genes 
correlates with the increased usage of both antiseptics and antibiotics in clinical 
environments. Therefore, the spread of SMR homologues make them a critical protein to 
characterize and important candidates for transport mechanism studies.  
SMP subclass proteins are primarily characterized in gram-negative (EmrE from 
Escherichia coli) and gram-positive (Smr from Staphylococcus aureus) bacteria as well 
as Archaea (Hsmr from Halobacterium salinarum) from the expression of a single gene. 
EmrE, a member of the SMR family, confers resistance to MvrC and Ebr (referred to as 
methyl viologen resistance protein, MvrC, and ethidium bromide resistance protein, Ebr) 
(Morimyo, Hongo, Hama-Inaba, & Machida, 1992; Purewal, 1991). Other characterized 
proteobacterial SMP proteins include Pseudomonas aeruginosa Pau-EmrE (γ-
proteobacteria) (Li, Poole, & Nikaido, 2003) and Brodetella pertussis Bpe-EmrE (β-
proteobacteria) (Ninio et al., 2001). Pau-EmrE and Bpe-EmrE share 45% and 50% 
identity with EmrE, respectively, and are fairly similar in protein length (107-110 amino 
acids).  
The first SMR family member, Sau-SMR, was identified and characterized in the 
gram-positive bacteria, Staphylococcus aureus (Grinius & Goldberg, 1994). Mtu-SMR 
from Mycobacterium tuberculosis is the only class of SMR protein that has similar 
functionality to Sau-SMR. These two proteins have a substantial sequence identity of 
41% and 38%, respectively, to EmrE. 
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EmrE: A Small Multidrug Transporter 
Escherichia coli utilizes EmrE expression as a means of protection against toxic 
compounds such as ethidium, an intercalating dye (Lambert & Le Pecq, 1984). The EmrE 
gene was first identified and cloned on the basis of its ability to confer resistance to 
ethidium (Purewal, 1991; Purewal, Jones, & Midgley, 1990). The same gene under 
different pseudonym, mvrC was identified by Morimyo and colleagues in 1992 
(Morimyo et al., 1992). The mvrC gene was cloned on the basis of its resistance to 
methyl viologen.  
 Subunit c of F1F0 ATP synthases was utilized for determining the nature of the 
energy required for extrusion of drugs by EmrE (Fillingame, 1992). In E.coli the F1F0 
ATP synthases utilizes the energy of a transmembrane electrochemical proton gradient to 
catalyze ATP synthesis during oxidative phosphorylation. Therefore, to identify the 
driving force of EmrE, the unc operon strain deletion was used. It was then possible to 
manipulate independently both the proton electrochemical gradient (ΔH+) and ATP. 
Effects of different agents on ethidium entry into the cell was tested (Yerushalmi, 
Lebendiker, & Schuldiner, 1995). Agents that inhibit ΔH+ but did not affect ATP levels in 
this strain induced ethidium entry into the cell, suggesting a failure of the extrusion 
machinery. In contrast, inhibitors that decrease ATP levels without any alteration on ΔH+ 
had no effect on ethidium uptake either. The experimental work strongly suggests that 
EmrE functions as a proton/substrate antiporter. This antiporter mechanism utilizes the 
electrochemical gradient of protons (ΔH+) generated by a bacterial primary pump to 
extrude toxic cations and reduce their concentration in the cytoplasm (Yerushalmi et al., 
1995).  
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Substrate Recognition 
 The SMR protein family has been shown to exhibit a wide range of drug binding 
affinities with nanomolar to micromolar KD values. These values are associated with the 
sequence variation in the SMR family of proteins, some of which are found in human 
pathogens such as Myobacterium tuberculosis (TBsmr), Pseudomonas aeruginosa 
(PAsmr), and other pathogens such as Bordetella pertussis (BPsmr). For example,  
tetraphenylphosphonium (TPP+) binding affinity among the SMR proteins ranges from 
either low binding to TBsmr (41% homologous to EmrE), and  PAsmr (45% homologous 
to EmrE) to  intermediate  binding to BPsmr (58%  homology to EmrE) (Ninio et al., 
2001). The difference in the drug binding affinity of SMR homologues suggests a unique 
profile that is adapted to the activity of their host.   
 Grinius and Goldberg were the first to demonstrate that the efflux of substrate by 
SMR is energy dependent and is driven by a proton motive force (PMF) (Grinius & 
Goldberg, 1994; Littlejohn et al., 1992). In their experiments, Smr from Staphylococcus 
aureus was reconstituted into proteoliposomes and TPP+ efflux was demonstrated via an 
electrochemical gradient. The result was confirmed for EmrE under similar experimental 
conditions (Yerushalmi et al., 1995). The nature of the compound affects the energy 
requirements for transport as observed in EmrE. Transport of monovalent lipophilic 
cations, such as TPP+, appears to be electrogenic. In contrast, transport of divalent 
lipophilic cations such as methyl viologen (MV) is electroneutral (Rotem & Schuldiner, 
2004). These findings suggest that SMR proteins depend on the energetic state of the cell 
and the proton gradient across the membrane. In addition, it offers important implications 
for the differences in drug resistance by host cells harbouring SMR proteins. 
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The Substrate Binding Site  
 The role of carboxylic acid residues in substrate recognition has been documented 
for many transporters that are not related to multidrug resistance, such as vesicular 
monamine transporters (VMAT’s) (Merickel, Rosandich, Peter, & Edwards, 1995), 
serotonin transporters (SERT) (Kitayama et al., 1992), and plasma membrane dopamine 
transporters (DAT) (Barker, Moore, Rakhshan, & Blakely, 1999).  
The bacterial multidrug transporter, lactose permease, is one of the best 
characterized coupled ion transporters. It has six residues, three of which are acidic 
amino acids that are important for active transport. E126 and R144 are involved in 
substrate binding and specificity (Frillingos & Kaback, 1996). 
 In addition, closely related multidrug efflux pump from the bacterial pathogen 
Staphylococcus aureus, QacA and QacB, were shown to have different substrate 
specificities due to a single amino acid substitution at position 323 (Paulsen et al., 1996). 
The acidic residue aspartate is present in QacA and is essential for substrate recognition 
(Mitchell, Brown, & Skurray, 1998; Paulsen et al., 1996). Mutating D323 to another 
acidic residue had no effect in the resistant phenotype while mutating to an alanine 
residue (similar to the residue position in QacB) reduces the resistance to divalent 
cations.  
The Bacillus subtillis protein BmrR controls the transcription of the multidrug 
transporter gene bmr. It has been shown that the C-terminal domain of BmrR (BRC) has 
no sequence homology to other proteins of the same MerR family of transcription 
regulators. The apo-state of BRC reveals no pocket or cavity that would appear to serve 
as an obvious drug-binding site. However, the hydrophobic pocket of the protein revealed 
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a completely buried acidic residue, glutamate 134 (Glu134) (Figure 2). This residue is 
considered energetically unfavourable, yet in the structure the glutamic acid is hydrogen 
bonded to Tyrosine 33 (Tyr33) and Tyrosine 68 (Tyr68). This arrangement of amino 
acids makes it an attractive binding site for aromatic/hydrophobic cationic substrates, 
such as TPP+ (Zheleznova, Markham, Neyfakh, & Brennan, 1999).  
 
 
 
 
 
 
 
 
 
Figure 2: Drug binding site in BmrR. Residues that are involved in drug binding are shown in 
ball-and-stick configuration. Left: structure based model with bound rhodamine (purple ball and 
sticks). The key residue Glu 134 is shown. Right: structure based model with bound TPP+ (in red) 
together with bound water molecule (Wat 1). Dashed lines are hydrogen bonds (Zheleznova et al., 
1999). 
 
 
EmrE contains eight charged residues, seven of them located in the hydrophilic 
loops and only one of them is a membrane-embedded charged residue, glutamate14 
(Glu14 or E14), which is conserved in more than 200 homologous proteins in bacteria 
and archaea (Ninio et al., 2001; Sharoni, Steiner-Mordoch, & Schuldiner, 2005) are 
shown in Figure 3. Further characterization of the mutant showed that the replacement of 
E14 with a cysteine (Cys), glutamine (Gln), histidine (His), tyrosine (Tyr), or aspartic 
acid (Asp) has a large effect on the phenotype (Grinius & Goldberg, 1994; Yerushalmi & 
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Schuldiner, 2000a). Studies have also shown that out of the three acidic residues, only 
E14 (located in TM1) is important for drug transport activity (Muth & Schuldiner, 2000; 
Yerushalmi & Schuldiner, 2000b). E14 is thought to be involved in direct binding of both 
substrate and proton (Gutman, Steiner-Mordoch, & Schuldiner, 2003). 
 
 
 
 
Figure 3: Amino acid sequence alignment of EmrE from E.coli shown with other homolog’s 
from human pathogens. Conserved residues are coloured according to their acidic (red), basic 
(blue), polar (green), or hydrophobic (grey) character (Ma & Chang, 2004). 
 
 
 Evidence has shown that residues located in the vicinity of E14 in TM1 are part of 
the substrate-binding domain (Gutman et al., 2003). Further work has also shown that 
mutation of E14 to a cysteine results in an inactive protein while a mutation to an 
aspartate was able to bind substrate and transport it down its concentration gradient. The 
protein was, however, impaired in its ability to couple substrate flux to the proton 
gradient (Yerushalmi, Mordoch, & Schuldiner, 2001). This indicates that E14 plays a 
central role in both substrate and proton binding. It was shown that substrate binding to 
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wild type EmrE increases dramatically with increasing pH, suggesting that deprotonation 
of E14 is essential (Muth & Schuldiner, 2000; Yerushalmi et al., 2001). Furthermore, it 
was observed in detergent solubilised EmrE that substrate binding induces proton release 
(Soskine, Adam, & Schuldiner, 2004).  
 Several studies have demonstrated the equivalence of E14 in the dimer (Ninio, 
Elbaz, & Schuldiner, 2004; Weinglass et al., 2005) where both E14’s are in similar 
hydrophobic environments. Tetraphenylphosphonium (TPP+) is a substrate that binds 
with high affinity to EmrE. TPP+ was shown to reduce chemical modification of E14 by 
more than 80%. The data suggests that E14 residues are in the functional unit of EmrE.  
The functional unit is in close proximity to the binding site (Ninio et al., 2004). This 
work was also supported by previous work in our lab that showed that a population of 
spin labels at position 14 from both monomers are in close proximity (Koteiche, Reeves, 
& McHaourab, 2003).  
 Biochemical evidence has shown that the E14 residue in TM1 has an unusually 
high pKa of 8.3-8.5 (Soskine et al., 2004) while the pKa of a glutamic acid residue in 
solution is 4.0. The large increase in pKa could be due to a decrease in the dielectric 
environment of E14 in EmrE. Furthermore, the dissociation constant (KD) of the substrate 
is also sensitive to pH. An increase in pH from 6.2 to 8.8 results in a corresponding 200 
fold decrease in KD (Adam, Tayer, Rotem, Schreiber, & Schuldiner, 2007). The 
replacement E14 with aspartic acid results in a decrease in the pKa of the carboxyl and 
generates a protein that is independent of pH when substrate is bound. Consequently, at 
physiological pH the carboxyl is deprotonated. The protein is able to bind substrate but it 
cannot couple the substrate to the proton gradient (Soskine et al., 2004; Yerushalmi & 
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ES + 2H+
E + 2H+ + S EH2 + S
E: H2: S
Schuldiner, 2000a). Overall, the single mutation of E14D transforms an antiporter 
mechanism in EmrE to a uniporter. 
The findings presented above are summarized in Figure 4, which suggests a 
reaction path where the protonated EmrE (EH2) plus the substrate (S) dissociates from E 
+ 2H+ + S, and it rapidly forms ES + 2H+. That is, the binding of either the substrate or 
the protons requires the dissociation of the other.  
 
 
 
 
 
Figure 4: The substrate binding reaction cycle in EmrE. E, non protonated EmrE; EH2, 
protonated EmrE; ES, substrate bound EmrE; E:H2:S hypothetical ternary complex (Adam et al., 
2007). 
 
Structure Controversy 
 EmrE is an ion-coupled transporter. Although it is widely accepted that the 
monomer cannot transport drugs, the oligomeric state of EmrE has been controversial. 
The question was first addressed by direct measurements of substrate binding 
stoichiometry to the detergent solubilised EmrE. This resulted in high affinity of substrate 
binding in the nanomolar range, giving a ratio of EmrE:TPP+ higher than two. The high 
ratio initially suggested that EmrE could be a trimer (Muth & Schuldiner, 2000). A 
possible explanation of the overestimation of the ratio of EmrE:TPP+ was because the 
measurements made were at a very low concentration of EmrE that may have dissociated 
the dimer (Tate, Ubarretxena-Belandia, & Baldwin, 2003). Binding assays using higher 
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concentrations of EmrE in vitro confirmed a ratio of EmrE:TPP+ of 2 (Elbaz, Tayer, 
Steinfels, Steiner-Mordoch, & Schuldiner, 2005; Tate et al., 2003). It is unclear if EmrE 
in vivo exists in a higher oligomeric state, but in vitro studies indicate the dimer is the 
basic functional unit. 
A two-dimensional crystal of EmrE reconstituted in a lipid bilayer gave the first 
insight into the structure of the protein. The images of frozen hydrated crystals were 
collected by cryo-electron microscopy and a projection structure of EmrE was calculated 
to 7Å resolution (Tate, Kunji, Lebendiker, & Schuldiner, 2001). The structure from their 
projection map shows EmrE as a dimer comprised of highly tilted helices. They 
concluded that there was no obvious two-fold symmetry axis perpendicular to the 
membrane within the dimer, but there is a 2-fold axis in the plane of the membrane 
relating the two asymmetric structures to each other in the functional unit. The features of 
the electron density map were interpreted from a projection map of bacteriorhodopsin 
(bR) that has the same resolution as EmrE (Figure 5) (Grigorieff, Ceska, Downing, 
Baldwin, & Henderson, 1996).  
In 2003 another EM model of substrate bound-EmrE was published (Tate et al., 
2003). The data suggested that the substrate tetraphenylphosphonium (TPP+) was bound 
at the monomer-monomer interface in the centre of the EmrE dimer. This binding caused 
a tilt in at least one transmembrane segment.  
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Figure 5: Projection map of EmrE at 7 Å. (A) A crystallographic dimer is shown from a 
projection map of EmrE at 7.0 Å resolution, with the asymmetric structure outlines. The 
asymmetric units are related by a 2-fold axis in the plane of the membrane, having different 
orientation in the membrane. P, an α-helix nearly perpendicular to the membrane plane; T, 
probably a single α-helix tilted with respect to the membrane normal; A, an arc of probably four 
tilted α-helix. (B) The projection map of bacteriorhodopsin at 7.0 Å resolution has been scaled 
exactly to EmrE, allowing a direct comparison of sizes (Tate et al., 2001). 
 
 
In 2004 the high resolution X-ray structures of EmrE in the apo- and substrate 
bound TPP+-state were published  (Ma & Chang, 2004; Pornillos, Chen, Chen, & Chang, 
2005). The crystal structure of EmrE in the apo-state was shown to be a tetrameric 
arrangement of two conformational heterodimers (Figure 6A). Helices 1, 2, and 3 from 
one subunit were rearranged in an approximately inverted orientation relative to the other 
monomer, forming a six-helix bundle with a hydrophobic core. Helix-4 from one subunit 
is nearly parallel to the membrane surface while the other is perpendicular (Ma & Chang, 
2004). Subsequently, the crystal structure of EmrE in the presence of the substrate was 
published (Figure 6B) showing large structural differences from the apo-state. The 
substrate-bound state was shown to be homodimeric with substrate binding at the 
dimerization interface. Each of the subunits had opposite orientation in the membrane, 
forming an asymmetric antiparallel dimer (Pornillos et al., 2005).  
 
BA 
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Figure 6: Retracted crystal structures of EmrE 
 (A) X-ray crystal structure of the apo-state EmrE at 3.7Å. Each heterodimer contains subunits 
with different conformation (shown in pink, black, blue and green). The residue Glu-14 is shown 
in red spheres. (B) X-ray crystal structure of the substrate-bound state at 3.8Å is composed of two 
subunits (subunit A in yellow and subunit B in green). The N and C-terminal of the two subunits 
are indicated, and one bound TPP (red). 
      
The two crystal structures were later retracted in 2006. Prior to the retraction, the 
suggestion of an antiparallel topology of the monomers in a homodimeric membrane 
protein attracted widespread interest because of the implications regarding insertion and 
evolution of ion-coupled transporters.  
The antiparallel rearrangement of the monomers has been supported by a 
reinterpretation of previously published electron density maps of 2-D crystals of EmrE, 
where parts of the structure are related by quasi-symmetry (Ubarretxena-Belandia, 
Baldwin, Schuldiner, & Tate, 2003). 
 
 
 
 
(A) Apo-state (B) Substrate-bound state 
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Figure 7: The position of the α-helices of EmrE viewed perpendicular to the membrane 
plane. The helices are labelled A-H. The grey mesh indicates electron density at 1.1σ. The arrow 
indicates the position where helices F and H are connected via what could be a rigid loop. The 
yellow asterisk mark the approximate in-plane position of the centre of the TPP+ molecule 
(Fleishman et al., 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: EmrE binds TPP+ as an antiparallel dimer. Left panel is a front view of the EmrE 
transport in complex with TPP+. The two monomers are shown in blue and yellow, and the bound 
TPP is pink. Anomalous Fourier density from SeMet (coloured red in one monomer and green in 
the other) markers in TM1 and the arsonium analogue of TPP (magenta). The N-termini of the 
monomers are labelled .Right panel is a stereo view ribbon representation of the EmrE-TPP x-ray 
structure docked into the EM density map. The TM helices are labelled, with the two monomers 
distinguished by asterisks. The bound TPP in the EM map is indicated by the red arrow (Y. J. 
Chen et al., 2007). 
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Using this symmetry relationship with sequence conservation data, 
transmembrane segments were assigned to the densities seen in the cryo-EM structure 
(Figure 7). In addition, after re-evaluating the crystal structure, in 2007 Chen and 
colleagues solved the corrected Cα model of the EmrE substrate bound crystal structure 
at a resolution of 3.8 Å suggesting an antiparallel homodimer (Figure 8) (Y. J. Chen et 
al., 2007). The structure showed a pseudo two-fold rotational axis running along the 
dimer interface and parallel to the membrane plane.  The new crystal structure produced a 
Cα model that was similar to the Cα EM model derived from the 2-D crystals (Y. J. Chen 
et al., 2007). Figure 8 (right panel) shows the superimposed EM model with the X-ray 
structure of EmrE, where a 6 helix bundle surrounds the substrate (TPP+) and two helices 
are further from the substrate binding site. The crystal structure was obtained by 
solubilizing the protein in Nonyl-β-D-Glucoside (NG), whereas the EM structure was 
obtained in lipids (dimyristoylphosphatidylcholine). Evidence has shown that detergents 
such as Octyl- and Nonyl-β-D-Glucoside cause a 10-30 fold decrease in the affinity of 
the substrate and a decrease in the number of binding sites (Soskine, Mark, Tayer, 
Mizrachi, & Schuldiner, 2006). It was also shown that both detergents when used in the 
preparation of the protein may have a large effect on the oligomeric state of EmrE 
causing an increase in its monomeric fraction. This suggests that the antiparallel 
orientation may reflect the arrangement of the monomers in the crystal (Schuldiner, 
2007b; Soskine et al., 2006). 
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Topology of EmrE 
 
 In membrane proteins, the topology describes which segments of the polypeptide 
chain form TM helices and their orientation relative to the membrane. Not all membrane 
proteins have TM helices spanning the full length of the lipid bilayer, such as the 
Chloride channel ClC, and the Bovine Ca2+- ATPase (Dutzler, Campbell, Cadene, Chait, 
& MacKinnon, 2002; Sorensen et al., 2004). A membrane protein of two subunits can 
either, theoretically, adopt a parallel or antiparallel orientation.  A parallel orientation is 
when the N- and C-termini of both subunits in the dimer are on the same side of the 
membrane (i.e. adopt a single topology) such as LacY (Abramson et al., 2003), AcrB 
(Seeger et al., 2006).  On the other hand, for an antiparallel orientation, the N- and C-
termini of each subunit are on opposite sides of the membrane and thus adopt a dual 
topology, where the dimers are a mixture of both Cin and Cout (Schuldiner, 2007a).  
 The retraction of the crystal structure of EmrE in 2006 led to a controversy 
regarding the topology of the two monomers. It has been suggested that EmrE is likely to 
be an antiparallel dual topology homodimer composed of Nin-Cin and Nout-Cout monomers 
(Butler, Ubarretxena-Belandia, Warne, & Tate, 2004; Fleishman et al., 2006; Rapp, 
Granseth, Seppala, & von Heijne, 2006; Ubarretxena-Belandia et al., 2003). Other data 
had suggested a parallel dimer made of Nin-Cin monomers (Ninio et al., 2004; Soskine et 
al., 2006). The topology of membrane proteins has been shown to be governed by the 
positive inside rule, where loops rich in lysine (K) and arginine (R) tend to orient towards 
the cytoplasmic side of the membrane (Heijne, 1986). Thus, the dual topology of EmrE 
was largely speculated due to the weak topological signal of the protein (weak K+R bias) 
of -2. The topology of EmrE remains unresolved. Therefore, determining the topology of 
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EmrE is essential not only to understand its function but also to learn how the protein has 
evolved. In this section the details of this controversy will be clarified. 
 Biochemical results of crosslinking studies were consistent with parallel topology 
of the two monomers (Soskine, Steiner-Mordoch, & Schuldiner, 2002). Additionally, a 
second crosslinking experiment that used a rigid bifunctional crosslinking agent was 
introduced to a specific site in TM4 at a distance of about 35 to 45 Å, a distance that is 
too long for crosslinking in an antiparallel structure. Regardless of the distance, 
crosslinking was observed as expected from a parallel topology (Soskine et al., 2006). 
The crosslinked monomers displayed identical substrate binding properties to the non-
crosslinked species in detergent as well as reconstituted into proteoliposomes (Soskine et 
al., 2006).  
 Further investigations have supported the parallel rearrangement of the 
monomers. A combination of both in vivo and in vitro studies were carried out on a 
genetic fusion construct, connecting the C-terminal of one monomer to the N-terminal of 
the second monomer by a linker that is either too hydrophilic or too short such that it 
cannot be compatible with an antiparallel topology (Steiner-Mordoch et al., 2008). The 
tandem dimer was shown to confer resistance to ethidium. Moreover, the purified protein 
bound TPP+ with high affinity. It was also shown through a negative dominance study 
that mixing the tandem dimer with an inactive mutant does not inhibit the activity of the 
tandem dimer. This evidence supports the tandem dimer is the functional unit. 
 Genetic work has also been performed to investigate the topology of membrane 
proteins. A comprehensive global analysis of the topology of a large fraction of the E.coli 
membrane proteins were investigated by von Heijne and collaborators (Daley et al., 
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2005). In this study two topology reporters were used: alkaline phosphatase (PhoA) that 
can fold into an active conformation only when present in the periplasm, and green 
fluorescent protein (GFP) which can only become fluorescent when present in the 
cytoplasm. Therefore, the location of the C-termini of the membrane proteins can be 
determined by making a PhoA and a GFP fusion. A high PhoA/low GFP activity 
indicates a periplasmic location, while a low PhoA/high GFP activity indicates a 
cytoplasmic location. Consequently, the C-terminal location (Cin, Cout) was determined in 
this manner for 502 of the 665 cloned proteins. The C-terminal assignment for 69 out of 
71 proteins agreed with previously published work. However, EmrE was vaguely 
assigned as Cout. The rationale behind this assignment was that the GFP fluorescence was 
higher than background as it was for about 30 other proteins (Daley et al., 2005). To 
further support the dual topology concept, mutational studies were performed showing 
that the topology of the EmrE fusion proteins in the membrane is sensitive to the 
distribution of positively charged residues (lysine and arginine) in the protein (Rapp, 
Seppala, Granseth, & von Heijne, 2007). Manipulating the positively charged residues 
forces the protein to have either Cout or Cin topology (Rapp et al., 2006; Rapp et al., 
2007). The expression of EmrE (Cin) and EmrE (Cout) (having three mutations each), 
individually (in single or double copy) does not confer resistance to EtBr. On the other 
hand, co-expression of these inactive mutants restores the ethidium bromide resistance 
phenotype to the same level as observed with wild-type EmrE (Rapp et al., 2007). The 
conclusion of these results suggests the formation of a functional, antiparallel 
heterodimer. 
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 A recent publication from our lab (McHaourab, Mishra, Koteiche, & Amadi, 2008) 
challenged the conclusion of von Heijne and colleagues (Rapp et al., 2007) that the only 
determinant of EmrE topology is the positive inside rule. Therefore, in this study the 
topology of EmrE was investigated by manipulating the (K+R) bias and using the 
reporter protein cerulean fluorescent protein-CFP (Malo et al., 2007) to show the 
orientation of the two monomers by observing the fluorescnece of CFP in vitro. 
Moreover, site directed mutagenesis and EPR spectroscopy were used to derive structural 
constraints to observe the packing of the two EmrE monomers. The results showed four 
important facts. First, manipulation of the (K+R) bias did not change the interface 
between the monomers of EmrE. Second, the oligomeric state of the Cin mutants was 
similar to the cysteine less-EmrE (WT*) consistent with maintaining the dimer structure. 
Third, GFP fluorescence is dependent on the efficient folding of the tagged protein 
(Pedelacq, Cabantous, Tran, Terwilliger, & Waldo, 2006). The difference in level of the 
fluorescence between mutants may reflect misfolding of the chimeras. Fourth, results 
from the in vivo study of ethidium bromide resistance and in vitro study of TPP+ binding 
show that the mutant that forces EmrE into Nin-Cin orientation had measurable resistance 
to ethidium bromide and also binding to TPP+, respectively. Overall, the results 
demonstrated that the K+R bias is not the only determinant of CFP fluorescence.  
The conclusion of von Heijne and colleagues was based upon the fact that the 
membrane insertion efficiency of all mutants was similar (Rapp et al., 2007) even though 
a direct analysis of membrane insertion was not performed.   
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Figure 9: SDS-PAGE and Western blot analysis of EmrE-CFP. A) SDS-PAGE analysis of 
equal amounts of purified membrane inserted EmrE*-CFP shows the inconsistency in yield. 
Bottom panel is the Western blot analysis with antibodies against the C-terminal CFP. B) SDS-
PAGE and Western blot analysis (bottom panel) of inclusion bodies pellets from 11 cultures. 
Lane 1 is purified EmrE*-CFP from the membrane fraction (McHaourab et al., 2008). 
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The highly fluorescent chimera reported by Rapp et al. was based on the R29G, a Cin 
mutation that induced more than 90% of the observed increase in GFP fluorescent (Rapp 
et al., 2006; Rapp et al., 2007), while the Cout mutants were based on L85R. However, the 
results in Figure 9A show that the nature of the substitution profoundly changes the level 
of insertion of the protein into the membrane, where some mutants partition into 
membrane fractions while others partition into inclusion bodies (Figure 9B). In addition, 
independent mutations having similar K+R biases had considerably different levels of 
CFP fluorescence, as well as an inverse effect relating temperature of expression with 
fluorescence, suggesting that thermodynamic stability is another contributing factor. 
Therefore, it was proposed that the favorable energetic of helix-helix interaction in the 
parallel dimer take priority over the unfavorable (K+R) bias in the near neutral region, 
leading to a native all Cin orientation. The study is also supported by other published 
work showing that membrane proteins are dependent on neighboring helices, the primary 
sequence, and interaction of helices with lipids (Bowie, 2004, 2005; Hessa et al., 2007; 
White & Wimley, 1999).  
The evolutionary challenge of recognition and transport for a wide variety of 
substrates may have selected SMR heterodimers that originated from a gene duplication 
of more ancient homodimers. Therefore, after gene duplication a small number of 
mutations in the hydrophilic domains might be adequate to assume either parallel or 
antiparallel orientation of the monomers within the heterodimer (Schuldiner, 2007a). A 
protein with only a slightly modified sequence could extend the range of substrate 
specificity. Starting from the SMR heterodimers that can fuse to form larger proteins, the 
topology evolution of large proteins can be visualized.  
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The controversy regarding the interaction of the subunits in the SMR dimer, 
especially EmrE, and also its structure in detergent micelles, makes it an attractive model 
to investigate the conformational dynamics using biochemical and biophysical studies. 
These studies may resolve the disagreements that have been identified by different groups 
and also may provide additional information regarding conformational changes that occur 
during the transition from the apo-state to the substrate bound-state.   
 
Research Overview 
 Over the past decades extensive study of EmrE from Escherichia coli has proved 
to be a valuable model system for the understanding of the coupling mechanism of the 
ion coupled transporter family (Adam et al., 2007; Schuldiner, 2007b; Soskine et al., 
2004; Yerushalmi & Schuldiner, 2000a, 2000b). EmrE extrudes positively charged 
aromatic drugs in exchange for two protons generating bacterial resistance to a wide 
variety of toxic compounds (Schuldiner et al., 2001; Yerushalmi et al., 1995). The small 
size of this protein and the retention of its function upon solubilisation in detergent 
(Sikora & Turner, 2005; Soskine et al., 2006) make it a good model system for structural 
and functional studies that would contribute to the understanding of the mechanism of the 
SMR family of transporters.  
 In the last three years EmrE was center stage due to the controversy regarding its 
structure and topology. The crystal structure of EmrE in the apo-state was published by 
Chang and colleagues (Y. J. Chen et al., 2007). It was proposed that the conformation of 
the apo-state did not support known biochemical data. In addition, the helix packing in 
the non-native state could not be compared to the EmrE substrate bound-state crystal 
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structure (Y. J. Chen et al., 2007). It was believed that the structure of the apo-state was a 
non-native conformation that was stabilized by crystal contacts.  
The EM model of the apo-state of EmrE (Tate et al., 2001) provided a glimpse 
towards assessing the helix packing and tertiary structure. Both the EM model and the 
substrate bound-state crystal structure of EmrE have shown that EmrE is a dimer with an 
antiparallel orientation of the two monomers. The low resolution of the two models made 
it difficult to precisely identify the residues for each of the transmembrane segments. In 
addition, conformational changes in the transmembrane segments were not investigated.  
The work described in this PhD dissertation explores the two conformational states of the 
SMR transporter in the apo-state and the substrate bound-state. It investigates the packing 
of the two monomers of EmrE in the dimer which will explain the EmrE topology at 
physiological pH. Two different environments were used to evaluate the EmrE structure 
of the substrate bound-state, detergent micelles and liposomes. 
The main biophysical techniques used to investigate the structure and 
conformational changes are based on electron paramagnetic resonance spectroscopy 
(EPR) combined with site-directed spin labelling (SDSL). These combined methods have 
emerged as a powerful tool to investigate protein structure and dynamics, allowing 
resolution at a level of the backbone fold (Hubbell and Altenbach 1994). Additional 
structural information will be expressed in terms of the accessibility parameter (Π) 
(Altenbach, Froncisz, Hemker, McHaourab, & Hubbell, 2005) that will provide 
information on protein secondary structure, the tilt of the membrane protein, and position 
of the protein at the membrane interface (Hubbell, Gross, Langen, & Lietzow, 1998). 
Furthermore, pulse EPR methods will be used to investigate distances in the range of 20-
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60 Å giving another dimension to the structural analysis of EmrE. All the above 
techniques will be used to obtain high resolution structural analysis that enables 
identification of the arrangements between the two monomers of EmrE.  
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CHAPTER  II 
 
 
ELECTRON PARAMAGNETIC RESONANCE SPECTROSCOPY 
 
 
Theory of Electron Paramagnetic Resonance 
Zeeman and Hyperfine Interactions 
 The science of electron paramagnetic resonance (EPR) spectroscopy deals with 
the interaction between unpaired electrons and an external magnetic field. The unpaired 
electron has an intrinsic magnetic moment, thus any rotating particle would have a vector 
known as angular momentum. In quantum mechanics, angular momentum is quantized so 
that the allowed magnitude is given by: 
 ( )( ) h211+JJ         (1) 
where J is the primary angular-momentum quantum number (J =0, 1, 2, 3, …..), π2
h=h  
which equal approximately 1.054 x 10-34 Js, (h is the Planck’s constant). The magnitude 
of angular momentum along any selected direction is given by the secondary angular 
momentum quantum number MJ, that takes values of 
( )JJJJM J ,1,,1,.....0,...1, −+−−= .   
The angular momentum of an unpaired electron is known as the spin angular 
momentum. For a single unpaired electron has a spin of ½, the primary spin angular 
momentum quantum number is S= ½ that corresponds to the doublet state (2S+1) since 
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unpaired electrons can have two states. These two states are the secondary spin quantum 
number, Ms that can either be ½ or -½. For two unpaired electrons, the primary spin 
angular momentum quantum number can either be S= 0 for a singlet state, or S= 1 for a 
triplet state.  In contrast, a nucleus such as 14N has a primary spin angular momentum 
quantum number I= 1, and a secondary spin quantum number MI (MI = -1, 0, +1). 
In quantum mechanics, both the magnetic moment and the spin angular 
momentum are proportional to one another for particles that have non-zero magnetic 
moments: 
         S
gS h
βγμ ±==            (2) 
γ, is the magnetogyric ratio converting angular momentum to magnetic moment, g is the 
Zeeman factor for the particles considered, β is the Bohr magneton (constant for a 
specific particle), and ± reflects whether the direction of both spin angular momentum 
and magnetic moment are parallel or anti-parallel. For an electron, γ is negative, while for 
nuclei it is positive.  
These particles having different states with different secondary spin quantum 
numbers would have the same energy level if the external field is not imposed. When the 
external field is imposed, the energy of the magnetic dipole, including unpaired electrons 
is given by: 
HE ˆμ−=                                  (3) 
Ĥ is the direction of the magnetic field. For an unpaired electron, the two values of 
sM are ½ and -½. Then the two allowed spin states have the energy: 
          
HgE ee ˆ2
1 β±=                                 (4) 
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This is referred to as the electronic Zeeman energy. The energy difference between the 
two electronic Zeeman levels is geβeĤ. The transition between these two energy levels 
can be induced by an electromagnetic field of appropriate frequency υ such that the 
photon energy hυ matches the energy separation (ΔE) that is described by the resonance 
equation: 
 HghvE ee ˆβ==Δ         (5) 
 If the interaction of the unpaired electron with the external applied magnetic field 
were the only effect, then all EPR spectra would consist of one line. However, in EPR the 
interaction between the unpaired electron and neighboring nuclear dipole moments, result 
in the splitting of the resonance. This interaction is known as the nuclear hyperfine 
interaction.  
 In a nitroxide spin label, the unpaired electron (S=½) interacts with the nitrogen 
14N nucleus (I=1) forming six spin states with different energy levels for nitroxid (Figure 
1). Due to the selection rule of spin transitions ΔMs = ±1 and ΔMI = 0 for EPR 
absorption, there are three allowed transitions (Figure 1). In a field-sweep experiment at 
constant frequency, the resonance condition must be modified as: 
AMHghvE Iee +==Δ ˆβ        (6) 
where MI is the secondary spin quantum number of nitrogen having values of (+1, 0, -1) 
and A is the hyperfine interaction. 
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Figure 1: Energy levels due to Zeeman and hyperfine interactions. Energy levels and allowed 
EPR transitions shown in vertical blue arrows between different spin states. Ms is the secondary 
spin quantum number of the unpaired electron, and MI is the secondary spin quantum number of 
nitrogen nucleus.  
 
 
 There are two important mechanisms that give rise to the hyperfine interaction; 
they are either isotropic (orientation independent) or anisotropic (dependent on the 
orientation of the magnetic field with respect to a molecular axis) interaction. The 
isotropic hyperfine Hamiltonian interaction is defined by: 
ISAISggH nneeiso ˆˆˆˆ)0(3
2ˆ
0
20 =Ψ⎟⎠
⎞⎜⎝
⎛= ββμ     (7) 
where )0(Ψ  is the wavefunction value of the unpaired electron at the position of the 
nucleus. 0A  is the isotropic hyperfine coupling constant that can be expressed in 
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magnetic field units and identified as the hyperfine splitting (
eeg
A
a β
0
0 = ). Ŝ and Î are the 
spin angular momentum of the electron and nucleus, respectively. 
 For the anisotropic hyperfine Hamiltonian, the interaction is expressed with 
respect to the dipolar interaction between the nucleus and the electron separated by a 
distance r: 
⎥⎥⎦
⎤
⎢⎢⎣
⎡
⎟⎟⎠
⎞
⎜⎜⎝
⎛−⎟⎠
⎞⎜⎝
⎛−= 530
ˆˆ3ˆˆ
4
ˆ
r
rIrS
r
ISggH nneedipolar ββπ
μ
     (8) 
Since the unpaired electron is in the pπ orbital of the nitroxide bond, the dependence of 
the dipolar Hamiltonian on the orientation is obtained by averaging over the electron 
spatial distribution. Both isotropic and anisotropic hyperfine terms can be combined and 
described as a tensor (A) having principle 3 x 3 unit matrix, corresponding to the 
principle axis of the nitroxide spin label (Figure 2).  
 
 
 
 
 
 
 
 
 
 
Figure 2: The principle axes of the nitroxide spin label. 
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In addition to the A tensor, the g factor is also orientation dependent (anisotropy). 
Therefore, the coupling between the electron-spin angular momentum and orbital angular 
momentum corresponds to the anisotropy of the g factor. The g tensor in the lab frame 
can be expressed as a 3 x 3 matrix: 
 
gzz
gyy
gxx
g
00
00
00
=          (9) 
 
 The above matrix corresponds to a rotation of the axes known as the principle axes. gxx 
and gyy are perpendicular to the symmetry axis Z, while gzz, is parallel to the Z axis. Both 
the g tensor and the A tensor can be calculated by the random orientation of the nitroxide 
spin label in an external magnetic field: 
 
)(cos)(sin)(sin)(cos)(sin),( 22222 θϕθϕθϕθ zzyyxx gggg ++=   (10) 
)(cos)(sin)(sin)(cos)(sin),( 222222222 θϕθϕθϕθ zzyyxx AAAA ++=   (11) 
 
The complete spin Hamiltonian for the nitroxide spin label combines the A tensor, 
electron Zeeman and nuclear Zeeman terms. Therefore, 
IASIHgSHgH nnee ˆˆˆˆˆˆˆ +−= ββ       (12) 
where Ĥ is the external magnetic field, Ŝ and Î are the spin angular momentum of the 
electron and nitrogen nucleus, respectively. A is the hyperfine interaction tensor.  
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Overall, after approximation of the Hamiltonian and merging of orientation dependence 
of  the A and g tensors, the resonance of the anisotropic condition becomes:  
 
),(ˆ),( ϕθβϕθ AMHghvE I+==       (13) 
 
Spin Relaxation 
 The difference in spin populations between the upper ( sM = ½ ) and lower ( sM =-
½) energy states allows us to detect the resonance absorption that defines the intensity of 
the EPR signal. The ratio of the two populations is determined by the Boltzman 
distribution: 
KT
E
e
N
N Δ−
−
=
2
1
2
1
         (14) 
Where 
2
1N  and 
2
1−N  are the spin populations of the two states, 
2
1
2
1 −−=Δ EEE ; K is 
the Boltzman distribution constant; T is the absolute temperature at thermal equilibrium.  
 A change in the magnetic field (H) or in temperature shifts the spin system from 
thermal equilibrium. The Boltzman equilibrium can be restored by an efficient relaxation 
pathway. The relaxation pathway can be measured by T1, spin-lattice relaxation time 
(longitudinal relaxation time) or by T2, spin-relaxation time (transverse relaxation time). 
The relaxation results from the random fluctuation of local magnetic field experienced by 
the spin. In quantum mechanics these two relaxation times can be calculated by the 
perturbation method. Alternatively, they can be measured experimentally.  
 The dynamics of the total spin magnetization vector can be described by the 
Bloch equations. This model gives a clear picture regarding the dynamics of the spin 
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systems. In an external magnetic field, Ĥo, along the z axis, the bulk magnetization M is 
in the x-y plane. Therefore, when the oscillating electromagnetic field, 1Hˆ  
( )cos(11 wtHH x = , )sin(11 wtHH y = , 01 =zH ) is imposed in a direction perpendicular 
to the static magnetic field Ĥo (along z-axis), the Bloch equations are: 
( )
2
10 )cos( T
M
wtHMMH
t
M x
zye
x −−=∂
∂ γ      (15) 
( )
2
01 )sin( T
M
MHwtHM
t
M y
xze
y −−=∂
∂ γ      (16) 
( ) ( )
1
11
0
)cos()sin(
T
MM
wtHMwtHM
t
M zz
zze
z −+−=∂
∂ γ    (17) 
The steady state solutions of the Bloch equations in the rotation frame are:- 
 
( )( )212122220
2
201
)(1
)(0
TTHTww
TwwHM
M
e
ez
x γ
γ
+−+
−−=       (18) 
 
( )( )212122220
2
21
)(1
0
TTHTww
THM
M
e
ez
y γ
γ
+−+=       (19) 
 
( )( )212122220
2
2
2
0
)(1
)(10
TTHTww
TwwM
M
e
z
z γ+−+
−+=       (20) 
 
where ωo is the larmor frequency of the spin. The actual spectrum is determined by the 
average power absorbed per cycle. Therefore, under field-sweep conditions, the 
absorption line of the My component is a Lorentzian function with half width at half 
height given by Γ= 
2
1
Teγ  (1+ γe
2H12T1T2)½. The peak-to-peak width of the first derivative 
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equation is Γ
3
2
 
. In non-saturation conditions where γe2H12T1T2 <<1, the EPR central 
linwidth ( ppHΔ ) is approximately
23
2
Teγ
.  
 
Spin-Spin Interactions 
The basis of spin-spin interaction is the overlap of the orbital (electron exchange 
interaction) of the unpaired electrons and the dipolar interaction between the magnetic 
moment of the two spin labels.  
In a two spin system, two magnetic moments can be constructed in two equivalent 
ways, an uncoupled representation (S1 and S2) and coupled representation (S). For two 
unpaired electrons there are four spin states. If the two unpaired electrons interact 
considerably, such that the electron orbital overlap, forming a bond or quickly collide 
with each other, the system separate in energy into triplet (S=1) and singlet (S=0) state 
(Hustedt & Beth, 1999). The interaction between the two unpaired electrons is known as 
the exchange-energy, J. This operator is represented by the spin Hamiltonian: 
 
(Ĥ exch)iso = Jo Ŝ1. Ŝ2            (21) 
 
In practice, only the isotropic part of Jo is considered important. The isotropic electron-
exchange coupling constant Jo is the analog of the isotropic hyperfine coupling parameter 
Ao.  
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 In addition to the exchange interaction, there exists an anisotropic hyperfine 
dipolar interaction between two electronic magnetic dipoles. The magnetic dipole-dipole 
interaction is given by the Hamiltonian: 
 
 
( )( )
215
21
3
212
21
0 ˆˆ
ˆˆ3ˆˆ
4
ˆ SDS
r
rSrS
r
SSggH
ess
=
⎥⎥⎦
⎤
⎢⎢⎣
⎡
⎟⎟⎠
⎞
⎜⎜⎝
⎛ ′−⎟⎠
⎞⎜⎝
⎛= βπ
μ
    (22) 
ŕ is the interspin vector, r is the scalar length of the ŕ vector, g1 and g2 are the tensor 
defining the zeeman interaction for spin 1 and spin 2, respectively; Ŝ1 and Ŝ2 are the spin 
angular momenta for spin 1 and spin 2, and D is the dipolar coupling tensor. As the g and 
A tensor, a 3x3 matrix D can be diagonalized. The inter-electron distance is larger than 
the size of the moleuclar orbital of the unpaired electron on the nitroxide, the D tensor is 
axially symmetric and the principle z-axis of the diagonalized D tensor aligns with the 
inter-electron vector (Hustedt & Beth, 1999). The dipolar interaction is 1/r3 dependent, 
therefore, when the distance between the two nitroxde decreases, the dipolar interaction 
increases, and vice versa. Overall, the distance measurement is dependent on the spin-
spin interaction.  
 
Pulse EPR 
Magnetization in the Lab Frame 
 The lab frame in EPR is defined by the magnetic field Bo and is parallel to the z 
axis, the microwave magnetic field, B1, is parallel to the x axis and the y axis is 
orthogonal to the x and z axes.  
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 When an electron spin is placed in a magnetic field, a torque is exerted on the 
electron spin, causing the magnetic moment to precess about the magnetic field Bo. The 
angular frequency of the precession is commonly called the larmor frequency (ωL), and it 
is related to the magnetic field by 
 
0BL γω −=          (23) 
 
When considering a large number of electron spins, the electrons are characterized by 
two quantum mechanical states, Ms= ± ½, one with its magnetic moment parallel to Bo 
and one antiparallel. The parallel state has lower energy and at thermal equilibrium, there 
is an excess of electron spins in the parallel state (Ms=-½) according to Boltzman 
distribution. Therefore, there should be a net magnetization parallel to the z axis. The 
electron spins are still precessing about the z axis, however, their orientations are random 
in the x-y plane. For a very large number of electron spins, the various transverse (i.e. in 
the x-y plane) components of the magnetic moments cancel each other out. The result is a 
stationary magnetization, 0M  parallel to 0B  (Figure 3). 
 
 
 
 
 
 
Figure 3: The Larmor precession and the resultant stationary magnetization 
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Magnetization in the Rotating Frame 
 EPR experiments are usually performed with a resonator using linearly polarized 
microwaves. The microwave resonator is designed to produce a microwave magnetic 
field, B1, perpendicular to the applied magnetic field, Bo. In most cases |B1| << |Bo|. At 
resonance, ωL= ωo, where ωo is the microwave frequency. By rotating the coordinate 
system at an angular frequency ωo, B1 appears to be stationary and parallel to the x axis 
and the Larmor precession around the z axis is absent. Therefore, Bo disappears in the 
rotating frame while M rotates about the x axis following the right hand rule at a 
frequency 11 Bγω −= , where 1ω is the Rabi Frequency.  
 
 
 
 
 
 
 
Figure 4: The tip angel of bulk magnetization in the rotating frame. 
 
The angle by which M rotates in the yz plane is called the tip angle, ptB1γα −= . The tip 
angle depends on both the magnitude of B1 and the length of the pulse (tp) that is in the 
range of several nanoseconds. In continous wave EPR (CW-EPR), tp→∞, B1 has the 
constant amplitude with time. B1 drives the spins back and forth between Ms= ±1/2. In 
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pulse EPR, pulses are often labeled by their tip angles as π/2 pulse and π pulse (i.e. 90 
and 180 degrees). 
 
Application of EPR Spectroscopy 
Spin Labeling  
 Site-directed spin labeling (SDSL) has become a powerful tool in structural 
biology, combining both molecular biology with EPR spectroscopy (Altenbach, Marti, 
Khorana, & Hubbell, 1990). The basic strategy of SDSL is mutating all native cysteines 
(non-disulfide bonds) to an alanine or a serine followed by replacing the native residue 
(or residues) of interest with a cysteine. The cysteine residues in the protein of interest 
can be subsequently modified with a variety of sulfhydryl-specific nitroxide spin labels, 
such as proxyl-iodo acetamide (IAP) and proxyl-maleimide (MSL). The most currently 
utilized spin label is proxyl-methanethiosulfonate (unsaturated methane thio sulfonate) 
spin label (MTSSL) (Berliner, Grunwald, Hankovszky, & Hideg, 1982). The pyrroline 
derivative of MTSSL contains four methyl groups to protect the unpaired electron in the 
pπ orbital of the nitroxide from reducing agents (Figure 2), such as ascorbic acid. 
Therefore, the unsaturated methanethiosulfonate spin label (MTSSL) is the most 
commercially available spin label that generates a disulfide-linker nitroxide side chain, 
designated as R1. The R1 side chain is comparable to a tryptophan in molecular in size. 
In addition, they have a negligible influence on biological activity of a protein structure 
and function, especially for sites located on the surface of the protein (Bolin, Hanson, 
Wright, & Millhauser, 1998; McHaourab, Lietzow, Hideg, & Hubbell, 1996). For buried 
sites, the labeling efficiency decreases but in most cases they can accommodate the spin 
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label and restore packing of the protein core. In some cases spin labeling may affect the 
function of the protein but not the protein folding. Generally, protein structure is less 
affected than protein function by spin labeling as long as the cysteine mutation does not 
affect protein folding. If the protein is denatured or aggregated a unique EPR line shape 
would be observed. Thus, the shape of the EPR spectrum is an indication of the protein’s 
native folding.  
 
Mobility 
 The continuous wave (CW) EPR lineshape of the nitroxide side chain is sensitive 
to the local environment in the nanosecond time scale. The nitroxide dynamics is 
reflected by anisotropy of its motion and distribution of the motional states. Thus, the 
motion of the spin label attached to a protein is mainly manifested by the rotation 
correlation time, τ. τ is a measure of the average lifetime of a particular spatial orientation 
of the nitrogen p-orbital and 1/τ is a measure of the rate of motion (Columbus & Hubbell, 
2002). Consequently, the rotational motions that change the spin label orientation 
modulate the EPR line shape. Overall, the effect of rotational motion on CW-EPR line 
shape is illustrated in Figure 5.   The effect of fast rotation (τ= 0.01ns) causes the CW-
EPR spectral line shape to exhibit three sharp lines, while the central line position and the 
hyperfine splitting is determined by the relative orientation of the external static magnetic 
field. Therefore, when the rotation correlation time increases, the rate of motion 
decreases, thus, the central line and the overall spectrum are broadened. For the spectrum 
of a crystalline powder at the slow motion limit (τ =∞), each of the three lines experience 
extreme anisotropic motion. 
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Figure 5: The effects of rotational motion of a nitroxide spin label on CW-EPR line shape. 
  
 
When R1 is bound to a specific site on the protein backbone (Figure 6), the 
motion of the nitroxide ring will have a contribution from the rotational diffusion of the 
protein, the local backbone fluctuation and internal dynamic modes of the side chain. 
Experimental conditions have been used so that the contribution of protein rotation and 
tumbling can be reduced by increasing the viscosity of the solution (McHaourab et al., 
1996). Under these conditions, the side chain mobility relative to the protein at room 
temperature is not affected. As a result, the χ4/χ5 model of R1 (Figure 6) on a helix, with 
no contact with nearby side chains, has been proposed according to crystallographic data, 
chemical modification of the R1 side chain, and fitting of the spectra to models for side 
chain motion (Columbus, Kalai, Jeko, Hideg, & Hubbell, 2001; Langen, Oh, Cascio, & 
Hubbell, 2000; McHaourab et al., 1996).  
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Figure 6: When a protein is labeled with MTSSL. The nitroxide moiety is tethered to the 
backbone via a side chain referred to as R1. The dihedral angles X1-X5 are shown. The Cα and 
Cβ are on the cysteine residue with the Cα position in the backbone (Borbat, McHaourab, & 
Freed, 2002). 
 
 
In this model, the internal anisotropic motion is largely limited to torsional oscillations 
about the dihedral angles X4 and X5 since the Sδ sulfur atom forms a non covalent 
hydrogen bond with the Cα hydrogen atom in the protein backbone (Langen et al., 2000). 
The overall motion of the nitroxide remains strongly coupled to the motions of the 
backbone. Despite the complicated nature of the nitroxide dynamics, which is reflected 
by the anisotropy of the nitrogen p orbital motion and distribution of the motional states, 
EPR lineshapes have been analyzed using semiquantitative methods. The first is the 
inverse central line width of the central resonance line ( 10
−ΔH ). Plotting this parameter as 
a function of residue number reveals secondary structure, since the periodicity of the spin 
label mobility refers to a sequence of surface, contact or buried sites (McHaourab et al., 
1996; Perozo, Kloda, Cortes, & Martinac, 2001; Pfeiffer, Rink, Gerwert, Oesterhelt, & 
Steinhoff, 1999). Second, is the separation between the outer hyperfine extrema ( parA2 ) 
which can also be taken as a measure of label mobility (Figure 7). 
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Figure 7: Spin label mobility revealed by EPR spectral line shape. On the left, motionally 
restricted spin label of buried side chain of a helix.On the right is an exposed side chain of the 
same helix. The separation between the outer hyperfine extrema (2Apar) and the peak-to-peak 
separation of the central line width (ΔHo) provides a measure of label mobility (Czogalla, Pieciul, 
Jezierski, & Sikorski, 2007). 
 
The second moment provides a measure of the overall breadth of the spectrum 
(Columbus & Hubbell, 2002; McHaourab et al., 1996). The reciprocal plot of 
12 −H versus reciprocal central line width 10
−ΔH is roughly linear and has been found to 
group side chains into defined types based on the plot from T4 lysozyme crystal structure 
(Figure 8).  
The mobility increases in the order from buried sites, tertiary contact sites, and helix 
surface sites to loop sites, respectively. Some buried sites have low mobility that is 
consistent with sites located in a densely packed interior reflected by highly ordered R1 
motion, while the loop sites are all located in a highly mobile region. The overlap 
between tertiary interaction sites, buried sites, and helix surface sites may be affected by 
the backbone dynamics superimposed on the effect of tertiary interactions. Mobility can 
also serve as a sensitive monitor of conformational changes in helices (Columbus & 
Hubbell, 2004), β-structure (Jayasinghe & Langen, 2004; Kusnetzow, Altenbach, & 
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Hubbell, 2006), and in the folding process (Cobb, Sonnichsen, McHaourab, & Surewicz, 
2007; Koteiche & McHaourab, 1999; Morin et al., 2006).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Mobility map. A mobility map constructed as a plot of the inverse second moment of 
the EPR spectrum (<H2>-1) versus inverse central line width (ΔHo-1), indicating the correlation 
between the measured parameters and regions of protein topology for selected R1 side chain 
positions in T4 lysozyme. Regions of buried sites, tertiary contact, helix surface, and loops are 
represented in yellow, green, red, and pink circles, respectively (McHaourab et al., 1996). 
 
  
A quantitative understanding of the motions that generate a given line shape is 
accomplished by simulation of EPR spectra. The simulation will help to get a precise 
view of dynamics of the analyzed system (Barnes, Liang, McHaourab, Freed, & Hubbell, 
1999; Borbat, Costa-Filho, Earle, Moscicki, & Freed, 2001; Livshits, Kurad, & Marsh, 
2006). In addition, molecular dynamics EPR spectral simulation facilitates the study that 
influence the structure adjacent to the spin sites on the spectral lineshape (Steinhoff et al., 
2000). Spectral simulations help determine whether the lineshape corresponds to 
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isotropic or anisotropic motion and also can be used to detect multiple components of the 
spectra. 
 
Solvent Accessibility 
One of the most informative features of the protein structure is solvent 
accessibility of side chain R1 to paramagnetic reagents. Solvent accessibility is 
determined from collision frequency of the nitroxide with paramagnetic reagents such as 
oxygen and NiEDDA. The presence of a paramagnetic reagent provides an additional 
pathway for relaxation, which leads to a decrease of the spin lattice relaxation time T1. 
The change in T1 of the nitroxide can be characterized by the relative collision rate 
between the nitroxide and the paramagnetic exchange reagent R, known as the 
Heisenberg exchange, exW . The exchange reagent R that is used for measurement of 
solvent accessibility should have high water solubility, have limited accessibility to the 
interior of a well packed protein, should be electrically neutral, and should have similar 
size to the nitroxide itself. It is also important that the exchange between the nitroxide 
and R be in the strong exchange limit, where the rate is solely determined by the rate of 
diffusional encounter. 
 The interaction of the reagent with the nitroxide is only manifested by the 
Heisenberg exchange, with little contribution from distance dependent magnetic dipolar 
coupling. An interaction that occurs through space may provide an overestimation of 
solvent accessibility. This is insured for reagents with T1R < τc, where T1R is the 
longitudinal relaxation time for the reagent and τc is the encounter complex lifetime.  
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Both O2 and NiEDDA meet the above criteria as an exchange reagent for determining 
solvent accessibility.  
 For bimolecular encounter between a small nitroxide N and exchange reagents in 
solution, the Heisenberg exchange frequency, exW , experienced by a particular nitroxide is 
given by: 
Rexex CkW =          (24) 
where exk is the exchange rate constant and CR is the concentration of R. In the strong 
exchange limit, where Heisenberg exchange is diffusion controlled,  
 ( ) cRNADRexex rDDNfPfKPCkW +⎟⎠
⎞⎜⎝
⎛===
1000
4maxmax π    (25) 
where maxP is the maximum exchange efficiency (Pmax=1,  when the strong exchange limit 
and cRT τ<1  are satisfied). The steric factor, KD, is the diffusion-controlled rate constant, 
and ND and RD are diffusion constants for the nitroxide and the reagent, respectively. 
The collision radius, cr , is RN rr + , where Nr and Rr are effective radii of the nitroxide and 
reagent, respectively. For a nitroxide bound to a protein the translational diffusion 
becomes that of the protein, and thus RRN DDD ≈+ . However, the nitroxide retains 
rotational freedom about the bonds of the tether. R and the nitroxide are still viewed as a 
colliding species, rather than R and the spin labeled protein, the definition of collision 
radius, cr , is retained. The local protein environment and interaction of the nitroxide with 
the protein are reduced by the number of effective collisions below those characteristics 
of the nitroxide in solution, and all such effects are collectively accounted for by a factor 
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ρ  (accessibility factor). Thus, for a protein associated nitroxide, PexW  in the strong 
exchange limit is 
 RCRA
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for a small, electrically neutral but polar exchange reagent, ρ varies from zero for a 
nitroxide buried in the protein to a limiting value of infinity for a nitroxide at a 
completely exposed site on the protein surface. 
For exchange reagents with cRT τ<1 , eT1  Heisenberg exchange leads to equal changes in 
eT1 and eT2 of the nitroxide 
 Rex
ee
ex CkTT
W =⎟⎟⎠
⎞
⎜⎜⎝
⎛Δ=⎟⎟⎠
⎞
⎜⎜⎝
⎛Δ=
21
11       (28) 
Measurements of either eT2 or eT1 can be employed for experimental determination of 
exW . Methods based on eT2 rely on the fact that Heisenberg exchange leads to Lorentzian 
line broadening. The broadening can be determined as the width at half height of the 
Lorentzian line (
2
1HΔ ) that, when convoluted with the spectrum in the absence of 
collision, yields the interacting spectrum. Alternatively, the broadening can be directly 
measured as the increase in peak-to-peak central line width of the first derivative EPR 
spectrum ( PPHΔΔ ) under non saturated condition 
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In CW saturation EPR, the amplitude (A) of the first derivative central resonance (MI= 0) 
line is measured as a function of microwave power (P) 
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eγ  is the gyromagnetic ratio of the electron ( h
ββπγ g
h
g
e == 2 ),ε  is the line shape 
adjustment parameter (ranging from ε = 1.5 for the homogenous saturation limit to ε = 
0.5 for a completely inhomogeneous saturation limit), Λ  is an instrumental factor, I is the 
scaling factor, and 
2
1P is the half saturation power, where the incident microwave power 
where the first derivative amplitude is reduced to half of its unsaturated value. For the 
common case where
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For the purpose of normalization and to standardize measurements from different 
resonators, a dimensionless accessibility parameter Π is defined as 
ex
DPPH
DPPH
PP
W
H
P
H
P
PP
α=
⎟⎟
⎟
⎠
⎞
⎜⎜
⎜
⎝
⎛
Δ
⎟⎟⎠
⎞
⎜⎜⎝
⎛
Δ
Δ
=Π
2
1
2
1
        (36) 
DPPH (Diphenylpicryhydrazide) is selected as the reference to normalize for variations 
in resonance frequency (Altenbach et al., 2005).  
 The protein environment has a local effect on the collision rate of the nitroxide 
side chain and the exchange reagent. In turn, the accessibility of a spin labeled site is 
highly sensitive to the local environment. Therefore, one can determine secondary 
structure of a protein along the polypeptide chain revealing an α helical or a β sheet fold 
with an accessibility Π pattern that is likely to show an approximate periodicity of 3.6 
and 2, respectively.  
 Solvent accessibility is a powerful tool for probing the secondary, tertiary, and 
protein folding such as water soluble α-crystallin (Berengian, Bova, & McHaourab, 
1997; McHaourab, Berengian, & Koteiche, 1997), prokaryotic voltage-dependent K+ 
channel (KvAP) (Cuello, Cortes, & Perozo, 2004), and also conformational changes in 
dynamics processes such as Bacterial rhodopsin (Thorgeirsson et al., 1997), multidrug 
transporter MsbA (Dong, Yang, & McHaourab, 2005), and mechanosensitive channel, 
MscS (Vasquez, Sotomayor, Cordero-Morales, Schulten, & Perozo, 2008; Vasquez, 
Sotomayor, Cortes et al., 2008). 
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Spin-Spin Distance 
 When a pair of nitroxides is introduced at selected sites on a protein the magnetic 
dipole interactions between them can be analyzed using EPR spectroscopy, to measure 
the distance distribution between the two spin labeled sites. The spin Hamiltonian of two 
interacting nitroxide spin labels is given by: 
 
( ) 212122211121220110 ˆˆˆˆˆˆˆˆˆˆˆ SSJSDSSAISAIIISgHSgHH eezznee +++++−+= γγωββ    (37) 
 
The two nitroxides are labeled as 1 and 2, where eβ is the Bohr magneton, g1 and g2 are 
the zeeman tensors defining the interaction of the electron spin of nitroxide 1 (Ŝ1) and 
nitroxide 2 (Ŝ2) with the magnetic field Ho, ωn is the Larmor frequency of the nitrogen 
nucleus, A1 and A2 are the hyperfine tensors defining the interaction of the nitrogen 
nuclear spins (Î1 or Î2) with Ŝ1 or Ŝ2, D is dipolar coupling tensor, and J is the scalar 
exchange interaction between electron spins. In this Hamiltonian, the unpaired electron 
density is highly localized to the N-O bond of the nitroxide. The principal axes of the g 
and A tensors of a spin label are essentially coincident and are well defined within the 
molecular frame of the nitroxide. Given that the inter-electron distance to be  observed is 
normally considerably larger than the size of the molecular orbital of the unpaired 
electron on the nitroxide, the D tensor is axially symmetric, with the principal z-axis of 
the diagonalized D-tensor aligned with the inter-electron vector; term in D  are 
proportional to 1/ R3, where R is the inter-electron distance. Significant J coupling can 
only arise for inter-nitroxide distances less than 10 Å.  
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These distances or distance distributions can be used to build structural models of 
a protein as well as structural changes related to protein function. To obtain the distance 
distribution between two nitroxide is a complicated task. It is crucial to determine the 
global motion of the protein and the local motion of the nitroxides since CW-EPR spectra 
are strongly dependent on the relative orientation and distribution of the two probes. 
Therefore, three cases have been addressed to deal with distance measurement between 
nitroxide spin labels (Hustedt & Beth, 1999). 
The first case deals with statically arranged spins. The distance between the two 
nitroxides and its orientation adopts a fixed, static value and the protein has a global 
rotational correlation time of ≥ 1μs. The inter-nitroxide distance, R, and all five angles (ξ, 
and η for one nitroxide, and α, β, and γ for the second nitroxide) define the steric 
geometry of the two probes. For a given set of 6 variables directly calculating from the 
Hamiltonian in equation 37 of two interacting spins can generate the EPR spectrum.  
Research that falls into this case are the extensive tertiary interaction of the 
nitroxide R1 side chain (McHaourab, Kalai, Hideg, & Hubbell, 1999), and the binding of 
substrate with high affinity to a large protein complex (Beth et al., 1984).  
 The second case deals with statically disordered spins. The two nitroxides adopt a 
static distribution of orientations with respect to one another. Both the local rotational 
motion of the nitroxides and the global rotation occur on a time scale ≥ 1μs. The number 
of applications that fall in this case is limited. However, by slowing the dynamics of side 
chain motion and the global tumbling by carrying out studies at low temperature or in 
viscous media, large applications that fall under case 3 will meet the requirements of case 
2. An example is the situation of a protein < 20 kDa in size and has a small rotation 
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correlation time (Hubbell, McHaourab, Altenbach, & Lietzow, 1996; McHaourab et al., 
1996). The rotational modulation of the dipolar interaction and the homogenous line 
broadening is given as: 
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where τ is the rotation correlation time of the inner spin vector; r is the inter-spin 
distance, υ is the frequency of the external magnetic field (microwave). In the frozen 
state, the two nitroxides are separated by the distance r and the sum of individual 
crystallites is disordered with certain distribution, known as Pake pattern. The EPR 
absorption lines are then split by B2 in the magnetic field eegB β5.12 =Δ  (Pake, 1948). 
Therefore, the dipolar coupled line shape can be described by the convolution of two 
non-interacting nitroxides with a Pake broadening function of the nitroxide side chain and 
the change in conformation of the protein: 
BdBBMBSBMBSB ′−′′=⊗=Π ∫∞
∞−
)()()()()(     (39) 
where )(BΠ  is the spectrum of double-labeled protein, )(BS is the average spectra of the 
two single labeled proteins (non-interacting). )(BM  is the weighed average broadening 
function with respect to distance r between the two nitroxides. By applying Fourier 
transformation on both sides of equation (39) and the convolution theorem one obtains 
)(BM  . Knowing )(BΠ  and )(BS , we get:  
)()()( wMwSw ∗∗∗ =Π        (40) 
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where )(w∗  represents the Fourier transformation of the corresponding function, 
therefore: 
dw
wS
wwBiBM ∫∞
∞−
∗
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)()2exp(
2
1)( ππ      (41) 
Thus, the average splitting B2  and average distance r  are: 
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The convolution-deconvolution method involves the estimation of inter-spin 
nitroxide distance for either a solid, at RT, or a frozen solution. This approach neglects 
the effect of the g and A tensors. Also, the inter-electron vector with respect to the 
nitroxide is randomly and isotropically distributed over a sphere. This cannot be valid as 
the attachment of the nitroxide to the protein backbone leads to one or both nitroxides 
being restricted to a specific orientation relative to the inter-electron vector. In this case, 
the g tensor, hyperfine A tensor and dipolar coupling D tensor of the spin Hamiltonian are 
all determined by a set of angles (Hustedt et al., 2006).  
The third case is related to the effect of dynamics. Mchaourab et al. (McHaourab 
et al., 1997) developed a method, based on the fast motion relaxation theory (the motion 
completely averages the anisotropy of the g and hyperfine tensors), for analyzing line 
broadening due to nitroxide-nitroxide dipolar coupling in the intermediate to fast motion 
60 
 
range. This study was performed on a small globular protein, T4 Lysozyme, with an 
isotropic correlation time of 6 ns.  For double mutants where the inter-nitroxide distance 
could be estimated from the known crystal structure, the observed line broadening due to 
dipolar coupling was proportional to 1/R6 (because the relaxation effects will be 
proportional to the square of the dipolar coupling). As the distance increases the spectral 
broadening decreases faster than in the second case (1/ R3). Overall, in the fast motion, 
when the energy of interaction is much lower than the reorientation of the dipolar 
interaction of the two nitroxides, R1, the dipolar splitting is nearly averaged to zero. 
 To measure the inter-nitroxide distance of more than 25 Å, a time domain EPR 
method was developed to overcome the limit of distance measurement by CW-EPR 
arising from inhomogeneous broadening of the EPR line.  The two advantages of using 
time domain pulse EPR method are: 
1. To increase the distance ranging from 20-60 Å. 
2. To simplify the probelm since the dipolar interaction between the two nitroxide 
spin labels is observed without a dominant effect of the hyperfine and g-tensors.  
 
A number of pulse methods have been developed for measuring the distance from 
20-60 Å between two nitroxides in the frozen state. Among the techniques that have been 
used for biological samples are double electron-electron resonance (DEER) (Pannier, 
Veit, Godt, Jeschke, & Spiess, 2000) and double quantum coherence (DQC) (Borbat et 
al., 2002). In DQC, EPR utilizes a DQC pulse sequence to preserve the contribution to 
the double quantum echo signal solely from the dipolar interaction between the two spins. 
The intensity of the echo is recorded as a function of time and a Fourier transform of the 
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echo generates the dipolar coupled Pake pattern spectrum that is directly related to the 
distance between the two spin labeled sites (Borbat et al., 2001).  
The work in this thesis project was performed using a 4 pulse DEER (Pannier et al., 
2000). In DEER the system consists of two electron spins, SA and SB. The resonance 
microwave frequency of A is Aυ and the one containing resonance frequency Bυ  will be 
the B spin. The four pulse pattern experiment is shown in Figure 9.  
At time 0 ns, spin packet A is excited first with a 2π  pulse that tips the 
magnetization of spin A into the xy plane, where the spin packet precesses with angular 
rate of Aυ . The presence of field inhomogeneties due to unresolved dipolar couplings of 
nearby spins, results in slightly different angular rates and causes de-phasing of the spins. 
At time 1τ , a π pulse is applied to spin A causing the spins to flip the magnetization 180˚, 
resulting in refocusing spin A and leading to spin echo at 12τ . Spin A continues to 
precess in the xy plane but a second π  pulse is applied after an evolution time of 
( )212 2 τττ +  and leads to a refocusing of the A spin magnetization at time 21 22 ττ + after 
the last phase, with smaller amplitude as the phase coherence is lost due to spin-spin 
relaxation (π/2-π  pulse generates a Hahn echo).  
The dipolar interaction can be studied if an additional π  pulse applied at time 
( )t+22τ is applied to spin B, therefore flipping the B spins and thus reverses the dipolar 
contribution experienced by the A spins from ABυ21  to ABυ21− . As a result, spin A cannot 
be fully refocused due to the variable time of flipping the B spins. 
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Figure 9: Four-pulse DEER. A) A diagram shows the EPR pulse sequence for the 4-pulse 
DEER. Spin A is excited by the observing microwave pulse (green bar) and spin B is excited by 
the pumping microwave pulse (red bar). When spin B is close to spin A, spin A senses the excited 
spin B (π pulse at υB) and  inverts the local dipolar field of spin A, therefore, an electron spin 
echo at position A (dotted echo) is observed. When a second π pulse is applied that inverts spin 
B, a change is observed in the local magnetic field and refocusing at the A spins. At variable time 
t the pumping pulse of spin B is applied, the refocused echo intensity of spin A oscillates with a 
frequency ωAB (Banham et al., 2008). B) The diagram shows the excitation profiles of the 
microwave pulses in the DEER experiment. 
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It is important to realize that the 4 pulse DEER experiment is a constant time 
experiment, thus, the second π  pulse is applied to avoid distortion of the signal or dead 
time due to the overlap in a short time after the π/2 pulse.  
After the 21 22 ττ +  the echo intensity of spin A oscillates with: 
)cos(0 tII ABυ−=        (44) 
Io and I are the initial and final echo intensity of spin A that oscillates with )cos( tABυ− . 
Thus, the DEER signal is the echo intensity as the pumping π  pulse is swept between the 
two π pulses.  
 It is important to correctly choose the magnetic field for observing and pumping 
frequency in order to obtain the best DEER result. One of the important criteria is that the 
bandwidths of the observable and pump pulses must not overlap. Typically, the frequency 
difference between the observable and pump pulses must differ at least 70 MHz to avoid 
overlap, as shown in Figure 9.  
 In principal, to detect longer distances than 60-80 Å, one could extend the 
evolution period (i.e. time between the π pulses). The evolution period is restricted by the 
phase memory time (Tm) or the spin-spin relaxation time (T2) of the nitroxide labels. In 
practice, the time between the pulses is limited to 2 μsec for a protonated nitroxide. 
Therefore, the maximum distance measured by DEER is limited to 60-80 Å. One of the 
advantages of the DEER signal is the easy way to estimate the average distance from the 
oscillation of the refocused echo intensity containing the information regarding the 
dipolar interaction. Thus, the analysis of the inter-spin distance and distance distribution 
can be obtained either from the Pake pattern after Fourier transformation (as mentioned 
above) or from de-convolution method and the data fitting model. 
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 In summary, the use of SDSL EPR techniques has become a powerful tool not 
only to obtain the global structure but also functional dynamics of a protein. Proteins can 
also be studied in their native environment (i.e. in solution for water soluble proteins or 
reconstituted proteoliposomes for membrane proteins).  
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CHAPTER  III 
 
 
MATERIAL AND METHODS 
EmrE Gene Cloning and Site directed Mutagenesis 
The EmrE gene was kindly provided by Geoffrey Chang (Scripps Institute, La 
Jolla, CA) in pET15b+ expression vector (Novagen, California, USA). The gene was 
located in the multiple cloning sites between two restriction sites Nde I and BamH I, and 
a 6-histidine tag at the N-terminus of the cloned EmrE gene.  
The wild type EmrE has three native cysteine residues at position 39, 41, and 95 
that were replaced by alanine residues using the QuikChange Mutagenesis Kit 
(Stratagene, La Jolla, CA). The new construct was named (EmrE-CLA, or WT*). Single 
cysteine mutants were made for all 110 amino acids of EmrE using WT* as the 
background. All the mutants were confirmed by sequencing at the Vanderbilt DNA 
Sequencing Facility.  
 
Protein Expression 
The plasmids containing EmrE cysteine mutants were transformed into BL21 
Gold (DE3) E.coli competent cells (Stratagene, La Jolla, CA). EmrE mutants were over-
expressed in one liter minimal medium (1g ammonium sulfate, 4.5g potassium phosphate 
monobasic, 10.5 g potassium phosphate dibasic, 0.5 g sodium citrate). The medium was 
supplemented with 1 mM magnesium sulfate (autoclaved 45 minutes), 100 μg/ml 
ampicilin (filter sterilized), 2.5 μg/ml thiamine (filter sterilized), 0.5% glycerol (v/v, 
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autoclaved 45 minutes), and 1 ml amino acid mixture (Gibco-BRL, Maryland, USA). 
Briefly, 30 ml of overnight seed culture in LB medium was used to inoculate the minimal 
medium. Cells were grown at 37°C until A600 ~1.5 was reached. Protein expression was 
induced with 1mM IPTG and cells were grown at 28°C for 5 hours (for some mutants the 
expression temperature was lowered to 20°C overnight).  
 Cells were harvested by centrifugation at 3500 x g for 15 minutes. The cell pellets 
were resuspended in lysis buffer (10 mM Tris, 250 mM sucrose, 150 mM choline 
chloride, 2.5 mM MgSO4, 0.02% NaN3, pH 7.5) supplemented with 10 mM DTT, 45 μg  
DNAse, and 10 μM PMSF. The cells were sonicated and homogenized using 
EmulsiFlex-C5 (Avestin). The lysates were centrifuged at 9000 x g for 5 minutes to 
remove cell debris. The supernatants were centrifuged for 1 hour at 388,000 x g to pellet 
cell membranes. The membrane pellets were solubilized with 1.5% n-dodecyl-β-D-
maltopyranoside (β-DDM, Anatrace, Ohio, USA) in resuspension buffer (50 mM sodium 
phosphate monobasic, 300 mM sodium chloride, and 10 mM imidazole, pH 8). The 
insoluble components were removed by ultracentrifugation for 1 hour at 388,000 x g and 
the supernatant was used for EmrE purification.  
 Two steps were used to purify EmrE mutants.  First, the His-tagged EmrE was 
purified using Ni-NTA resin as described by the manufacturer (Qiagen, Valencia, CA). 
Purified mutants of EmrE were spin-labeled with a 20-fold molar excess of 1-oxyl-
2,2,5,5-tetramethyl-Δ3-pyrroline-3-methyl-methanethiosulfonate spin label (MTSSL; 
Toronto Research Chemicals, Ontario, Canada) and incubated at room temperature for 2 
hours followed by a second and a third addition of 10-fold molar excess of spin label 
every two hours. After 6 hours at room temperature, the samples were stored at 4°C on 
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ice overnight. Under labeled mutants were spin labeled with 0.5-fold molar excess of 
MTSSL and incubated at room temperature for 1.5 hours then added 20-fold molar 
excess of diamagnetic spin label (1-Acetyl-2,2,5,5-tetramethyl-Δ3-pyrroline-3-methyl) 
Methane thiosulfonate (Toronto Research Chemicals, Ontario, Canada) and stored 
overnight at 4 °C. Second, the samples were concentrated 3-fold and further purified by 
size-exclusion chromatography (SEC) employing a superdex-200 column (Amersham 
Biosciences, New Jersey, USA) in SEC buffer (50 mM sodium phosphate monobasic, 50 
mM NaCl, and 0.02% β-DDM, and 0.02% NaN3 pH 7.2). Protein concentration was 
determined by UV absorption at 280nm using an extinction coefficient of 29450 M-1cm-1. 
The two step purification was sufficient to achieve single band purity as is evident by 
SDS-PAGE (Figure 1).  
 
 
 
 
 
 
 
 
 
 
Figure 1: Purified EmrE. Left panel is the gel filtration profile of WT* (EmrE-CLA). The right 
panel is the SDS-PAGE gel of purified WT* protein stained with comassine blue. 
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Protein Reconstitution 
Asolectin (purchased from Avanti Polar Lipids, Alabama, USA) was dissolved in 
chloroform resulting in a final lipid concentration of 20 mg/ml. Traces of solvent were 
removed by a rotary evaporation and left in a desiccator overnight. The dried film of 
asolectin was hydrated in the reconstitution buffer (50 mM HEPES, 50 mM sodium 
chloride, 2 mM magnesium chloride, pH 7.5) to a final lipid concentration of 10 mg/ml. 
The hydrated lipid was vigorously vortexed and subjected to cycles of freeze (incubation 
in dry ice/ methanol bath) and thaw (incubate at 37°C) 5 times. Unilamellar asolectin 
liposomes were made by extruding asolectin through a 50 nm Nuclepore Track-Etched 
Membrane filter (Whatman) 10 times. The unilamellar liposomes were destabilized by 
2mM β-DDM and mixed with 0.3-0.5 mg labeled protein at 500 to 1000-fold molar 
excess of lipid over protein. The detergent concentration was adjusted to 1.3- 1.5 mM 
such that lipid: detergent ratio was ~4000. The mixture was incubated with gentle 
agitation at 4°C for 2 hours, and then was diluted to 10ml with reconstitution buffer. Bio-
Beads SM2 (Bio-Rad, California, USA) were added into the sample at the quantity of 80 
mg per milliliter initial mixture and incubated for two hours at 4°C with the addition of 
fresh Bio-Beads twice at a two hour intervals followed by overnight incubation at 4°C. 
The reconstituted proteoliposomes were collected by ultracentrifugation at 388,000 x g 
for 45 minutes at 4°C and the pellet was resuspended with reconstitution buffer. 
The proteoliposome protein concentration was determined with the DC protein 
assay kit (Bio-Rad, Buckaklian et al, 2003). Proteoliposomes were diluted to about 1 
μg/μl of protein in reconstitution buffer. Twenty-five microliters of diluted 
proteoliposomes were mixed with 125 μl working reagent A. One milliliter of reagent B 
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was added to each tube and vortexed immediately. The solution was incubated at room 
temperature for 15 minutes, and absorbance at 750 nm was measured. Bovine serum 
albumin (BSA) was used as the standard, and liposome without EmrE protein was used 
as control. The BSA standard curve is shown in Figure 2. 
 
 
 
 
 
 
 
 
 
 
Figure 2: Standard curve of the Bio-Rad DC protein assay. 
 
Continuous Wave (CW)-EPR Measurements 
X-band (9.8 GHz) CW-EPR spectra were collected using a Varian spectrometer 
equipped with a loop-gap resonator at room temperature. The samples were prepared at 
100 μM spin concentration, then drawn into a round capillary of size 0.6 I.D. X 0.84 O.D. 
(VitroCom, Mt Lks, NJ) and sealed with Cha-seal (Chase scientific). The magnetic field 
scan range was set to 100, 160, or 200 Gauss sweep width, and the incident microwave 
power was set at 2mW. All spectra contained 1024 data points collected at 100 kHz 
Zeeman field modulation frequency of 1.6 Gauss amplitude (peak-to-peak). The spectra 
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were collected with EWWin 4.21 EPRware (Scientific Software Services, Michigan, 
USA), and analyzed with the program HMEPR version 4 written by Richard Stein 
(Vanderbilt University).  
 
Solvent Accessibility 
For power saturation experiments, reconstituted spin labeled samples were loaded 
into a gas-permeable TPX capillary (Medical Advances, Wisconsin, USA), and data was 
collected using Bruker ELEXSYS spectrometer equipped with a dielectric resonator 
(BrukerBiospin, Billerica, MA). The field scan of the central resonance line for each 
mutant was carried out at 25 Gauss. The amplitude of the central resonance line was 
obtained with a microwave power of 1, 2, 3, 4, 10, 16, 25, 40, 63, 79.6, and 100 mW, 
respectively. The power saturation experimental data were collected and analyzed by 
non-linear curve-fitting using Origin 7.1 software (OriginLab Corporation, 
Massachusetts, USA) to obtain the spectral amplitude (A) versus the square root of the 
microwave power ( )P  according to the following equation (Altenbach et al., 2005): 
 
( ) εε
⎟⎟⎠
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⎛ −+
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P
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where A is the peak-to-peak amplitude of the central line; I and ε are adjustable 
parameters; P1/2 is the half-saturation power; and P is the power of the incident 
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electromagnetic wave. The NiEDDA and oxygen accessibility (Π) were calculated by the 
following equation: 
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where Π  is the accessibility, 
2
1PΔ   is the difference of the half saturation power in the 
presence and absence of paramagnetic reagents (50mM NiEDDA or 20% O2), LTP 4
2
1 is the 
T4L half saturation power in the absence of paramagnetic reagent (T4L was selected as a 
reference to normalize for variations in the resonance frequency) and ΔHo is the central 
line width. 
 
Distance Measurements 
Double electron-electron resonance (DEER) was used to measure long-range 
distances (25 Å -80 Å) between two nitroxide spin labeled residues. The experiments 
were performed on an X-band (9.5 GHz) Bruker E680 pulse EPR instrument (Bruker 
Spectrospin, Billerica, MA) using a 4 pulse sequence (Pannier et al., 2000). Spin labeled 
EmrE samples were concentrated to 200 μM and supplemented with 30% (v/v) glycerol. 
DEER measurements were carried out at 83°K using a 16 nanosecond 90° (π/2) pulse and 
a 32 nanosecond 180° (π) pulse and an 800 nanosecond shot repetition time (SRT) in an 
over-coupled dielectric resonator (ER4118X-MD5, Bruker Biospin, Billerica, MA). The 
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DEER signals was analyzed by Tikhonov regularization (Chiang, Borbat, & Freed, 2005) 
of the software DeerAnalysis 2008 to determine the average distances and distributions in 
distance, P(r).  
 
Fluorescence Binding 
The extent of binding of tetraphenylphosphonium (TPP+) was estimated by 
quenching of native intrinsic tryptophan (Trp) fluorescence emission (Elbaz et al., 2005). 
Tryptophan emission spectra were recorded at room temperature. Each spin labeled EmrE 
mutant diluted to 3 μM with SEC buffer (50 mM sodium phosphate monobasic, 50 mM 
NaCl, and 0.02% β-DDM, pH 7.2) without and with 2x and 4x molar excess of the 
substrate at 295 nm excitation and 310-350 nm emission using a quartz cuvette (1cm path 
length). The experiment was carried out on an L-format Photon Technology International 
Fluorometer. Maximum fluorescence intensity was obtained from the emission curves by 
in-house software (“LambdaMax” written by Marco Bortolus) and analyzed using Origin 
7.1 software (OriginLab Corporation, Massachusetts, USA) to obtain relative 
fluorescence with and without the substrate for each EmrE mutants. 
 
Subunit exchange 
Purified EmrE mutant and cysteine-less EmrE were concentrated 4 fold and 
mixed at a ratio of 1:2. The mixture was then injected into a desalting column (HiTrap, 
GE Healthcare) equilibrated with SEC buffer (50 mM sodium phosphate monobasic, 50 
mM NaCl, and 0.02% β-DDM, and 0.02% NaN3 pH 7.2) supplemented with 0.8 mole 
fraction of sodium dodecyl sulfate (SDS). The eluted mixture was incubated at room 
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temperature for 10 minutes. To refold the sample it was injected back onto a Superdex-
200 column equilibrated with SEC buffer (50 mM sodium phosphate monobasic, 50 mM 
NaCl, and 0.02% β-DDM, and 0.02% NaN3 pH 7.2). CW-EPR spectra of the sample with 
and without SDS were collected at room temperature. The magnetic field scan range was 
set to 160, 200, or 250 Gauss sweep width, and the incident microwave power was set at 
9 mW.  
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CHAPTER IV 
 
 
FUNCTIONAL CHARACTERISTICS OF EMRE 
 
 
Introduction 
The main goal of this thesis was to compare the structure of EmrE obtained via 
SDSL and EPR spectroscopy to the crystal structure and the EM model (Y. J. Chen et al., 
2007; Fleishman et al., 2006). Since the SDSL method involves mutating each residue of 
EmrE one at a time to cysteine it is important to measure the activity of each mutant to 
insure the mutations and the subsequent spin labeling have minimal effect. Thus, a 
second goal of the work presented in this chapter is to evaluate the functional 
consequence of the cysteine mutations and subsequent spin labeling.   
EmrE is part of the multi-drug transporter family that recognizes a broad range of 
substrates with high affinity and removes them from the cytoplasm. EmrE extrudes 
various drugs in exchange for protons, causing bacterial resistance to these compounds 
(Grinius & Goldberg, 1994; Paulsen et al., 1996). Therefore, both binding and 
translocation of the substrate are important functional characteristics of EmrE mutants.  
In vivo and in vitro assays are used to evaluate EmrE mutants. To assess in vivo 
transport activity, previous work has judged the ability of cells expressing mutant 
proteins to grow in the presence of toxic compounds (Mordoch, Granot, Lebendiker, & 
Schuldiner, 1999). It was shown that most sites can be replaced with cysteines without 
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serious impairment of function, with the exception of mutant sites that are located at 
positions 11, 14, 18, 60 and 63 that seem to be important for activity (Yerushalmi, 
Lebendiker, & Schuldiner, 1996). Therefore, the selective growth of cells containing 
EmrE that is resistant to a specific substrate gives a qualitative measurement of activity.  
Previous studies have also shown that out of the 8 charged residues of EmrE, only 
one acidic residue at position 14 when replaced with cysteine, causes complete loss of 
activity (Morimyo et al., 1992). This was supported and confirmed in other multidrug 
transporters (Edgar & Bibi, 1999; Paulsen et al., 1996), suggesting that the central role of 
the acidic residue in multidrug transporters is in recognizing positively charged substrates 
(Yerushalmi & Schuldiner, 2000b). 
In vivo activity is qualitative, since a mutant that is inactive may indicate a role 
for that site in the mechanism of translocation, but could also indicate a role in stability, 
folding, or decreasing the affinity for the substrate. An in vitro assay gives direct 
evidence with respect to substrate binding for each mutant of EmrE. 
The TPP+ dissociation constant for binding to wild-type EmrE in solution was 
determined to be (20 ± 15 nM), which was similar to EmrE-His (10 ± 3 nM) bound 
(Muth & Schuldiner, 2000). Therefore, the high affinity of TPP+ towards EmrE makes it 
a good substrate for analyzing activity of EmrE in vitro. Previous work on the binding 
sites of transcription factors (Godsey, Zheleznova Heldwein, & Brennan, 2002; Neyfakh, 
2002) has shown an interaction of the substrates with aromatic residues. Aromatic 
residues such as tryptophan can interact with cations through strong, non-covalent force 
(Zacharias & Dougherty, 2002). It has been suggested that the aromatic residues in a 
protein can pull the cationic substrate out of water into a hydrophobic environment. This 
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was also suggested in EmrE, where the three aromatic residues (Trp63, Tyr40, and 
Tyr60) in each monomer stabilize the carboxyls of Glu14 in the binding cavity, the low 
dielectric constant of the protein interior created by the hydrophobic and aromatic 
residues (at least three from each monomer) would strongly favor the electrostatic 
interaction between the negatively charged glutamate and a positively charged drug 
(Elbaz et al., 2005; Rotem, Steiner-Mordoch, & Schuldiner, 2006).   
The focus of this chapter will be to analyze each of the cysteine mutants and the 
spin labeled mutants for activity using in vivo and in vitro assays, leading to a better 
understanding of the functionality of each site in EmrE in comparison to previous 
published work.  
 
Experimental Methods 
Ethidium Resistance Assay 
The in vivo assay was carried out by Dr. Hanane Koteiche and the results are 
presented in this chapter for completeness. The DNA containing the EmrE open reading 
frame was amplified from E.coli MG1655 and cloned into the NdeI and HindIII sites of 
plasmid pET20b+. The EmrE gene is controlled by the T7 promoter in pET20b+ vector. 
This promoter is known for background ‘leaky’ expression; unlike the highly regulated 
pET15b+ vector containing the T7 lac promoter that controls basal expression (Studier, 
Rosenberg, Dunn, & Dubendorff, 1990). All 110 single cysteine mutants were made in a 
cysteine-less (WT*) background using QuikChange Mutagenesis (Stratagene, La Jolla, 
CA). All mutants were confirmed by the Vanderbilt DNA Sequencing facility. 
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The ability of mutants to confer resistance was determined as previously 
described (Mordoch et al., 1999). Overnight cultures of E.coli expressing mutant EmrE’s 
were grown to saturation ~4.0 OD600. The cultures were then diluted 10-, 103, and 106-
fold, and 5μl of the dilutions was spotted on LB-amp plates containing 200μg/ml 
ethidium bromide. Growth was examined after incubation at 37°C for 24 hours.  
 The mutants were classified into three groups based on the growth profile of the 
transformed cells. A resistance phenotype at all dilutions (10-106) was interpreted as 100 
% active EmrE; growth only in the 10-103 dilution was considered 50 % active; while 
abnormal phenotype in the 10-103 dilution, was recorded as compromised activity. If the 
cells did not grow in any dilutions then they were concidered to be inactive mutants. 
Assays were repeated twice.   
 
Intrinsic Tryptophan Fluorescence  
Details of this method are described in Chapter III. To obtain similar fluorescent 
intensities, all the spin labeled samples were diluted to a final concentration of 3 μM in 
0.02 % w/v β-DDM, pH 7.2 phosphate buffer. Each EmrE spin labeled sample was 
incubated at room temperature for 20 minutes after the addition of 2x or 4x molar access 
of TPP+. For the high concentration experiments, the spin labeled samples were diluted to 
a final concentration of 20 μM and each sample had the addition of 4x and 6x molar 
acess of TPP+. A substantial portion/part of these experiments was carried out by Sanjay 
Mishra. 
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Purification of EmrE using different buffers 
 Details of the purification of EmrE are given in Chapter III. All mutants were 
purified in a phosphate buffer (50 mM NaH2PO4, 50 mM NaCl, 250 mM imidazole, 0.02 
% NaN3, and 0.08 % β-DDM, pH 7.2). Cys-less EmrE (WT*) was also purified in 
comparable Tris buffer (20 mM Tris, 20 mM NaCl, and 0.3 % (w/v) NG or 0.02 % β-
DDM at pH 7.2 and 8) (Chen. et al. 2007).  SDS-PAGE (4-20 %) was used to confirm the 
homogeneity of the purified WT* protein. 
 
 
Results and Discussion 
Stability of the EmrE Dimer 
Previously, it has been shown that the exposure of detergent solubilized EmrE to 
high temperature for a specific amount of time causes only a 20-30% decrease in the 
ability of EmrE to bind and transport substrate (Soskine et al., 2006) suggesting a highly 
stable structure. However, the requirement of the proper detergent is quite stringent. For 
instance, it was shown that using the detergent nonyl-glucoside (NG) instead of dodecyl-
β-D-maltoside (β-DDM) to purify EmrE, caused a 10 fold decrease in the binding of 
TPP+, suggesting an effect on the oligomeric state of the protein (Soskine et al., 2006).  
 
 
 
 
 
 
 
 
 
79 
 
20 22 24 26 28 30 32 34 36 38 40 42
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
Time (minutes)
A
28
0
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
A
280
WT* in phosphate 
buffer, β -DDM 
(0.02 %), pH 7.2 WT* in phosphate 
buffer, NG 
(0.3 %), pH 7.2
20 22 24 26 28 30 32 34 36 38 40 42
0.0
0.1
0.2
0.3
0.4
0.5
0.6
tR (minutes)
A
28
0
0.0
0.1
0.2
0.3
0.4
0.5
0.6
A
280
WT* in Tris buffer,
β-DDM (0.02 %), pH 7.2
WT* in Tris 
buffer, 
NG (0.3 %), pH 8
200
66.2
31
14
25
 m
in
 p
ea
k
28
.5
 m
in
 p
ea
k
25
 m
in
 p
ea
k
34
.5
 m
in
 p
ea
k
B)
A)
C)
tR (minutes)
t (minutes)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: SEC profile of EmrE-CLA (WT*) using different buffer components. 
A) The retention time (tR) of WT* purified with similar buffer and pH but different detergent. 
The profile of WT* in β-DDM is shown in black dotted trace, and of NG is shown in grey 
trace.  
B) The retention time (tR) of WT* purified with similar buffer, but different pH and detergent. 
The profile of EmrE-CLA in β-DDM, pH 7.2 is shown in grey trace, and in NG, pH 8.0 is 
shown in black trace.  
C) SDS-PAGE of WT* purified using different detergent component at different retention 
times.  
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This is relevant because the crystal structure of EmrE was obtained from protein 
purified and crystallized in a Tris buffer containing 0.3 % w/v (NG) at pH 8.0 (Y. J. Chen 
et al., 2007). An important question that we addressed is: could the content of the buffer, 
pH, or the detergent have an influence on EmrE oligomer structure?  To answer this 
question, we analyzed the effect of detergent and pH on the dimer structure using size 
exclusion chromatography (SEC). At pH 7.2, we found that substitution of NG for β-
DDM had a slight effect on the retention time, as shown in Figure 1A. In contrast, for 
Figures 1B and C, the detergent had a large influence in the retention time of the cys-less 
EmrE (WT*) when purified with buffer containing 0.3 % NG detergent micelles, at pH 8, 
showing a shift in the retention time , tR, to ~34.5 minutes. Notably, we observed 
substantial loss of protein implying either precipitation or irreversible interactions with 
the column. The longer retention time suggests that NG destabilized the EmrE dimer. 
These results demonstrate that the detergent used to purify EmrE for 
crystallization (Y. J. Chen et al., 2007) has a large influence on the oligomerization state. 
Previous work has shown that other membrane proteins purified with β-DDM are much 
more stable than when purified with NG (Serrano-Vega, Magnani, Shibata, & Tate, 
2008). Both detergents are nonionic, but the length of the hydrocarbon side chain of NG 
is 9 while in β-DDM it is 12. Therefore, the length of the hydrocarbon chain has an effect 
in stabilizing the highly hydrophobic EmrE (i.e. when comparing NG micelles to β-DDM 
micelles) as supported by a recent publication confirming that different detergent 
micelles have a great influence on the structural dynamics of membrane proteins 
(Columbus et al., 2009).  
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Overall, it is clear that the use of NG is likely to destabilize the dimer structure. 
The detergent NG could be the reason behind the misfolding of the apo-state. Since the 
exact buffer in the crystal is not known, a definite determination of whether EmrE is a 
dimer in the TPP+ bound crystal is not possible. At the high concentration used during 
crystallization, TPP+ (Y. J. Chen et al., 2007) may stabilize the dimer or bind to the 
monomer. 
All purified spin labeled mutants were analyzed by SEC. Most had similar 
retention time to the WT* of ~28 minutes, as shown in Figure 2 (dotted trace profile), 
suggesting a destabilization by the mutation and subsequent labeling. Exceptions are spin 
labeled sites 90, 94, 97, and 101 (Figure 2, G90C-SL is shown as an example) where an 
increase in the aggregation fraction at a retention time of ~25 minutes was observed.  
 
 
 
 
 
 
 
 
 
 
Figure 2: Elution profile of stable and unstable mutants of EmrE. SEC profile of EmrE cys-
less (WT*) (black dotted trace) compared to G90C-SL, an unstable mutant (black trace). Arrow 
points to the aggregation peak. 
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These four mutants are all located in TM4 and are one helical turn away from one 
another, thus, facing the same side of the helix. This result suggests that the oligomeric 
state of TM4 is compromised when these sites are mutated and spin labeled. 
 
Activity of EmrE Mutants 
 Sequential cysteine mutants spanning the full length of EmrE (i.e. 110 amino 
acids) were constructed in a cysteine less mutant of EmrE where its three native cysteines 
at position 39, 41, and 95 were mutated to alanine. Cysless EmrE has been shown to have 
similar activity to the native EmrE in vivo and in proteoliposomes (Lebendiker & 
Schuldiner, 1996).   
 An in vivo functional assay was used to test whether the cysteine mutants of EmrE 
were able to confer resistance to ethidium bromide.  The in vivo activity of EmrE mutants 
is determined by three important characterizations. First, the affinity of the substrate 
towards the mutant protein; second, the coupling of substrate to proton movement; and 
third the oligomeric structure of EmrE, the loss of which impairs transport. Examining 
the cysteine mutants of EmrE in vivo would therefore provide another dimension when 
exploring the structure of EmrE.  
 From the 110 residues analyzed by Hanane Koteiche, 80 % of the EmrE cysteine 
mutants retained their activity, and 10 % of the cysteine mutants were inactive (sites 10, 
14, 17, 18, 60, 63, 67, 90, 97, 101, and 102). The rest, 7 %, were only 50 % active (sites 
3, 4, 7, 22, 47, 55, 57 and 94), and only 2 % had compromised activity (sites 40 and 54). 
 Previous published work has shown that sites on TM1 located at a distance of 
about one helical turn from E14, such as residues 10 and 18, were nonfunctional and 
seem to be in the drug binding pathway (Koteiche et al., 2003). Mutated sites located in 
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TM3 (sites 60, 63, and 67) and in TM4 (sites 90, 97, 101, and 102) were also inactive. 
Site 60 is a tyrosine and site 63 is a tryptophan, and these two aromatic sites have been 
shown to be important for substrate binding and translocation (Elbaz et al., 2005; Rotem 
et al., 2006). Furthermore, sites 67, 90, and 97 that showed no resistance to ethidium 
bromide are all glycine residues. Biochemical evidence has shown that the glycine 
residue at site 67 in TM3 is important for the flexibility of the helix and may participate 
in the translocation of the substrate (Elbaz, Salomon, & Schuldiner, 2008). The glycine 
sites at positions 90 and 97 of TM4 seem to have an important role in the dimerization of 
EmrE (Elbaz et al., 2008; Gottschalk, Soskine, Schuldiner, & Kessler, 2004; Soskine et 
al., 2002), which has also been confirmed by the SEC profiles presented above. The data 
also show that the replacement of TM2 residues with cysteines did not yield an inactive 
protein, suggesting that TM2 residues may have an important role in stabilizing the 
substrate but not in the transport activity of EmrE.  
 
Intrinsic Tryptophan Fluorescence for Cys-less and Spin Label Mutants of EmrE 
One of the main goals of this thesis project is to compare the structure of EmrE 
upon the binding of the TPP+ at physiological pH with the crystal structure of the 
substrate-bound state determined at pH 8. Therefore, it is important to independently 
confirm that the spin labeled mutants can bind TPP+. For this purpose, we used a 
tryptophan fluorescence quenching assay introduced by Schuldiner and colleagues (Elbaz 
et al., 2005). EmrE has four tryptophan residues, with tryptophan 63 fully conserved 
within the SMR family of transporters (Ninio et al., 2001). 
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Figure 3: In vitro functional activity of each spin label mutants of EmrE. 
A bar graph of the Trp fluorescence properties of each spin labeled mutants of EmrE shown in the 
absence (grey), or in the presence of saturating amount of TPP+, 6 μM and 12 μM, shown in red 
and blue bar graph, respectively. The four graphs signifies the location of the mutants; upper left 
panel is the TM1, upper right panel is TM2, lower left panel is TM3, and lower right panel is the 
TM4 mutants. The loop region is outlined by a rectangle for each of the TMS. The horizontal 
dotted grey line shows the cutoff of the quenching in comparison to WT*. 
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This is the only tryptophan in EmrE that could sense substrate binding and/or 
conformational change following the binding reaction (Elbaz et al., 2005). For each spin 
labeled mutant the magnitude of the decrease in the fluorescent intensity compared to the 
cysless-EmrE (WT*) was collected (Figure 3).  
The addition of saturating amounts of TPP+ to the WT* induced significant 
quenching (~22 %) of the Trp fluorescence (Figure 3) with no detectable shift in the 
emission maxima, suggesting that there are no major changes in the hydrophobic 
environment. The majority of the spin labeled mutants seems to show relative quenching 
with respect to its apo-state, with the exception of some mutants that will be described 
below. 
The tryptophan at position 63 is conserved in the SMR family of transporters, for 
which, Trp quenching is only observed at higher concentrations of TPP+, as shown in 
Figure 3. This confirms that the tryptophan at position 63 is involved in the function of 
the protein and most likely in substrate binding. Moreover, the in vivo activity shows that 
W63C has a damaging effect on the resistance to ethidium, suggesting that this site is 
important in both binding and translocation of the substrate. Similarly, for E14C-SL, a 
residue that is an absolute requirement for substrate binding and translocation, the 
addition of saturating amounts of substrate did not change the fluorescence with respect 
to its apo-state. In the case of sites 40, 44, and 60, the addition of TPP+ showed similar 
Trp emissions to their apo-state. However, Trp quenching is restored by increasing the 
concentration of EmrE and TPP+ as shown in Figure 4, suggesting that the three mutant 
sites reduce the affinity for TPP+.  
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Figure 4: In vitro functional activity of spin label mutants using higher concentrations of 
EmrE. The bargraph represents the apo-state EmrE (black bar) and in the presence of 4x (dark 
grey) and 6x (ligh grey) molar excess of TPP+.  
 
Generally, the in vitro functional study is well correlated with the in vivo data, 
suggesting that the mutants of EmrE in detergent micelles have similar functional 
characteristics to those of the mutants in cells. 
 
Conclusion 
In this chapter, each of the cysteine mutants of EmrE was characterized using a 
qualitative in vivo assay.  Some of these mutants located in TM1, TM3 and TM4 were 
nonfuctional, which suggests that they might play a role in either insertion, stability of 
folding, or in the catalytic cycle. On the other hand, TM2 cysteine mutant sites were fully 
functional, suggesting that these sites do not play a role in the translocation of the 
substrate but may play a role in stabilizing the substrate prior to translocation.  
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The oligomeric state of spin labeled cysteine mutants of each of the 110 sites of 
EmrE were analyzed and compared to its unlabeled cysless-EmrE (WT*) using size 
exclusion chromatography (SEC). Most of the purified spin labeled mutants had similar 
retention times to WT*, suggesting that the oligomeric state was not perturbed. However, 
certain sites located in TM4 showed an increase in the aggregation fraction compared to 
that of WT*, suggesting a change in the oligomeric state of the protein. This result 
correlates well with the in vivo assay, suggesting that TM4 might play a role in folding.  
Extracting and purifying WT* in different buffers showed that the eluted protein 
sample was unstable when using NG instead of β-DDM. This conclusion might imply 
that the crystal packing of EmrE in the dimer that is located in the unit cell is not the 
native-state of EmrE.  This data is also supported by previous work suggesting that using 
NG decreases the fraction of the functional protein. The tryptophan fluorescence data of 
the spin labeled sites of EmrE showed that most of the mutants bind TPP+. 
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CHAPTER  V 
 
 
CONFORMATIONAL DYNAMICS OF APO EMRE IN LIPID BILAYERS 
 
 
Introduction 
One of the challenges in crystallographie analysis of secondary multidrug 
transporters is their hydrophobic nature and flexibility. In the past decade, several crystal 
structures of secondary multidrug transporters were published such as Lactose permease 
(Lac Y) and EmrD (Abramson et al., 2003; Yin, He, Szewczyk, Nguyen, & Chang, 2006) 
from the MFS family, and AcrB from E.coli and MexB (Murakami, Nakashima, 
Yamashita, Matsumoto, & Yamaguchi, 2006; Sennhauser, Bukowska, Briand, & Grutter, 
2009) from the RND family of transporters. The only published crystal structure of EmrE 
in the absence of substrate (apo-state) was soon retracted in 2006 due to faulty analysis of 
the software (Ma & Chang, 2007).  
One of the first models of EmrE in the apo-state was determined by cryo-EM and 
image reconstruction of 2D crystals (Tate et al., 2001). The projection map with overall 
dimensions of approximately 31 x 40 Å at 7 Å resolution (see Figure 5, Chapter I) was 
shown to represent an asymmetric dimer related by a 2-fold axis in the plane of the 
membrane with no obvious 2-fold symmetry axis perpendicular to the membrane.  Thus, 
the monomers have identical amino acid but do not have identical structures in the 
functional unit. 
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(A) (B)
  In 2003 Tate and colleagues determined the three dimensional structure of EmrE 
in the substrate bound-state from 2-D crystals at 7.5 Å. The substrate-bound EmrE crystal 
was more ordered and well defined than the apo-state crystals. Nevertheless, the 
projection of the substrate bound-state was proposed to be identical to the apo-state. The 
asymmetric homodimer of EmrE was composed of eight transmembrane helices (TM) in 
total (four TM helices from each monomer) (Ubarretxena-Belandia et al., 2003). The low 
resolution of the structure made it difficult to assign the helices to specific segment of 
primary structure. Yet, the presence of a pseudo two fold axis in the plane of the 
membrane suggested novel architecture of the two monomers consisting of an antiparallel 
dimer.  
In 2007 the crystal structure of the apo-state of EmrE was recalculated by using 
anomalous diffraction from mercurial derivatives to 4.5 Å resolution (Y. J. Chen et al., 
2007), Figure 1A. The asymmetric units contained distorted monomers. The first three 
helices form a three-helix bundle that packs against the equivalent helices forming a 
dimer.  
 
 
Figure 1: Crystal structures of EmrE. (A) Ribbon representation of the distorted apo-EmrE 
dimer. One monomer is rendered in color gradient with the TM helices labeled, and the other 
monomer is shown in grey. (B) Side view of EmrE-TPP+ dimer. The dimensions of the bilayer 
are shown by the gray shading (Y. J. Chen et al., 2007).  
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The fourth helix from each monomer interacts with one another and project 
laterally from the main body of the dimer. Since the apo-EmrE was crystallized at pH 4, 
it was proposed that the non-native conformation reflects partial denaturation of the 
protein. Indeed, our size exclusion chromatography data (see Chapter IV) suggests that 
the dimer dissociates in the detergent (nonyl-glucoside) used for crystallization. To date, 
the crystal structure of native EmrE in the apo-state has not been published where the 
resolution was high enough to confirm not only the packing of the helices, but also the 
location of the amino acids and their contributions to the substrate binding site.  
To gain insight into the conformation of EmrE in liposomes (a native like-
environment), the structural dynamics of EmrE were investigated using site-directed spin 
labeling (SDSL) and EPR spectroscopy. Both spin label motion and solvent accessibility 
which reflect local environment in the dimer, were analyzed. The analysis distinguishes 
sites that are either at the dimer interface, buried within the protein, exposed to the 
aqueous environment or to the membrane milieu. In this chapter a thorough investigation 
of spin label mobility and accessibility to oxygen and NiEDDA is reported to deduce the 
structural dynamics from an EPR perspective and compare it to the overall crystal 
structure of the substrate bound-state.  
 
Experimental Methods 
EPR spectra of spin labeled mutants reconstituted in liposomes were collected on 
a Varian E9 equipped with a loop gap resonator as described in chapter II. Power 
saturation was performed on Bruker Elexsys spectrometer equipped with a dielectric 
resonator; the P1/2 was obtained by curve fitting to the equation: 
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where A is the peak-to-peak amplitude, ε  is the line shape adjustment parameter, I is the 
scaling factor,
2
1P is the half saturation power, and P is the power of the incident 
electromagnetic wave.  
 The solvent accessibility data of each position in the segment was mapped onto 
the crystal structure of EmrE in the substrate bound-state (Y. J. Chen et al., 2007) using 
the UCSF Chimera package from the Computer Graphic Laboratory, University of 
California, San Francisco (Pettersen et al., 2004; Sanner, Olson, & Spehner, 1996).  
The immersion depth (Φ) was calculated using the equation: 
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The immersion depth is related to the standard state chemical potential of the reagent at 
any depth, independent of viscosity or steric constraints forced by the environment and 
also independent of the EPR lineshape. Therefore, the ratio of two paramagnetic reagents 
such as oxygen and NiEDDA would relate to the relative measure of depth in the bilayer, 
that is, on distance through the concentration gradient (Altenbach, Greenhalgh, Khorana, 
& Hubbell, 1994). 
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Results and Discussion 
EmrE Structural Constraints  
CW EPR spectra of the spin labeled EmrE mutants in the apo-state along the full 
length of the protein were recorded at room temperature. The regions include TM1 
(residues 3 to 22), loop 1 (residues 23 to 29), TM2 (residues 30 to 49), loop 2 (residues 
50 to 58), TM3 (residues 59 to 75), loop 3 (residues 76 to 84), TM4 (residues 85 to 103), 
and loop 4 (residues 104 to 110).  
The local steric restrictions on the mobility of the nitroxide probe is reflected in 
the EPR spectral line shapes shown in Figures 2, 4, 6, and 9. The mobility refers to the 
reorientation of the spin label relative to the protein backbone. In a sterically packed 
environment such as the protein core, the spin label will have restricted mobility leading 
to spectral broadening and the appearance of outer splittings as described in Chapter II. 
On the protein surface, the lack of tertiary contacts results in high mobility. The mobility 
can be quantified by the inverse of the central resonance line width (ΔHo-1). ΔHo-1 values 
for each TMS of EmrE are shown in Figures 3 A, 5 A, 8 A, and 10 A. 
Additional information can be obtained by investigating the accessibility 
parameter (Π) of the spin label to reagents of different solvation. The two reagents that 
were used are molecular oxygen, which is highly soluble in the low dielectric lipid 
environment, and NiEDDA (Nickel(II)ethylenediaminediacetate), a water-soluble 
reagent. Each transmembrane helix will have an accessibility pattern that describes its 
position relative to the bilayer. High oxygen accessibility indicates that the nitroxide spin 
label is exposed to the lipid bilayer, while high NiEDDA accessibility signifies the 
exposure of the nitroxide spin label to the aqueous environment. NiEDDA and oxygen 
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accessibility (Π(NiEDDA) and Π(O2)) (see chapter II for the definition of Π) profiles of 
the full length reconstituted EmrE in the apo-state for each of the four helices are shown 
in the lower panel of Figures 3 B, 5 B, 8 B, and 10 B. 
 
Mobility and Accessibility of Transmembrane Helix One (TM1) 
 The profiles of the mobility, NiEDDA and oxygen accessibility of TM1 in 
detergent micelles have been previously published (Koteiche et al. 2003). A visual 
inspection of the EPR spectral line shape of TM1 in liposomes, as shown in Figure 2, 
reveals that residues on the same side of the helix (i, i+4) relative to site 3 are in tertiary 
contacts leading to an immobilized line shapes.  Sites 6, 10 and 14, which are on the same 
side of the helix, show a gradual increase in steric constraints at the dimer interface to a 
point where the two spin labels are close enough to be within van der Waals contact at 
position 14. Along this face of the helix, EPR spectra at sites 14 and 18 show strong 
dipolar coupling. The EPR spectrum of 14 show a broad (arrows, shown in Figure 2) and 
a narrow component reflecting two populations of spins each separated by a different 
distance. The broad component feature was suggested to represent two spin labels in 
close proximity (Koteiche et al., 2003; McHaourab et al., 1997), whereas the narrow 
component represents spins that are separated by distance of ≥ 20 Å.  Moreover, the 
spectrum of T18C-SL shows a broadening of the spectrum that falls in the range of ≤ 15 
Å in distance.  
 
94 
 
G8C-SL
G9C-SL
A10C-SL
L12C-SL
A13C-SL
V15C-SL
I16C-SL
G17C-SL
T18C-SL
L20C-SL
M21C-SL
K22C-SL
F23C-SL
S24C-SL
E25C-SL
G26C-SL
F27C-SL
R29C-SL
P3C-SL
Y4C-SL
I5C-SL
Y6C-SL
T19C-SL
I11C-SL
T28C-SL
E14C-SL
25G
L7C-SL
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: EPR spectra of TM1. X-band CW EPR spectra of EmrE mutants along TM1 (residue 
3 to 22), and Loop 1 (residues 23 to 29) reconstituted in liposomes. All spectra were recorded 
with a 160 G scan width with the exception of site 14 was recorded with a scan width of 250 G. 
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Figure 3: Mobility and accessibility profile of TM1. A) Inverse central linewidth (ΔHo-1). B) O2 
accessibility (Π(O2), red), and NiEDDA accessibility (Π (NiEDDA), blue) parameters along TM1 
(3-22), and Loop 1 (23-29) reconstituted in liposomes. The different regions are separated by a 
vertical black dotted line. 
 
 
Sites 21 and 22 that are one turn away from site 18 show a highly immobilized EPR 
spectral line shape as reflected by the prominent outer splittings at the low and high field 
extrema. The lack of spin-spin coupling emphasizes that sites located at the C-terminal 
are further apart from the dimer interface and are interacting with other helices in the 
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vicinity of TM1. Conversely, sites 12, 15, 16, and 20 and the loop region 23 to 29, with 
the exception of site 27, show little, if any restriction in mobility. These results support 
the conclusion previously proposed (Koteiche et al., 2003), that TM1 is in an X-shaped 
arrangement where the close contact of sites 14 and 18 at the dimer interface would be 
lining the binding chamber. 
In Figure 3, both mobility (ΔHo-1) and oxygen accessibility indicate a 3.6 residue 
periodicity along TM1 reflecting an α-helical secondary structure. Furthermore, the 
oxygen accessibility (Π(O2)) profile shows increasing amplitude at successive maxima 
reflecting the oxygen concentration gradient towards the middle of the lipid bilayer. The 
highest Π(O2) is at residue 12 which also possesses a highly mobile spectral line shape 
indicative of a residue facing the lipid milieu near the middle of the bilayer. Therefore, 
site 12 provides the reference position of the protein relative to the middle of the lipid 
bilayer. Residues with maximum oxygen accessibility such as 5, 8, 12, 16, and 20 face 
the lipid bilayer and have high spectral mobility (ΔHo-1). The helical surface defined by 
oxygen accessibility minima at residues 10, 14, and 18 seem to participate in tertiary 
contacts.  
In the loop region connecting TM1 to TM2 following residue 22, the periodicity 
is lost and the spin label mobility is uniformly high. Sites 25 and 29 show the highest 
NiEDDA accessibility, suggesting that these two sites are located beyond the lipid-water 
interface. Only residue 27 in this loop shows low NiEDDA accessibility. Coincident low 
mobility suggests that the spin label at this position is in tertiary contacts with the 
surrounding region. Overall, the accessibility parameters are in good agreement with the 
CW-EPR spectral line shape. Also, the results of the liposomes samples of TM1 are 
97 
 
similar to the published data of the spin labeled samples in detergent micelle (Koteiche et 
al., 2003).  
 
Mobility and Accessibility of Transmembrane Helix Two (TM2) 
The loop merges into transmembrane 2 at around residue 30 where distinct 3.6 
residue periodicity in Π(O2) resumes. In Figure 4 highly mobile spectral line shapes are 
observed at the N-terminal region of TM2, sites 30 to 35, suggesting that the spin labeled 
sites are undergoing fast motion with no tertiary contacts. This conclusion is also 
supported by high accessibility to oxygen observed on both faces of the helix (grey dotted 
vertical lines in Figure 5B). In contrast, the following helical turns show distinct evidence 
of tertiary contacts. Immobilized line shapes and low oxygen accessibility define the 
packed face of TM2 consisting of residues 36, 40, 44, 47, and 51. Distinct dipolar 
splittings are observed in the EPR spectrum for sites 40 and 44 indicating an inter-probe 
distance of less than 10 Å. Furthermore, both sites have low oxygen accessibility 
consistent with a buried environment.  
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Figure 4: EPR spectra of TM 2. X-band CW EPR spectra along TM2 (residue 30 to 49), and 
Loop 2 (residues 50 to 58) reconstituted in liposomes. All spectra were recorded with a 160 G 
scan width with the exception of sites 40 and 44 were recorded with scan width of 200 G. 
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Figure 5: Mobility and accessibility profile of TM2. A) Inverse central linewidth (ΔHo-1). B) O2 
accessibility (Π(O2), red), and NiEDDA accessibility (Π (NiEDDA), blue) parameters along TM2 
(30-49), Loop 2 (50-58) of EmrE. The different regions are separated by a vertical black dotted 
line. 
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A loss of the 3.6 periodicity is observed in the oxygen accessibility profile for 
sites 51-58. These sites are in the loop region connection TM2 to TM3. In parallel, 
NiEDDA accessibility increases at sites 52 and 53 suggesting locations well beyond the 
membrane-water interface compared to the other loops of EmrE that seem to be localized 
at the membrane interface. Sites 54 to 58 report extensive motional restriction that is 
reflected by a decrease in Π(NiEDDA) suggesting that the loop is located in the lipid 
bilayer connecting to TM3.  
 
Mobility and Accessibility of Transmembrane Helix Three (TM3) 
The N-terminal regions of TM3 from both monomers are in close proximity, as 
reflected by the broadened spectral line shape at positions 60 and 64 (see Figure 6). The 
side chains of residue 64 are within 6.9 Å in the crystal structure as a result of a distortion 
of one of the helices (Figure 7). Furthermore, the N-termini of these antiparallel helices 
are pulled towards the middle of the membrane bringing residue 60 from each monomer 
into close proximity. Agreement with the EPR data requires helix rotation to allow for the 
projection of the spin labels towards each other. Further down the TM helix, residue 68 
which faces the same side of the helix as 60 and 64 does not show evidence of spin-spin 
coupling suggesting that only the first turn of TM3 helices are in close contact at the 
dimer interface. However, the spin label at this site has low mobility (ΔHo-1) and low 
oxygen accessibility (see Figure 8 A and B, respectively) consistent with tertiary 
contacts.  
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Figure 6: EPR spectra of TM 3. X-band CW EPR spectra along TM3 (residue 59 to 75), and 
Loop 3 (residue 76 to 84) reconstituted in liposomes. All spectra were recorded with a 160 G scan 
width with the exception of site 64, which was recorded with a scan width of 200 G, and sites 80, 
and 82-84 were recorded with scan width of 100 G.  
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Figure 7: Location of residues 60 and 64 in the crystal structure. The two monomers are 
shown in blue and wheat. Residues 60 and 64 are represented in sticks (red). The residue in the 
second monomer is shown in asterisks.  
 
Maximum oxygen accessibility is observed at positions 65, 66, 69, and 70, 
defining the helix surface facing the lipid bilayer and coinciding with the highest mobility 
(ΔHo-1). Based on the crystal structure, the C-terminal turns of TM3 are expected to be 
closer to the lipid-water interface leading to a decrease in oxygen accessibility. This was 
not the case, since spin labeled sites 72 to 76 are highly mobile, report a high level of 
oxygen accessibility, and a loss of the 3.6 periodicity of the α-helix secondary structure. 
These interesting characteristics suggest that this small segment is not helical and is 
exposed to the lipid bilayer. This may indicate that the loop region following TM3 is 
longer than expected, starting in the lipid bilayer at site 73 and continues towards site 79, 
where it reaches the lipid-water interface. A gradual increase is detected in NiEDDA 
accessibility, with spin labeled site 80 showing the maximum collision rate. The loop 
reenters the lipid bilayer at site 81 to 84, where a decrease in NiEDDA accessibility and 
an increase in steric restrictions are observed.   
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Figure 8: Mobility and accessibility profile of TM3. A) Inverse central linewidth (ΔHo-1). B) O2 
accessibility (Π(O2), red), and NiEDDA accessibility (Π (NiEDDA), blue) parameters along TM3 
(59-75), Loop 3 (76-84) of EmrE. The different regions are separated by a vertical black dotted 
line. The vertical grey line indicates the only site that is close at the dimer interface. 
 
In general, TM3 is highly hydrophobic and from the mobility analysis appears to 
be surrounded by other helices. Furthermore, the loss of periodicity between sites 73 and 
76 suggests that TM3 has either a specific motif (such as a helix-turn-helix or a helix-
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loop-helix) or it may be that TM3 is shorter than the crystal structure predicts. In the 
latter case, a longer loop connecting TM3 to TM4 extends from the lipid bilayer at site 73 
and moves toward the aqueous environment at position 80.  
 
Mobility and Accessibility of Transmembrane Helix Four (TM4) 
 The crystal structure and the low resolution model constructed from cryo-electron 
crystallography data placed both TM4 helices at the dimer interface (Chen, et al. 2007, 
and Tate, et al. 2001, Figure 5, Chapter I). However, no spin-spin interactions between 
symmetry-related nitroxides across the dimer interface were detected along this helix (see 
Figure 9). This would be especially evident at 93 and 97 since these two residues are in 
close proximity in the crystal structure, with Cα distances of 10.5 Å and 6 Å, 
respectively. However, this was not reported from the EPR spectral line shape, leading us 
to hypothesize that the packing of TM4 segments in the apo-state in solution is different 
from the proposed crystal structure of the substrate bound-state.  
The accessibility data in Figure 10 B shows that residues 89, 93, 96, and 99 are 
facing the lipid bilayer, and have similar high values of Π(O2).  Moreover, both EPR 
spectral line shapes and (ΔHo-1) (Figure 10 A) suggests that these sites do not have 
extensive tertiary contacts.  
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Figure 9: EPR spectra of TM4. X-band CW EPR spectra along TM4 (residue 85 to 103), and 
Loop 4 (residue 104 to 110) reconstituted in liposomes. All spectra were recorded with a 100 G 
scan width with the exception of sites 95, 103, 109, and 110 were recorded with scan width of 
160 G. 
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Conversely, sites 87, 91, 94, 98, and 102 have similar low Π(O2) characteristics of sites 
that are in tertiary contacts, according to the immobilized spectral line shape (Figure 9). 
Thus, the accessibility data along TM4 suggests that one side of the helix is lipid facing 
while the other side is in tertiary contacts with other protein segments. It is possible that 
TM4 is tilted more than 11° relative to the membrane normal (Ubarretxena-Belandia et 
al., 2003), resulting in similar oxygen accessibility for the sites facing the membrane lipid 
bilayer.  
The values of NiEDDA accessibility at the N-terminal of TM4 (residues 85-88) 
are higher than for sites 89-99, suggesting that the N-terminal region is near the lipid-
water interface. Conversely, the C-terminal region (103-110) shows the highest NiEDDA 
accessibility especially for sites 106 and 109 indicative of sites beyond the lipid-water 
interface. Thus, it could be that the sites beyond 103 are in the loop region or represent an 
extended TM4 helix. 
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Figure 10: Mobility and accessibility profile of TM4. A) Inverse central linewidth (ΔHo-1). B) 
O2 accessibility (Π(O2), red), and NiEDDA accessibility (Π (NiEDDA), blue) parameters along 
TM4 (85-102), Loop 4 (103-110) reconstituted in liposomes. The different regions are separated 
by a vertical black dotted line. The vertical grey lines indicate the sites that are facing the lipid 
bilayer. 
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TMS Amino acid length 
Length of
TMS (Å) 
1 20 28.5 
2 20 28.5 
3 17 24 
4 19 27 
EmrE Topology within the Lipid Bilayer 
Even though the collision frequencies of NiEDDA along the transmembrane 
segments of EmrE are low, there is still evidence that some regions along the 
transmembrane segments are in contact with the aqueous phase as described in the 
accessibility sections. Overall, the four transmembrane segments of EmrE are highly 
hydrophobic as shown by the environmental parameters of oxygen and NiEDDA 
accessibility. The results are supported by several other published works (Edwards & 
Turner, 1998; Schwaiger et al., 1998) emphasizing the hydrophobic nature of EmrE.   
The length of each helix of EmrE was estimated from the periodicity of the 
accessibility data (see Table 1, below) that was described in the previous sections.  
 
 
 
 
 
 
 
Table 1: Length of the transmembrane segments (TMS) from the experimental data of 
EmrE. 
 
 
The thickness of the hydrocarbon core of the lipid membrane is ~30-40 Å (Jaud S, 
et al. 2009). On average a transmembrane segment of 20 amino acids would extend the 
full length of the lipid bilayer as long as the helix is parallel to the membrane normal 
(Jaud et al., 2009). Table 1 indicates that only TM1 and TM2 and TM4 extend across the 
full length of the lipid bilayer, while TM3 seems to be the shortest.  
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Another approach for localizing the transmembrane helices in the lipid bilayer is 
by using the immersion depth (Φ) in membranes. This measurement takes advantage of 
the concentration gradients of paramagnetic relaxing agents (O2 and NiEDDA) in the 
lipid bilayer (Altenbach et al., 1994). Generally, a depth (Φ) of 0 indicates sites that are at 
the lipid-water interface, while a positive (Φ), indicates sites that are in the lipid bilayer. 
Depths were obtained for all the residues in TM1, 2, 3, and 4, as shown in Figure 11 A 
and B. TM1 and TM2 are the only two transmembrane helices that span the full length of 
the lipid bilayer. TM3 (Figure 11B) is in the lipid bilayer since all the spin labeled sites 
have positive immersion depth values. Given the disposition of the N-terminus of TM3 
well below the membrane/water interface, it would be expected that the C-terminal would 
have negative immersion depth value. Our data suggests that this segment bends back 
towards the bilayer probably facilitated by a kink in the helix. This proposed 
configuration of TM3 rationalizes the distances between spin labels determined in 
Chapter VIII. 
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Figure 11: The immersion depth of the full length EmrE. A) The immersion depth (Ф) of 
TM1, and TM2. B) The immersion depth of TM 3, and TM4 (numbered in roman numerals). The 
grey horizontal line indicates the lipid-water interface. The separation of regions is shown by 
black vertical dotted line. C) The depth (Ф) of all 110 residues mapped on a surface 
representation of one subunit of the crystal structure. The second subunit is shown in grey 
surface. The cyan oval points to a region in the N-terminal of TM4, sites 89, 92, and 93. The 
depth (Ф) is represented by three colors: blue sites located in the aqueous environment, white 
sites in the lipid-water interface, and red sites located in the middle of the lipid bilayer. The N- 
and C-terminal of EmrE indicates by N and C. 
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The depth parameters were mapped onto the crystal structure of EmrE in the TPP+ 
bound-state using UCSF Chimera package (Pettersen et al., 2004; Sanner et al., 1996), as 
shown in Figure 11 C. Segments located in the lipid bilayer are shown in red while those 
in water are colored in blue. The mapping reinforces the points discussed above including 
the discrepancy between the EPR parameters along TM4 and the crystal structure. The 
dark red color at the N-terminus of this helix (circled in cyan) indicates that this segment 
is deep within the lipid bilayer, whereas, in the crystal structure these sites are located 
near the lipid-water interface. In general, the accessibility, mobility, and depth data seem 
to confirm that the packing of TM4 in the lipid bilayer in the apo-state deviates from the 
helical packing of TM4 helices in the crystal structure of the substrate bound-state.  
 
Mapping the Accessibility Data to the Crystal Structure of EmrE  
 Both oxygen and NiEDDA accessibility (Figure 12 and 13, respectively) were 
mapped onto the two asymmetric subunits of the crystal structure of EmrE in the TPP+ 
bound-state using the UCSF Chimera (Pettersen et al., 2004; Sanner et al., 1996). There 
are multiple EmrE regions where the EPR parameters in the apo-state deviates from what 
are expected based on their environments in the crystal structure.  
The oxygen accessibility (Figure 12) reports that one side of transmembrane helix 
one (TM1) is facing the lipid bilayer and samples the oxygen concentration gradient 
while the opposite side of the helix seems to show very low or no oxygen accessibility, 
such as residue E14 (Figure 12) supporting the crystal structure.  
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Figure 12: Mapping the oxygen accessibility of apo-EmrE onto the crystal structure of the 
TPP+ bound-state. The Π(O2) data of the 110 sites (represented by sticks) of EmrE mapped on a 
surface representation of the two subunits (upper and lower panel) of the crystal structure. The 
second subunit in each panel is shown as a surface. The asymmetry in loop 3 from both subunits 
is shown in oval dotted line. The Π(O2) is encoded by two colors: white stands for small Π(O2); 
red stands for large Π(O2). 
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TM2 accessibility data in the absence of TPP+ is not compatible with the 
disposition of TM2 in the crystal structure, suggesting a change of this segment upon 
substrate binding. The maximum oxygen accessibility is mapped to residues 34 and 38, 
yet according to the crystal structure, residues 31 and 34 are located in the loop region for 
one of the two monomers. The accessibility is in agreement with the CW-EPR line shape, 
signifying that the sites with high oxygen accessibility have a highly mobile spin labeled 
side chain, confirming that the N-terminus of TM2 is more tilted than what is reported in 
the crystal structure.  
It has been suggested by the EM model that TM3 in one monomer has a tilt of 24° 
and in the second monomer 38°, with respect to the membrane normal (Ubarretxena-
Belandia, et al. 2003). This was also supported by the crystal structure of the substrate-
bound state superimposed on to the density map of the EM model (Y. J. Chen et al., 
2007) showing that TM3 of one monomer seems to be less kinked than the segment in the 
second monomer.  Thus, the inconsistency between the accessibility data and the crystal 
structure is well observed for residues 66 to 76, especially residue 74.  It appears that 
these residues at the C-terminus having maximum oxygen accessibility are buried in the 
crystal structure while the minimas are lipid facing in the crystal structure. The 
discrepancy continues through the loop connecting to TM4 (76-84) where significant 
accessibility to O2 and NiEDDA can only be rationalized by a highly dynamic backbone 
allowing large movement of the loop between the aqueous and the lipid environment. The 
asymmetry between the two monomers may have an important role in the mechanism of 
transport, where one monomer functions independently from the other.  
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Mapping TM4 oxygen accessibility data suggests that one side of the helix is 
exposed to the lipid bilayer while the other is in tertiary contacts. If TM4 is perpendicular 
to the membrane normal (as is shown for TM1), there would be a decrease in the 
collision rates with oxygen at sites further from the middle of the lipid bilayer. However, 
the pattern of oxygen accessibility is similar for the sites facing the lipid bilayer. This 
suggests that the TM4 segment is at a steep angle to the membrane normal, much higher 
than proposed by the EM model (Fleishman et al., 2006; Ubarretxena-Belandia et al., 
2003).  
The NiEDDA accessibility data were also mapped onto the crystal structure, as 
shown in Figure 13. In general, high NiEDDA accessibility signifies an area that is either 
in a cytoplasmic or periplasmic milieu.  It is known that the NiEDDA accessibility is 
180˚ out of phase in comparison to the oxygen accessibility for a symmetrically solvated 
helix that is perpendicular to the membrane normal (Hubbell et al., 1998).   
When mapping the NiEDDA accessibility onto the crystal structure measurable 
collision to the reagent is observed mostly at the termini of TM1, TM2 segments at 
certain sites show minimal oxygen exposure. In contrast, the termini of TM3 and TM4 
such as residue 79 to 82 seems to have measurable collision to both oxygen and NiEDDA 
(in phase) (see above for explanation).  
The sites 103-105 that are located in TM4 shows high NiEDDA accessibility that 
could only be mapped to one monomer since these residues are not resolved in the other, 
suggesting a dynamic backbone. The data implies that TM4 is at an angle with respect to 
the membrane normal, therefore, residues 103-105 might well be at the lipid-water 
interface giving rise to a similar collision rate to NiEDDA and oxygen.  
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Figure 13: Mapping the NiEDDA accessibility of apo-EmrE onto the crystal structure of the 
TPP+ bound-state. The Π(NiEDDA) data of the 110 sites (represented by sticks) of EmrE 
mapped on the two subunits (upper and lower panel) of the crystal structure. The second subunit 
in each panel is shown as a surface. The Π(NiEDDA) is encoded by two colors: white stands for 
a small Π(NiEDDA); blue stands for a large Π(NiEDDA). 
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The sites beyond 105 show an increase in NiEDDA accessibility that suggests that this 
part of the helix appears out of the lipid bilayer.  
 
Conclusion  
 In this study, EmrE was reconstituted into liposomes which mimic the native 
environment. The purpose was to assess the similarity of the structural restraints obtained 
by EPR spectroscopy to the crystal structure of EmrE in the TPP+ bound-state. 
SDSL and EPR spectroscopy were used to study EmrE in liposomes in the apo-
state and evaluate its conformational dynamics. The CW-EPR data of sites located in 
TM1, 2, and 3 confirms that the apo-state of EmrE exists as a dimer due to the dipolar 
interaction of certain sites that are in close proximity within the dimerization unit. The 
proximity along the three transmembrane segments appears to be consistent with the 
crystal structure. However, the flexibility of TM3 may account for the discrepancy 
between the EPR data and the crystal structure. Finally, the EPR data of TM4 sites 
suggest that they are futher apart at the dimer inteface than what has been proposed by 
the crystal structure of EmrE.  
It is important to note that the reported results of the apo-state are compared to the 
crystal structure of the substrate bound state. Therefore, the inconsistencies between the 
EPR data and the crystal structure in this study may well be due to conformational 
changes that take place upon the binding of TPP+. The experimental data of the substrate 
bound-state of EmrE will be assessed and analyzed in the next chapter.  
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CHAPTER VI 
 
 
CONFORMATIONAL DYNAMICS OF EMRE UPON  
TETRAPHENYLPHOSPHONIUM (TPP+) BINDING 
 
 
 
Introduction 
A number of studies have investigated the conformational changes of EmrE upon 
substrate binding (Korkhov & Tate, 2008; Tate et al., 2003). One of those studies 
reported a two dimensional crystal of EmrE bound to TPP+ in the presence of lipid (Tate 
et al., 2003). The average images that were collected by electron cryo-microscopy of both 
the native EmrE and the substrate bound-state were compared (Figure 1). The differences 
in the density between the two images showed alteration in structural elements as a result 
of TPP+ binding. Two density regions were associated with substrate binding. The first, a 
positive density (circled in red) predicted to be the bound TPP+. The second, a positive 
density (circled in green) represents the movement of helix H, causing the ends of this 
helix to move away from the center of the EmrE dimer. The position of the TPP+ along 
the axis perpendicular to the membrane plane was not certain due to the low resolution 
(Ubarretxena-Belandia et al., 2003). This small change was strikingly different from 
other family members of multidrug transporters that showed large conformational 
changes (Chang & Roth, 2001; Rosenberg et al., 2001).  
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Figure 1: Structure of EmrE determined by cryo-EM. The density difference obtained by 
subtracting the native state EmrE and TPP+ bound state. The positive differences are in red and 
negative differences are in blue. The density representing TPP+ is ringed in red and the density 
difference identifying the conformational change in Helix H upon TPP+ binding is ringed in 
green. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Proposed model of conformational change of the EmrE dimer based on the cryo-
EM structure during substrate binding and translocation. The cytoplasmic- and periplasmic-
facing EmrE showing the two monomers (A and B) in green with red sphere indentifying E14. 
Each of the TM helices are assigned as M1-M4 for one monomer and M1’-M4’ for the second 
monomer. TPP+ is docked manually, shown in purple (Fleishman et al. 2006). 
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The second study was the published crystal structure of EmrE in the substrate 
bound-state (Y. J. Chen et al., 2007), that yielded a similar helix arrangements to the EM 
model mentioned above (Tate, 2006). In addition, the helices from the X-ray structure 
were superimposable on the EM model with an average root mean square deviation 
(rmsd) of 1.4 Å over equivalent Cα atoms. The crystal structure of the substrate bound-
state was, however, different from the apo-state in pair-wise helix packing and the 
monomer/monomer packing interface. It was suggested that the apo-state crystal structure 
represents the minimal energy fold for helices 1-3 after in vivo synthesis (Korkhov & 
Tate, 2008) whereas helix 4 is in contact with neighboring crystallographic tetramer 
instead of a mobile transbilayer orientation (as shown in Figure 1, chapter V). This 
discrepancy between the apo-state and the substrate bound-state crystal structure (Y. J. 
Chen et al., 2007) provides compelling rational to investigate the conformational changes 
of EmrE upon the binding of the substrate. 
From the model of TPP+ bound EmrE (Fleishman et al., 2006) derived from the 
EM density, a mechanism of binding and translocation was proposed. In this model the 
drug binds to the cytoplasmic-facing binding pocket causing a conformational change 
which closes the cytoplasmic–facing binding pocket and opens towards the periplasmic 
side. It was suggested that the transition of the substrate from the cytoplasmic-facing to 
the periplasmic-facing EmrE involves three important structural changes. First, TM1-
TM3 helices in both monomers reorient by ~20° with respect to the in-plane axis of 
symmetry. Second, TM3 undergoes kinking and straightening facilitated by a GXG 
motif. Third, there is small translation of TM1-3 in both monomers with respect to TM4 
helices (Figure 2). The periplasmic and cytoplasmic facing conformation of the TPP+ 
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bound EmrE are essentially identical but rotated by 180° and would require a single 
substrate binding mode.  
The model proposed above was based on the approximate positions of individual 
amino acids obtained only by biophysical experiments on EmrE and its homologues. 
Therefore, it was necessary in this chapter to make a detailed analysis of the 
conformational changes for each site of EmrE and its contribution to the binding of TPP+ 
that will either support or contradict the models proposed.  
The techniques used to explore the conformational changes of EmrE in a native-
like environment produced by binding of the substrate TPP+ are a combination of EPR- 
power saturation studies, lineshape analysis and double electron-electron resonance 
(DEER) spectroscopy experiments. The significance of this work lies in establishing the 
important conformational changes within the TM helices in the native-like environment 
of lipid bilayers. 
 
 
Experimental Methods 
EPR spectra were obtained on a Varian spectrometer equipped with a loop-gap 
resonator as described in chapter III. Tetraphenylphosphonium was used as a substrate 
for EmrE binding experiments as follows; TPP+ was added to a final concentration of 
16mM to7 μl proteoliposomes (~100 μM EmrE) and then the mixture was incubated at 
room temperature for 20 minutes so that all the TPP+ is bound to EmrE.  
For distance measurements, the substrate was mixed with EmrE in detergent 
micelles. TPP+ was added to a final concentration of 1 mM to 55 μl (200 μM EmrE) 
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sample in detergent containing 30% glycerol. The sample was incubated at room 
temperature for 20 minutes before collecting data at 83 °K (-190˚C). 
 
 
Results and Discussion 
TPP+ Binding Induces Conformational Changes 
 The CW-EPR spectral line shape of spin labeled EmrE mutants in the presence of 
the substrate TPP+ reveals significant changes compared to the apo-state indicating that 
TPP+ binding causes local structural rearrangements of specific regions located 
throughout the transmembrane domains of EmrE. These results are consistent with 
biochemical evidence showing that particular sites from each helix have an important role 
in binding of TPP+ (Elbaz et al., 2005; Rotem et al., 2006; Yerushalmi & Schuldiner, 
2000a) even though the sites that contribute to the binding might vary when using other 
substrates; as it has been shown in the different binding modes when using zwitterionic, 
neutral, or divalent cationic substrates to bacterial multidrug regulators and MDR 
transporters (Godsey et al., 2002; Lewinson & Bibi, 2001). TPP+ was, however, chosen 
for its high affinity in binding to EmrE (Muth & Schuldiner, 2000) that makes it a unique 
candidate in investigating the conformational changes arise during substrate binding. 
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Mobility and Accessibility of TM1  
It has been proposed from the previous chapter that the two monomers of TM1 
pack against each other in the apo-state. This conclusion confirmed previously published 
work in detergent micelles (Koteiche et al., 2003), suggesting that the packing interface is 
a V-shaped chamber where the N-terminal sites are further from the dimer interface. 
Furthermore, biochemical evidence has shown that the N-termini of TM1s are accessible 
to the aqueous environment and do not interact directly with the substrate (Sharoni et al., 
2005). Consistent with these results, the spectral line shape upon TPP+ binding of the N-
terminus of TM1 (residues 3-6) and the loop region, connecting TM1 to TM2 (residues 
23 to 29) are similar to that of the apo-state, indicating no changes to the structure in 
these regions. Sites proposed to be lining the binding chamber (10, 11, 13, and 16) 
demonstrate an increase in the order of the spin label in comparison to the apo-state, as 
shown in Figure 3. Furthermore, upon the addition of the substrate, the distance between 
the spin label sites at position 18 located at the dimer interface increases. This was 
reflected by the loss of spectral broadening.  In contrast, at sites 21 and 22, substrate 
binding causes a decrease in the order of the spin label. These observations suggest that 
the sites facing the same side as E14, such as sites 10, 11, and 18 show the largest 
conformational change upon substrate binding. The experimental data is also supported 
by biochemical evidence, which suggests that the substitution of I11 and T18 by 
cysteines led to compromised transport activity (Mordoch et al., 1999).  
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Figure 3: Conformational changes upon substrate binding reflected in the EPR spectra of 
mutants along TM 1. CW EPR spectra of spin-labeled mutants in TM 1 (residues 3 to 22), loop 
1 (residues 23 to 29) reconstituted in liposomes are plotted in the presence (red trace) and absence 
(black trace) of TPP+. All spectra were recorded at room temperature, with 160 Gauss scan width. 
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To provide a quantitative measure of mobility changes, the reciprocal of the 
central line width (ΔHo-1) is reported in Figure 4. Residues 8, 10, and 11 report increase 
in steric contacts with other regions of the protein as shown from the change in ΔHo-1 
minimum. However, smaller changes are observed for sites 15, 16, 19, and 20 compared 
to the apo-state, suggesting that these sites which are located towards the C-terminal of 
TM1 are less sensitive to the direct binding of the substrate.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Mobility changes in TM1 upon TPP+ binding. Inverse central line width (ΔHo-1) of 
TM1 (residues 3-22) and loop 1 (residues 23-29) in TPP+ bound-state (red trace) and the apo-state 
(black trace). The black dotted vertical line represents the boundary between the two regions. 
 
 
 
 
To better understand the structural basis of these changes in mobility, spin label 
accessibility to NiEDDA and molecular oxygen were investigated as shown in Figure 5 
and Figure 6. For NiEDDA, a reagent exclusively soluble in the aqueous phase, the sites 
located in the vicinity of the proposed substrate binding pocket such as sites 9-12, and 15-
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22 showed small changes in Π (NiEDDA). Changes in NiEDDA accessibility along TM1 
at sites 10, 12, 16, 17, and 20 are relatively small suggesting that the changes in mobility 
do not alter the solvation profile in the vicinity of TM1. The largest changes in Π 
(NiEDDA) are at sites located in the loop region connecting TM1 to TM2 especially for 
sites 23 and 25. By comparison, large site-specific changes in oxygen accessibility are 
observed (Figure 6). The direction of the changes is in agreement with the mobility 
changes. Spin labels located at positions 8 and 15 report the largest changes in Π(O2). In 
the apo-state, these two sites are facing the lipid bilayer and are one turn away from site 
12. Upon the binding of the substrate the oxygen accessibility decreases. This observation 
correlates well with the spectral line shape, since the addition of the substrate increases 
the tertiary contact with surrounding sites. In contrast, spin labeled site 15 shows little 
change in the spectral lineshape upon binding of the substrate, suggesting that the spin 
label site is only affected by the change in the environment without an alteration in 
mobility. The overall oxygen accessibility profile of TM1 upon binding of the substrate 
does not show any phase shift, which indicates that there is no global helix rotation. 
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Figure 5: NiEDDA accessibility changes of TM1 upon TPP+ binding. The NiEDDA 
accessibility of TM1 and Loop 1 in the TPP+ bound-state (blue trace) and in the apo-state (black 
trace). The black dotted vertical line represents the boundary between the two regions. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Oxygen accessibility changes of TM1 upon TPP+ binding. The oxygen accessibility 
of TM1 and Loop 1 in the TPP+ bound-state (red trace) and in the apo-state (black trace). The 
black dotted vertical line represents the boundary between the two regions. 
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TM1 Conformational Changes are Substrate-Specific 
In vivo activity (see Chapter IV) and previous published work have confirmed 
mutation of E14 detrimentally affects the activity of EmrE (Weinglass et al., 2005). We 
took advantage of this observation to establish the specificity of TPP+ induced 
conformational change. For this purpose, an E14A mutation was introduced into selected 
spin labeled EmrE mutants. 
 In the apo-state of EmrE, the spectral line shape at sites 18 exhibits low mobility 
and dipolar splittings at the dimer interface. In the presence of TPP+, the pair of nitroxide 
at position 18 looses the spin-spin interaction, suggesting that the site move further apart 
and becomes in tertiary contact with surrounding sites, reflected by an immobilized 
spectral line shape. Introduction of the E14A background mutation affected the spectral 
line shape of the spin labeled site at positions 18 in the apo-state and reduced dipolar 
coupling. Furthermore, the spectral line shape in the presence of substrate was identical 
to the apo-state (Figure 7 B). This result confirms that the spectral changes are a 
consequence of specific substrate binding.  
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Figure 7: Interaction of sites in TM 1 located in the substrate binding pathway. A) A ribbon 
representation of the two subunits of EmrE (grey and blue). Sites 14 and 18 are colored in 
magenta and orange, respectively. TPP+ (colored in light cyan) is in the center of the binding 
pocket. B) CW-EPR spectra of spin labeled mutant of site 18 plotted in the presence (red trace) 
and absence of TPP+ (black trace). The spectra were recorded at room temperature, with 160 
Gauss scan width. 
 
 
Mobility and Accessibility of the TM2 Helix  
The EPR spectra of spin labeled EmrE mutants of TM2 (residues 30-49) and loop 
2 (residues 50-58) bound to TPP+ are shown in Figure 8. Conformational changes 
induced by TPP+ binding are reflected at certain sites of the helix, such as at the N-
terminus (site 31 to 33). However, the C-terminal region and part of the loop region (sites 
48 to 53), show no change in spectral line shapes. Sites located on the side of the helix 
involved in tertiary contact, such as sites 36, 37, 40, and 44 shows the most significant 
change in the spectral line shape upon substrate binding.  
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Figure 8: Conformational changes upon substrate binding reflected in the EPR spectra of 
mutants along TM 2. CW EPR spectra of spin-labeled mutants in TM 2 (residues 30 to 49), loop 
2 (residues 50 to 58) reconstituted in liposomes are plotted in the presence (red trace) and absence 
(black trace) of TPP+. All spectra were recorded at room temperature, with 160 Gauss scan width, 
except sites 40 and 44 which were recorded with a 200 Gauss scan width.  
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Figure 9: Interaction of sites in TM 2 located in the substrate binding pathway. A) A ribbon 
representation of the two subunits of EmrE (grey and blue). Sites 40 and 44 are colored in 
magenta and blue, respectively. TPP+ (colored in light cyan) is in the center of the binding pocket. 
B) CW-EPR spectra of spin labeled mutant of site 40 (lower left), and 44 (lower right) plotted in 
the presence (red trace) and absence of TPP+ (black trace). The two spectra were recorded at room 
temperature, with 200 Gauss scan width. 
 
 
 
The spectral changes at sites 40 and 44 indicate that TM2 undergoes a 
rearrangement when substrate is bound. Strong spin-spin interaction in the apo-state, as 
evident from the broadening of the spectral line shape, suggests that both spin labeled 
sites are located within close distance at the dimer interface. However, in the substrate-
bound crystal structure site 40 of each monomer is facing away from one another (Figure 
9 A), indicating a change in orientation of this site upon the binding of the substrate. 
Indeed, upon binding of the substrate, site 40 from each monomer moves apart, as shown 
from the decrease in the intensity of the broad spectral features (see arrow in Figure 9 B). 
This may suggest two possible scenarios. Either there is a change in the orientation of 
TM2 upon the binding of the substrate, which is consistent with the reduction in spin-spin 
coupling, or the crystal structure of the substrate bound-state EmrE is a snap shot of one 
of several intermediates. On the other hand, site 44 seems to move closer when the 
131 
 
substrate is bound, which is evident from the increase in the spin-spin interaction at the 
dimer interface (red trace, Figure 9 B).  Sequence analysis has shown Y40 and F44 to be 
conserved within the SMR family of transporters (Arkin et al., 1996; Rotem et al., 2006), 
suggesting that both aromatic residues have an important role in the activity of EmrE and 
also in stabilizing the binding pocket with and without TPP+ (Zheleznova et al., 1999). 
The in vitro fluorescence data (Figure 3, Chapter IV) of the two spin labeled sites suggest 
that both spin labeled mutants at position 40 and 44 seems to bind to TPP+ but with lower 
affinity.  
The reciprocal of the central line width (ΔHo-1) for TM2 sites is reported in Figure 
10. The decrease in ΔHo-1 at residue 31-33 does not represent a change in the level of 
tertiary interactions. Rather, the broadening observed across the spectrum may reflect a 
reduction in the flexibility of the backbone. In contrast, the increase in ΔHo-1 at position 
36 is associated with a change in the line shape reflected by a reduction in steric 
restriction. This observation is consistent with the location of residue 36 on each 
monomer that is on the same side as site 40. Sites 46-54 located in the C-terminal region 
show very little change in ΔHo-1, suggesting that the C-terminal of TM2 is less sensitive 
to the binding of the substrate. The end of TM2 loop region, sites 56-58, shows an 
increase in steric contact. All these changes deduced from the mobility parameters are 
consistent with the EPR spectral line shapes.  
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Figure 10: Mobility changes in TM2 upon TPP+ binding. Inverse central line width (ΔHo-1) of 
TM2 (residues 30-49) and loop 2 (residues 50-58) in TPP+ bound-state (red trace) and apo-state 
(black trace). The black dotted vertical line represents the boundary between the two regions. 
 
 
 
 
To further investigate the change along TM2 environmental parameters such as 
oxygen and NiEDDA accessibility were measured and compared to their values in the 
apo-state. The local changes in Π(NiEDDA), shown in Figure 11, for the spin label at 
positions 30 to 35 at the N-terminus of TM2 reflects a decrease in the collision rate with 
NiEDDA and as a consequence a decrease in water exposure. The loop region connecting 
TM2 to TM3 shows the largest increase in the collision rate of NiEDDA towards sites 52 
and 53, while the remaining loop region is unchanged. Residues 54-58 (Figure 8 and 10), 
report an increase in tertiary contacts when TPP+ is bound, although a small change in Π 
(NiEDDA) is observed. As a result, these changes suggest repacking of the loop region 
induced by TPP+ binding.  
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Figure 11: NiEDDA accessibility changes of TM2 upon TPP+ binding. The NiEDDA 
accessibility of TM2 and Loop 2 in the TPP+ bound-state (blue trace) and the apo-state (black 
trace). The black dotted vertical line represents the boundary between the two regions.  
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Oxygen accessibility changes of TM2 upon TPP+ binding. The oxygen accessibility 
of TM2 and Loop 2 in the TPP+ bound-state (red trace) and the apo-state (black trace). The black 
dotted vertical line represents the boundary between the two regions. 
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Changes in oxygen accessibility (Figure 12) correlates with those of NiEDDA 
accessibility at the N-terminus of TM2. An increase in oxygen accessibility upon 
substrate binding coincides with a decrease in the collision rate of NiEDDA suggesting 
that this part of the helix moves further into the lipid bilayer. Further into the helix, the 
spin label at position 36, which is one turn away from site 40, also show an increase in 
oxygen accessibility. This is consistent with the EPR spectral line shape and the mobility 
changes shown in Figures 8 and 10, where the binding of the substrate causes the spin 
label at position 36 to increase in mobility. In contrast to the changes observed in the N-
terminal region, the C-terminal and the loop region shows very little change with respect 
to the apo-state.  
 
Mobility and Accessibility of TM3 Helix 
EPR spectral line shape changes of each spin labeled mutant along TM3 are 
shown in Figure 13. Sites located at the N-terminus of TM3 show a conformational 
change when TPP+ is bound. It was mentioned in chapter V that residue 60 is at the dimer 
interface and is located near the N-terminus of TM3. The binding of the substrate 
marginally increases the dipolar coupling between the two spin labels at the dimer 
interface. This is also observed for site 61, where substrate binding causes the spin 
labeled sites to move closer toward one another as evident from a decrease in the spectral 
amplitude and broadening of the line shape. The conformational changes are detected in 
the EPR parameters of residues facing the same side of the helix as residue 60, 
specifically 63, 64 and 68.  
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Figure 13: Conformational changes upon substrate binding reflected in the EPR spectra of 
mutants along TM3. CW EPR spectra of spin-labeled mutants in TM 3 (residues 59 to 75), loop 
3 (residues 76 to 84) reconstituted in liposomes are plotted in the presence (red trace) and absence 
(black trace) of TPP+. All spectra were recorded at room temperature, with 160 Gauss scan width, 
except sites 80, and 82-84 were recorded with 100 Gauss and 64 with 200 Gauss. 
 
 
136 
 
60
60
61
61
64 64
S64C-SLY60C-SL A61C-SL
A)
B)
At site 64, the addition of the substrate causes the spin labels to move closer toward one 
another, as reflected by an increase in the spectral broadening observed at the low and 
high field of the spectral line shape (see arrow in Figure 14 B). The spectrum, similar to 
that of 14 and 40 spectral line shapes (see Figure 2, chapter V), has two distance 
components. One component is due to van der Waals contact between the labels, while 
the second is at a distance more than 20 Å apart. Therefore, the largest changes upon the 
binding of TPP+ are observed at sites located at the N-terminus of TM3 towards the 
middle of the helix. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: Interaction of sites in TM3 located in the substrate binding pathway. A) A ribbon 
representation of the two subunits of EmrE (grey and blue). Sites 60, 61, and 64 are colored in 
magenta, red and blue, respectively. TPP+ (colored in light cyan) is in the center of the binding 
pocket. B) CW-EPR spectra of spin labeled mutant of site 60 (left), 61 (center), and 64 plotted in 
the presence (red trace) and absence (black trace) of TPP+.  
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Figure 15: Mobility changes in TM3 upon TPP+ binding. Inverse central line width (ΔHo-1) of 
TM3 (residues 59-75) and part of loop 3 (residues 76-79) in TPP+ bound-state (red trace) and the 
apo-state (black trace). The black dotted vertical line represents the boundary between the two 
regions. 
 
 
The quantitative measurement of the mobility of sites in TM3 is reported in 
Figure 15. Most of the sites in TM3 show a change in ΔHo-1 in the presence of TPP+, 
especially for sites that are located in the N-terminus (60-66) and less towards the C-
terminal. The N-terminal region of TM3 is surrounded by other helices, thus the sites that 
showed a decrease in ΔHo-1 suggest that the spin label sites increase in steric contacts 
upon the binding of the substrate. 
 Changes reported for TM3 are consistent with two lines of biochemical evidence. 
First, Y60, is highly conserved within the SMR family (Ninio et al., 2001). The 
replacement of Y60 with an aromatic residue such as phenylalanine results in an inactive 
protein (Yerushalmi et al., 1996). This has also been confirmed in our lab, where 
mutation of Y60 to a cysteine did not yield a functional phenotype on solid media (see 
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Chapter IV). An in vitro binding activity assay has shown that the replacement of Y60 
with cysteine has a detectable TPP+ binding activity only at high concentrations (Figure 
4, Chapter IV). Also, previous published data have proposed that the tyrosine residue at 
position 60 has a major role in the transport activity where the hydroxyl group must be 
positioned in the exact place for its influence to be optimal (Rotem et al., 2006). Second, 
the two glycine residues at position 65 and 67 (GXG or GG1 motif; two glycine residues 
separated by one amino acid) are also conserved in the SMR family of multidrug 
transporters (Liu, Engelman, & Gerstein, 2002). Replacement of G67 with another amino 
acid yields a protein that does not confer resistance (Elbaz et al., 2008) (also see Chapter 
IV). In addition, glycine residues introduced in other proton-coupled transporters such as 
lactose permease (Weinglass, Smirnova, & Kaback, 2001) led to an increase in 
conformational flexibility. Moreover, the motif GXG also exists in potassium channels, 
and acts as a gating hinge (Jiang et al., 2002). Thus, TM3 may well participate in both the 
structural and functional aspects of EmrE. It is noted that the changes in the EPR spectral 
line shape may not be due to direct contacts with the substrate but could be due to 
backbone conformational dynamics (evidence supporting this interpretation will be 
presented in Figure 18).  
NiEDDA accessibility of TM3 is shown in Figure 16. The overall accessibility is 
low and the pattern is not periodic, consistent with TM3 being predominantly in the lipid 
bilayer. The change in NiEDDA accessibility observed at the C-terminal and loop region 
(74-79), specifically for site 79, suggests that this site moves towards the lipid-water 
interface upon TPP+ binding.  
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Figure 16: NiEDDA accessibility changes of TM3 upon TPP+ binding. The NiEDDA 
accessibility of TM3 in the TPP+ bound-state (blue trace) and in the apo-state (black trace). The 
black dotted vertical line represents the boundary between the two regions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17: Oxygen accessibility changes of TM3 upon TPP+ binding. The oxygen accessibility 
of TM3 in the TPP+ bound-state (red trace) and in the apo-state (black trace). The black dotted 
vertical line represents the boundary between the two regions. 
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The oxygen accessibility of TM3 is shown in Figure 17. The phase of the periodic 
pattern along TM3 sites in the substrate bound-state is very similar to the apo-state, 
suggesting the absence of significant rigid body rotation. Sites 60-68 show a decrease in 
Π(O2) upon the binding of TPP+, which when correlated with the EPR spectral line 
shapes, suggest that the increase in steric contacts causes a decrease in oxygen 
accessibility.  The C-terminus of TM3, especially near the loop region (75 and 76) shows 
a decrease in oxygen accessibility that is in phase with NiEDDA accessibility upon TPP+ 
binding. This suggests that the C-terminal and the loop region change their packing due 
to the flexibility of the helix when the substrate is bound. To further investigate the 
flexibility of TM3, especially at the C-terminus, distances were measured between spin 
labels at sites 68, 71, 74, and 76 (Figure 18 A).  
Given that EmrE is a dimer, there would be two equivalent cysteine residues. 
After spin labeling, the two spin labeled probes might show spin-spin interaction such as 
for site 60. If the distance between the two spin labeled sites is more than 25Å, DEER is 
used to measure the dipolar interaction. The distance measurement is an important 
constraint for the analysis and determination of protein structure and conformational 
changes that will give both magnitude and direction of global movements.  
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Figure 18: DEER distance measurements of inter-probe residues located in TM3 with and 
without TPP+. A) A ribbon representation of the two subunits of EmrE (grey and blue). The 
TPP+ is shown in light cyan. The location of sites 68, 71, 74, 76 are colored in magenta, green, 
orange, and blue, respectively. B) The distance distribution from the DEER experiments of the 
spin labeled site 68 (upper left), 71 (upper right), 74 (lower left) and 76 (lower right), in the 
presence (red trace) and absence (black trace) of TPP+. 
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The DEER analysis suggests that the binding of the substrate decreases the width 
of the distance distribution. The multi-modal distance distribution (Figure 18 B) in the 
apo-state of sites 71, 74, and 76, indicates multiple conformers of EmrE of by the 
structure of the loop connecting TM3 and TM4. The change in the shape of the distance 
distribution may be facilitated by glycine residues located at positions 65 and 67 of TM3 
(Elbaz et al., 2008), forming a flexible joint in the helix. As a result, the binding of TPP+ 
seems to increase the order of the distance distribution for sites that are located at the C-
terminal of TM3. Overall, TM3 is a highly flexible helix and its flexibility is decreased 
when TPP+ is bound.  
The model shown in Figure 1 had proposed that the transition of the substrate 
from the cytoplasmic-facing to the periplasmic-facing EmrE involves kinking and 
straightening of TM3 which was in agreement with the results mentioned above. 
However, the DEER results seem to indicate that the transition between the two sides of 
the lipid bilayer is not a one-step conversion but may involve intermediates between the 
two states. This was well illustrated for the spin label at site 64 upon the binding of the 
substrate, where the EPR spectral line shape suggests the existence of two components. 
The two components are indicative of possible heterogeneity in the EmrE dimer.  
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Figure 19: Conformational changes upon substrate binding reflected in the EPR spectra of 
mutants along TM4. CW EPR spectra of spin-labeled mutants in TM 4 (residues 85 to 103), 
loop 4 (residues 104 to 110) in detergent micelle are plotted in the presence (red trace) and 
absence (black trace) of TPP+. All spectra were recorded at room temperature, with 160 Gauss 
scan width. 
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Mobility of TM4 Helix 
Little if any changes in the EPR spectral line shapes of TM4 (residues 85 to 103) 
and loop 4 (residue 104 to 110), are induced by TPP+ binding in detergent micelles as 
shown in Figure 19. This suggests that the TM4 helix does not undergo rigid body 
movement upon TPP+ binding. As a result, we did not further investigate the changes in 
mobility of TM4 reconstituted in liposomes. Several studies demonstrating that the sites 
located in TM4 do not contribute to substrate binding (Gottschalk et al., 2004; Soskine et 
al., 2002). However, TM4 may have a significant function in dimerization, since two 
essential glycine residues at position 90 and 97 are conserved and form a protein motif, 
GG7, where the glycines residues are separated by six other residues. This motif was 
observed in transport/channel-like membrane proteins (Liu et al., 2002). Substituting the 
glycines to cysteines in these positions increases aggregation (see Figure 2, Chapter IV).  
 
Mapping the Changes in O2 and NiEDDA Accessibility with TPP+ bound 
To visualize the overall pattern of the average conformational changes revealed 
by the oxygen and NiEDDA accessibility data in a structural context, both were mapped 
onto the TPP+ bound-crystal structure of EmrE (Figure 20). Changes in oxygen and 
NiEDDA accessibility were calculated by subtracting the accessibility of the TPP+ 
bound-state from the apo-state to observe the largest changes when the substrate is bound 
to EmrE. 
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Figure 20: Mapping the ΔΠ(O2) and ΔΠ(NiEDDA) onto the crystal structure of TPP+ 
bound EmrE. A)  ΔΠ (O2) along residues 6-79.  The residues are represented by sticks. The (ΔΠ 
(O2)) is encoded by three colors: blue stands for decrease, white stands for no change, and red 
stands for increase in O2 accessibility. 
B) ΔΠ (NiEDDA) along residues 6-79. The residues are represented by sticks. The ΔΠ 
(NiEDDA) is encoded by three colors: red stands for decrease, white stands for no change, and 
blue stands for increase in NiEDDA accessibility. 
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The mapped changes in the oxygen accessibility (ΔΠ(O2)) are shown in Figure 20 
A. An overview of the data shows that sites located within the lipid bilayer have the 
largest change when the substrate is bound.  
The changes observed describe a pathway through which the substrate may 
permeate. Thus, the middle of TM1, the N-terminus of TM2, and the full length of TM3 
show the largest change in oxygen accessibility. For TM1, the changes are observed at 
residues 8, 11, 12, and 15 that are near the region of the substrate binding pocket. The N-
terminus of TM2 moves further apart from the dimer interface, while the C-terminus of 
the helix shows less change. This implies that the N-terminus might accommodate the 
hydrophobic substrate to enter the lipid bilayer. In TM3, the changes in the N-terminus 
accessibility are related to the close contact of the sites in the first turn of the helix at the 
dimer interface.  In the C-terminus the changes are related to the complete movement of 
the loop region connecting TM3 to TM4.  
 The change in NiEDDA accessibility (ΔΠ(NiEDDA)) is reported in Figure 20 B. 
There were no changes observed for sites located near the drug binding pathway. This 
indicates that TPP+ binding has little effect on the hydration of the transmembrane 
segments. The changes are only observed at specific sites located in the loop regions 
connecting each of the four transmembrane segments. These changes in NiEDDA are in 
accordance with the ΔΠ (O2), suggesting that the movement of the transmembrane 
segments induced by TPP+ binding causes the repacking of the loop regions. 
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Evaluating the Alternating Access Model of EmrE 
Alternating access models propose that substrate transport entails a change in the 
orientation of the substrate binding site between the two sides of the membrane. This in 
turn would lead to translocation of the substrate. The results presented in this chapter 
suggest not global but local conformational changes upon the binding of TPP+ to EmrE. 
Most of the changes in the EPR spectral line shapes are observed at sites that are near the 
substrate binding pocket such as sites 10, 18, and 64. However, one of the alternating 
access models, the rocker-switch model, proposes a motion of rocking or tilting around 
the binding site near the center of the membrane. The sites that are in direct contact with 
the substrate changes position the least in comparison to the motion at the extreme ends 
of the TMSs (Forrest & Rudnick, 2009). In our EPR result section of the first three TM 
helices of EmrE, the changes in the accessibility do not show any phase shift that would 
suggest a rotation of the transmembrane helices. The accessibility data suggest local 
changes in the N- and C-terminus of the TM helices that are related to changes in steric 
contacts with other sites of surrounding helices. This suggests a small tilt in the 
transmembrane helices. The changes, especially for TM3 in the N-terminus may serve to 
stabilize the substrate, while its flexible C-terminal region possibly serves to occlude the 
substrate from one side of the membrane; thus, TM3 has an important structural function 
that needs further investigation. 
EmrE is made of two identical monomers that have been proposed by both the 
EM model and the crystal structure to be arranged in an antiparallel asymmetric dimer. In 
most cases, however, membrane transport proteins that use alternating access have 
internal structural symmetry but not sequence symmetry (Forrest et al., 2008; Huang, 
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Lemieux, Song, Auer, & Wang, 2003; Zhou, Guan, Freites, & Kaback, 2008). For EmrE, 
an alternating access mechanism implies that identical residues on either side of the 
membrane would undergo distinct interactions with neighboring residues. The inverted 
monomers of EmrE may create a pathway that is symmetrical from either side of the 
membrane. This agrees with the proposed model of EmrE bound to TPP+ (Fleishman et 
al., 2006) where both the periplasmic- and cytoplasmic-facing side are identical but 
inverted by 180°.  
One question that persists is how can two identical monomers possess different 
conformations and interactions? Previously, it was suggested that one monomer during 
the transport cycle may be unstable, and therefore requires the second monomer to 
stabilize it (Ubarretxena-Belandia et al., 2003). To elucidate the importance of the 
asymmetry of EmrE would require a higher resolution structure of different 
conformational states. 
 
Conclusion 
 The TPP+ induced structural changes of EmrE in liposomes were investigated 
using SDSL EPR spectroscopy to characterize the local dynamics, accessibility, and 
distance of the spin labels in the dimer. The changes in the EPR data between the apo- 
and substrate bound-intermediates of EmrE in liposomes were compared to the crystal 
structure in detergent micelles.  
 The EPR data mapped onto the crystal structure of the substrate bound-state 
report changes distributed on both sides of the asymmetric dimer. The changes were 
prominent in the N-terminus of TM2 and along the full length of TM3. The tilt at the N-
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terminus of TM2 provides direct access to the bilayer from which hydrophobic substrates 
may enter. For TM3, the N-terminus moves closer towards the dimer interface, while the 
C-terminal and the loop region connecting TM3 to TM4 undergoes large amplitude 
motion. In TM1 the sites that were in direct contact with the substrate such as site 10 and 
18 showed large distance changes. Hence, the data reported in this chapter contradicts the 
proposed model that is shown in Figure 2 (Fleishman et al., 2006), where there is no net 
change in residues environment, or proximity across the dimer interface during the 
transition from one side of the membrane to the other.  
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CHAPTER  VII 
 
 
 
 
HELIX PACKING IN THE EMRE MONOMER  
 
 
 
 
Introduction 
 The accessibility data reported in Chapter V and VI revealed fundamental 
discrepancies between the crystal structure and the liposome structure. These include 
local steric packing in regions of helices 2 and 4 and the orientation of helix 3 relative to 
the lipid phase. While these differences may reflect the effects of detergent solubilization 
on the structure, they can also be a consequence of the low resolution of the published 
crystal structure deposited as a Cα carbon trace. The apo- and substrate bound-state were 
solubilized and crystalized using nonyl glucoside (NG) detergent micelle. Experimental 
data suggested that using NG to solubilize EmrE increases the monomeric fraction, 
leading to weaker interaction  between the monomers in the functional EmrE dimer (see 
Figure 1, Chapter IV). Therefore, the interface between adjacent helices within each 
monomer may also be distorted.  Conversely, solubilizing EmrE with β-DDM detergent 
micelle showed an increase in the stability of the EmrE dimer (Soskine et al., 2006; 
Soskine et al., 2002). In this chapter, we explore the veracity of the crystallographic 
model by determining the relative proximity between helices in the monomer.  
Confidence in the crystal structure is based on the position of the 
selenomethionine (SeMet) at positions 21, 91 and 92 in each monomer.  The Se heavy 
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atom was used to solve the phase problem, emphasizing that the pair of SeMet residues in 
the dimer are consistent with an antiparallel orientation. In addition, the Cα model of the 
crystal structure is practically identical to the Cα model derived from the 2D crystals (Y. 
J. Chen et al., 2007). The antiparallel orientation of the two monomers was investigated 
previously by studying the global topology analysis of a large fraction of the E.coli 
membrane proteins using reporter proteins (Daley et al., 2005). Reporter proteins, 
alkaline phosphatase (PhoA) that can only fold into an active protein when present in the 
periplasm (Manoil & Beckwith, 1986), and the green fluorescent protein (GFP) that 
fluoresces only when present in the cytoplasm (Feilmeier, Iseminger, Schroeder, Webber, 
& Phillips, 2000) were used to locate the C-terminus of membrane proteins. The results 
suggested that EmrE may have dual topology, suggesting architecture similar to the 
internal structural symmetry found in several membrane proteins, such as the ClC 
channel and aquaporin (Dutzler et al., 2002; Murata et al., 2000). The topology data were 
also supported by mutational studies, showing that EmrE fused to the reporter proteins in 
the membrane is sensitive to the distribution of positive charges (Rapp et al., 2006; Rapp 
et al., 2007).  
 Using mutations in positive charge distribution of EmrE similar to those done by 
von Heijne and collaborators (Rapp et al., 2007), a recent publication from our laboratory 
concluded that the helix-helix interaction supersedes the positive bias near the neutral 
region (McHaourab et al., 2008). This is also supported by previous studies showing that 
the folding of the membrane protein seems to be defined by many forces, such as the 
insertion of the TM helices of the protein into the bilayer, interactions within the protein 
itself, and also the interactions of the lipid and protein (Bowie, 2005; Hessa et al., 2007; 
152 
 
L. Zhang et al., 2007). Existing biochemical data is more consistent with parallel 
assembly of the EmrE monomers. Ninio and colleagues concluded both in a whole cell 
and under native conditions that the loops connecting transmembrane segments one and 
two of EmrE are in the periplasmic side while the two sites located near the C-terminal 
end are in the cytoplasmic side (Ninio et al., 2004). Previous work had also used a unique 
approach where the monomers are connected tail to head (C-terminus of the first with N-
terminus of the second monomer) by a defined linker that was not compatible with 
antiparallel topology. The fused dimer of EmrE (tandem-EmrE) showed indistinguishable 
functional characteristics to the wild-type EmrE, concluding that the tandem-EmrE has 
parallel topology (Steiner-Mordoch et al., 2008). These results clearly show that parallel 
topology EmrE is functional. In contrast, the functionality of the antiparallel dual 
topology dimer has not yet been proven.  
In summary, compelling evidence for an antiparallel monomer packing from EM 
analysis and the symmetry of the SeMet densities in the crystal structure are balanced by 
biochemical data supporting a parallel orientation. There are also concerns regarding the 
effects of detergent solubilization on the crystal structure. It is, therefore, important to 
analyze the arrangement of helices in the EmrE monomer since the in plane symmetry is 
only compatible with specific topologies. One of the goals of this chapter is to challenge 
the monomer packing model deduced from the crystal structure and supported by the 
EM-based computational model. For this purpose, spin label pairs were introduced at 
sites predicted to be separated by less than 20 Å in neighboring helices. The pattern of 
proximity deduced from CW-EPR analysis and DEER confirm the topology of helices 1-
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3 in the monomer. However, the EPR distance restraints suggest significant distortion in 
the crystal structure.    
 
Experimental Methods 
The double cysteine mutants were made on a cysteine-less EmrE (WT*) 
background. Purification and labeling were done as described in Chapter III. All the EPR 
spectra of the detergent samples for the spin labeled double mutants have a final protein 
concentration of 100μM obtained on a Varian EPR spectrometer equipped with a loop 
gap resonator as described in chapter III. DEER was used to collect the distance 
measurements for the double spin labeled samples at a final protein concentration of 200 
μM containing 30% glycerol. All DEER distance data were collected at 83°K (-190°C).  
 
Subunit Exchange 
The detergent purified doubly labeled samples were mixed with unlabeled 
cysteineless-EmrE (EmrE-CLA) at a molar ration of 1:2. The mixture was desalted on a  
desalting column (HiTrap, GE Healthcare ) pre-equilibrated with SEC buffer (50 mM 
sodium phosphate monobasic, 50 mM NaCl, and 0.02% β-DDM, and 0.02% NaN3, pH 
7.2) containing 0.8 mole fraction of sodium dodecyl sulfate (SDS). After desalting, the 
unfolded mixture was incubated at room temperature for 15 minutes, and then refolded 
by passing it through a SEC superdex-200 column equilibrated with SEC buffer without 
SDS. The CW-EPR spectra of the refolded and the unfolded samples were obtained on a 
EMX Bruker spectrometer. The above procedure was repeated for a negative control 
sample without the addition of WT*.  
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Molecular Modeling  
A molecular model of the side chains from the known crystal structure of EmrE 
(PDB ID: 3B5D; (Chen, 2007)) was manually constructed by Nathan Alexander in 
Meiler’s lab at Vanderbilt University. 
The distance between a pair of nitroxides (NO-NO) was estimated using the χ4χ5 
model, as shown in Figure 6, Chapter II (Columbus et al., 2001; Langen et al., 2000). 
This model takes into consideration that the first three bonds (χ1, χ2, χ3) between the Cα 
of the spin cysteine and the nitroxide ring are fixed, while the dominant contribution to 
the motion of the nitroxide is about the χ4 and χ5 bonds.  
These distances were calculated using the program “CalDihedral.exe” designed 
by Marco Bortolus. The position of the label is calculated by projecting along the α-β 
carbon bond at a desired distance. To account for the tether flexibility, error estimation is 
calculated assuming that a label can be found in a cone whose vortex is centered on the α-
carbon. Therefore, the program takes into account the projection of the α-β carbon and 
the tilt in the cone. This would reconcile the distance obtained by EPR experiments with 
the backbone distance. 
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Results and Discussion 
Characterization of the Double Mutants 
The packing of the helices of EmrE in the monomer and the orientation of its 
residues were investigated. Nitroxide spin labels were introduced at cysteine pairs 
between all possible helix pairs, TM1 and TM2, TM1 and TM3, TM1 and TM4, TM2 
and TM3, TM2 and TM4, and finally between TM3 and TM4. 
The spin label double mutants were fully characterized using a tryptophan 
fluorescence quenching assay (Elbaz et al., 2005), as described in Chapter IV.  The 
tryptophan at position 63 is sensitive to substrate binding and/or conformational changes. 
Thus, the tryptophan fluorescence of each of the double spin label mutants was measured 
in the presence of TPP+ and the level of quenching compared to the cysteine less-EmrE 
(WT*). The addition of saturating amounts of TPP+ to each of the double mutants 
induced quenching of tryptophan florescence that was similar to WT* (Figure 1) with no 
detectable shift in the emission maxima. Overall, the structure of EmrE was not 
compromised by the double cysteine substitutions.   
In addition, the hydrodynamic profiles of the double mutants was compared to the 
WT* using size exclusion chromatography (SEC) (data not shown). The purified spin 
labeled mutants had similar retention time to WT*, signifying no disruption of the 
dimeric structure. 
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Figure 1: In vitro substrate binding of the double spin labeled mutants of EmrE. A 
bar graph of EmrE tryptophan (Trp) florescence in the absence (black bar) or in the 
presence of saturated amount of TPP+, 6 μM and 12 μM in red and blue bar, respectively. 
The three graphs signify the location of the double spin label mutants in the TMS; A) 
TM1/TM2, B) TM1/TM3, C) TM1/TM4, TM2/TM4, and TM3/TM4. All mutants were 
compared to the unlabeled cysteine-less EmrE (WT*).  
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Figure 2: Pair-wise distances relating spin labels in the EmrE dimer. Structure of 
EmrE viewed perpendicular to the membrane plane. The two monomers of EmrE are 
colored in blue and wheat. The red sticks represent two sites located in each monomer. 
The black dotted lines represent the distance measured within the monomer or between 
monomers. 
 
 
Methodology 
EmrE is a dimer, thus the interpretation of the chosen double mutants in the 
monomer is complicated. Each of the two monomers would have two spin labeled sites, a 
total of 4 spin labeled sites in the dimer, and therefore six distance probabilities, as shown 
in Figure 2. This is not an issue for short range distance (8-20 Å) since in general the 
inter-monomer distances tend to be outside the range of dipolar coupling interactions and 
thus do not contribute to the spectral broadening of the EPR lineshape. For the 
measurements of distance between the chosen double labeled sites separated by a 
distance between 25 to 60 Å, double electron electron resonance (DEER) is used (review 
by (Pannier et al., 2000), also see introduction to EPR measurements, Chapter II). To 
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overcome the complexity of the resulting distance distribution, each of the intra-doubly 
labeled sites were normalized then compared to the DEER distance distribution of the 
inter-singly labeled sites to identify their contribution to the average intra-distance 
distribution in the monomer.  
For the intra-spin labeled sites that are separated by a distance of less than 18 Å 
showing strong spin-spin interaction the measurements can only be determined by CW-
EPR spectra. A convolution method utilizing a spectrum comprised of the sum of the 
corresponding single mutants was used to determine the distance distribution (Rabenstein 
& Shin, 1995).  
 
Is EmrE Domain Swapped?  
 Domain swapping is an efficient way of forming oligomers since the interactions 
of the helices within the monomer are used in the dimer. Evidence of domain swapping 
was first observed in G-protein coupled receptor activation mechanisms (Gouldson, 
Snell, & Reynolds, 1997). The published EM model and the crystal structure of the 
substrate bound-state of EmrE did not reveal evidence of domain swapping (Y. J. Chen et 
al., 2007; Fleishman et al., 2006). As a result, interpenetration of helices from one 
monomer with helices from another monomer (i.e. domain swapped) was ruled out.  
To confirm that EmrE helices are not swapped in the dimer, we selected pairs of 
mutants, 16/39 and 19/74 between helices 1 and 2, and 1 and 3. Only 16/39 was predicted 
to be in close proximity in the crystal structure. As a control, we selected a double mutant 
combining sites 22 and 56 at the dimer interface. The EPR spectra of all three doubly 
labeled sites are broadened by dipolar coupling (Figure 3, blue trace), indicative of 
nitroxides that are in close proximity. 
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To definitively demonstrate that spin-spin coupling arises from proximity within 
the monomer, each of the doubly labeled mutants was unfolded using SDS as a 
denaturant to dissociate the dimer (Lau & Bowie, 1997). The unfolded EPR spectra 
(dotted grey trace for only 19/74 and 22/56) are shown in Figure 3 A and 3 C, 
respectively. Mixing the denatured 19/74, 16/39 and 22/56 with the denatured unlabeled 
cysteine-less EmrE (WT*) followed by refolding did not eliminate the spectral 
broadening especially for site 19/74, which confirms the spin-spin interaction arises from 
the close proximity of the two nitroxide at position 19 and 74 within the monomer. In 
contrast, the spectrum of the positive control 22/56 showed a complete loss of spectral 
broadening confirming that both sites 22 and 56 are located at the dimer interface (Figure 
3 C). A relatively limited loss of broadening in the 16/39 pair results from the elimination 
of spin-spin coupling at site 39 across the dimer interface (Figure 3 B).  
The data suggests that TM1 and TM3 are not swapped in the dimer. Yet, the 
increase in amplitude of the central resonance line of 16/39 when mixed with the WT* 
(Figure 3 B) indicates that either the TM2 helices are swapped in the dimer, or the 
spectral broadening of 16/39 has contribution from dipolar coupling at site 39 at the 
dimer interface. 
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Figure 3: CW-EPR spectra for the subunit exchange of the intra- and inter-spin 
label sites. The EPR spectra of A) 19/74; B) 16/39; C) 22/56, shown in blue trace. The 
unfolded spectra are shown in dotted grey trace with the exception of 16/39 (spectra was 
not collected). The spectra of the refolded sample are shown in black trace. The grey 
solid trace spectra are the subunit exchange of the doubly labeled sites with WT*. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: CW-EPR spectra for the subunit exchange of the spin label site 39.  A) 
Spectral line shape of spin labeled site 39 is shown in blue trace. The refolded spectra 
(black trace). B) The subunit exchange spectra of 39 with WT* is shown in grey trace 
The inset is showing the high field spectral line shape change. 
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To explore the latter possibility, EPR spectra of the site 39 mutant refolded in the 
presence and absence of WT* were obtained (Figure 4 B). The result shows a decrease in 
the broadening of the spectral line shape (inset, Figure 4 B). Together with the analysis of 
Figure 3, this data suggests that TM2 is not swapped in the dimer.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Double mutants for TM1/TM2 packing modeled onto the EmrE crystal 
structure. The two monomers are represented in blue and wheat colored ribbons. The 
mutation sites in both transmembrane segments are shown as red sticks for only one 
monomer. The horizontal dashed line (light grey) shows the location of sites in the 
middle of the bilayer. The predicted lipid bilayer is indicated by two horizontal lines. The 
black arrow shows the predicted rotation of the helix from experimental data.  
 
 
The spin labeled double mutants was fully characterized for the spatial 
arrangement of the transmembrane segments in the monomer by CW-EPR. The line 
shapes are shown in Figures 6, 7, 10, 12, and 13. For a subset of mutants, distances were 
measured by DEER as illustrated in Figure 8 and reported in detail in Tables 1, 2, and 3. 
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The corresponding CW-EPR spectra of the double mutants upon TPP+ binding are shown 
in the appendix. In general, the spectral line shapes were similar to those of the apo-state.   
 
Intra-Monomer Distances between Residues Located in TM1 and TM2 
Evidence from several biochemical and biophysical studies have proposed that 
sites located in both TM1 and TM2 have an important contribution to the activity of 
EmrE, including stabilizing, binding, and translocation of the substrate (Rotem et al., 
2006; Sharoni et al., 2005; Yerushalmi et al., 2001). In contrast, the spatial proximity of 
these two TM segments in the monomer has not been validated. The published crystal 
structure of EmrE in the apo-state is proposed to be in a misfolded form. The only 
structural evidence that has been published regarding the two transmembrane segments is 
from the crystal structure of the substrate bound-state where it has been proposed that 
TM1 and TM2 are in close proximity in the monomer.  
 The sites that were chosen to investigate the proximity of TM1 and TM2 are 
show in Figures 5. The spectral line shape of each of the double mutants is shown in 
Figure 6 and 7. To avoid destabilizing the monomer fold, spin labels were introduced at 
the lipid-exposed surface of the helices as defined by the oxygen accessibility profile in 
Chapter V. CW-EPR spectra for each of the double labeled mutants were collected in the 
apo- and TPP+ bound-states (see the appendix, pages 210 and 211). All the chosen pairs 
in this chapter did not show large changes in spectral line shape upon substrate binding. 
Thus, the spectral line shape of the apo-state doubly-labeled mutants was compared to the 
crystal structure of the substrate bound-state.  
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Out of the 17 chosen sites only 7 (Figure 6) showed spectral broadening 
consistent with two spin labels in close proximity (quantitative analysis of the CW-EPR 
spectra is shown in the appendix, page 209). This is reflected by a decrease in spectral 
amplitude (and line width increase) of the CW-EPR spectra of the doubly labeled mutants 
with respect to the sum of the single mutants. In the apo-state accessibility data (Chapter 
V), site 12 had the highest oxygen accessibility, indicative of a site that is in the center of 
the TM1 helix and facing the lipid bilayer. Sites 16 and 20 are one and two turns away 
from site 12, respectively, facing the lipid bilayer. The spectra of 12/39, 16/39, and 20/39 
are broadened relative to the EPR spectrum of the sum of singles. Spectral simulation 
yields distances consistent with the direct packing of the two helices.   
To further investigate the TM1/TM2 interface, spin labels were introduced at sites 
16/38 and 15/38. Broadening was evident in the spectrum of 16/38 while the spectrum of 
the 15/38 double mutant and sum of singles are superimposable. Thus, residue 15 is away 
from the interface with TM2 consistent with the handedness implied by the crystal 
structure. Inconsistencies between the experimental data and the crystal structure are 
observed at a number of sites. These are highlighted in Figure 7 where the line shapes of 
the double mutants are similar to the corresponding sum of the single mutants, suggesting 
that none of the spin labels are in close contact as predicted by the crystal structure. 
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This is evident when comparing the EPR spectra of the doubly labeled mutant 
20/36 (Figure 7) with 20/35 (Figure 6). Two of these chosen sites 20 and 36 seem to be in 
close contact in the crystal structure while site 35 is facing away from site 20. EPR 
spectra of 20/36 showed no indication of spin-spin interaction, in contrast to the EPR 
spectrum of 20/35. Similarly the pairs 23/32 and 23/33 (Figure 6) are proposed from the 
crystal structure to be well within the range of strong dipolar coupling. Nevertheless, the 
EPR spectral line shapes show only 23/32 in close proximity in the monomer as indicated 
by spectral broadening. It is noted that the crystal structure had proposed both residues 32 
and 33 are located in the loop region connecting TM1 to TM2; however the accessibility 
data (see Chapter V) suggest that these two sites are within the N-terminus of TM2.  
To support the qualitative interpretation from the EPR spectral line shape in 
Figure 7, distances were measured using DEER. DEER is not affected by under labeling 
which could mask the dipolar coupling in CW-EPR analysis. As mentioned previously, to 
avoid the contribution of the multiple distance distributions expected from the labeled 
double mutants, the DEER distance distributions were compared to the corresponding 
single mutants. Only the peak distance of the intra-spin labeled distance was extracted 
and presented for the rest of the mutants (shown in Table 1 and Figure 8). Average 
distances were then compared to the distance predicted from the crystal structure. The 
spin label was modeled onto the wild type crystal structure to extrapolate the position of 
the label (see experimental methods). Table 1 shows that the experimental data does not 
agree with the molecular modeling of the spin labeled side chains at each of the chosen 
sites based on the static crystal structure. In some cases, such as the doubly labeled site 
20/36, the two residues in the monomer are at a distance of less than 11Å. The average 
167 
 
Residue  # R (Å) σ (Å) Ca- Ca (Å)
Monomer A
Ca- Ca (Å)
Monomer B
NO-NO (Å)
Monomer A
NO-NO (Å)
Monomer B
12/42 19 8.6 9.7 12.8 7 18.7
15/38 24 7.8 12.4 14.2 16.7 26.3
15/42 25 7 11.4 13.2 10.4 19.8
16/34 22 7.8 11.7 12.5 17.7 19.6
19/34 22 8 12 11.5 19.85 22.7
19/36 23 7.6 8.6 9.5 9.8 7
19/39 18 8.3 9.6 11.6 3 8.7
20/34 18 9.1 8.7 7.7 11 14.5
20/36 20 9.7 9.6 6.3 10.3 10.3
23/33 23 2 7.63 7.04 10.8 8.4
distance calculated from the EPR spectrum is ~ 20 Å. The pattern of deviation between 
the EPR data and the crystal structure suggests that there are fundamental distortions at 
the N-terminus of helix-2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Intra-monomer distance between selected sites located in TM1 and TM2 
determined by DEER. The grey shaded columns are the experimental average distance 
(R) and the width of the distance distribution (σ). The rest of the four columns are the 
calculated distances from the crystal structure, Cα-Cα and the spin labeled probe (NO-
NO) modeled onto the crystal structure for each of the two monomers (A and B).  
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Figure 8: Distances between TM1 and TM2 determined by DEER. The distance 
distribution of the double labeled mutants is shown in the blue trace. The dotted black 
trace and black line are the distance distribution of the corresponding single mutants. 
Distance distribution are shown for; A) 12/42; B) 15/42; C) 19/39; D) 15/38. The peak 
average distance distribution for each site is shown in blue arrow. 
 
 
The deviation of the EPR data from the crystal structure suggest that the N-
terminus of the TM2 helix from both monomers in the crystal structure may well be tilted 
with respect to the lipid bilayer. The tilt in the transmembrane helix would support the 
results reported in Figure 6 and 7. In addition, the simple rotation (see Figure 5, black 
arrow) of TM2 would also correlate well with the high oxygen accessibility data from the 
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previous chapter suggesting that both 34 and 38 are facing the lipid bilayer with no 
tertiary contact.   
To further support the data and the conclusions above, double mutants were 
chosen between TM1 and TM3 to test if similar trends can be observed and to confirm 
the orientation of the two monomers within the dimer of EmrE. 
 
Packing of TM1 and TM3 
 Given the proposed dynamic role of TM3 (Fleishman et al., 2006) confirmed by 
the results in Chapters V and VI, it is important to determine its relative location in the 
monomer. Towards this goal, double cysteine mutants were introduced at positions 6/58, 
12/70, 15/69, 15/74, 19/73, 16/74, 19/74, and 22/74 (see Figure 9 for the location of these 
sites in the crystal structure). Each of the double cysteine mutants were spin labeled, and 
CW-EPR spectra were collected as shown in Figure 10. Most of the chosen doubly 
labeled sites showed similar spectral line shapes to the corresponding sum of the single 
mutants. This suggests that the doubly labeled sites in the monomer are further apart than 
the proposed packing in the crystal structure. 
The EPR spectral line shape of the doubly labeled sites at position 15/74, 16/74, 
19/74, and 22/74 show broadening as would be expected for two spin labeled sites that 
are separated by less than 20 Å apart. This is in disagreement with the crystal structure, 
especially for the 22/74 pair where the sites are predicted to be facing away from each 
other (Figure 9). 
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Figure 9: Double mutants for TM1/TM3 packing modeled onto the EmrE crystal 
structure. The two monomers are represented in blue and wheat colored ribbons. The 
mutation sites in both transmembrane segments are shown as red sticks for only one 
monomer. The horizontal dashed line (light grey) shows the location of sites in the 
middle of the bilayer. The predicted lipid bilayer is indicated by two horizontal lines. The 
black arrow shows the predicted rotation of the helix from experimental data.  
 
 
 
The subunit exchange experiment shown in Figure 3, confirms that the spin-spin 
interaction of the two sites 19 and 74 arises from their interaction in the monomer. In 
contrast, hardly any broadening is observed in the 19/73 spectrum where the two spin 
labels are predicted to be 10 Å of one another in the crystal structure. In Chapter V the 
accessibility data showed site 74 to have high oxygen accessibility, suggesting that this 
site is facing the lipid membrane and not facing away from the lipid bilayer as suggested 
by the crystal structure. This orientation of TM3 would be consistent with the close 
proximity of site 74 with 15, 16, 19, and 22. 
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For the pairs 6/58, 12/70, 15/69, 15/74, 16/74, and 19/73 which did not show 
extensive spectral broadening, DEER experiments were carried out. Results of these 
experiments are compiled in Table 2 and analyzed to determine the average distance 
within the monomer. The table also compares the experimental data with the Cα-Cα and 
spin label distances measured from the crystal structure as described above.  
The experimental distance distributions do not correlate with the distance 
measured from the molecular modeling of the spin labeled side chain (NO-NO) at each 
site based on the crystal structure. The distance measured by DEER for the chosen sites 
of TM1/ TM3 showed a wide distribution of distances (Table 2). 
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Residue  
#
R (Å) σ (Å) Cα- Cα (Å)
Monomer A
Cα- Cα (Å)
Monomer B
NO-NO (Å)
Monomer A
NO-NO (Å)
Monomer B
6/58 35.9 12.4 11.5 10.8 3.7 5
12/70 33 8.2 8.7 10.5 14.6 21.6
15/69 26.4 10.3 9.2 6.8 9.3 5.6
15/74 34 11.4 7.7 12.2 18.9 19.2
16/74 15 10.8 9 13.7 21.9 25.9
19/73 31.6 10.3 7.4 8.6 7.9 11.2
19/74 7.9 1 6 6.4 10.8 18.6 19.8
22/74 17 1 6 7.1 11.4 6.8 11.4
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Intra-monomer distance between selected sites located in TM1 and TM3 
determined by DEER. The grey shaded columns are the experimental average distance 
and the width of the distance distribution (σ). CW-EPR average distance obtained by the 
convolution method1. The rest of the four columns are the calculated distances from the 
crystal structure, Cα-Cα and the spin labeled probe (NO-NO) modeled onto the crystal 
structure for each of the two monomers (A and B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Distance distribution using CW-EPR. The distance distribution from the 
convolution method (Rabenstein & Shin, 1995) is shown for both 19/74 and 22/74. The 
CW-EPR spectra of 19/74 and 22/74 collected with a scan width of 200 G and 160 G, 
respectively.  Double labeled mutant (blue trace), simulated spectra (black trace).  
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The broad distance distribution may be due to the proposed flexibility of TM3, 
thus, only the peak average distance distribution of the intra-spin labeled site 16/74 was 
determined. Both pairs 19/74 and 22/74 were analyzed using CW-EPR for the pair of 
nitroxides through the convolution method (Rabenstein & Shin, 1995), as shown in 
Figure 11 and Table 2. These two doubly labeled sites average distance do not agree with 
the nitroxide spin label modeled onto the crystal structure. In general, the measured 
distances of the chosen pair of nitroxides between TM1 and TM3 in the monomer are not 
in agreement with the crystal structure 
Together, both the accessibility data (chapter V) and the data presented here, 
confirmed that sites 70, 73, and 74 are not at the dimer interface but are facing the lipid 
bilayer. This suggests that the C-terminus of the TM3 helix in the crystal structure must 
be rotated counterclockwise (see Figure 9, black arrow) to support the results mentioned 
above. Furthermore, previous chapters and biochemical evidence (Elbaz et al., 2008) 
have shown that the TM3 helix is highly flexible, thus the crystal structure of the 
substrate bound-state of EmrE may well be a snap shot of one intermediate that was not 
observed in the solution structure examined here. 
 
Packing of TM2 and TM3 
To further investigate how the helices are arranged in the monomer, we analyzed 
the dipolar interaction in the 38/74 and 47/62 pairs relating TM2 and TM3. The CW-EPR 
spectra of each of the two pairs of nitroxide spin labels are shown in the appendix (see 
appendix, page 211). In both cases, spectra of the double mutants were similar to the 
corresponding sum of the single mutants, suggesting that the sites are more than 20 Å 
apart. Since the doubly labeled site 38/74 is further in distance than 19/74, the 
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arrangement of the transmembrane helices is in agreement with the crystal structure and 
the EM model, where the TM1 helix is sandwiched between TM2 and TM3 on each side.  
 
Intra-Monomer Distances between Residues Located in TM1/TM4, TM2/TM4, and  
TM3/TM4  
 The location of TM4 relative to the membrane normal has been controversial. The 
crystal structure of the substrate bound-state shows TM4 to be perpendicular with respect 
to the membrane plane. It is, therefore, important to investigate the distance between spin 
label pairs located in TM1/TM4, TM2/TM4 and TM3/TM4 in the monomer which will 
add another dimension to the apo-state model of EmrE. Towards this goal, double 
cysteine residues were introduced at: 12/88, 15/88, 16/88 for TM1/TM4; 32/85, 35/88, 
36/89 for TM2/TM4; 58/103 for TM3/TM4. Each of the doubly labeled mutants was 
spin-labeled and CW-EPR spectra (Figure 12 and Figure 13) and distances for each of the 
double mutants were determined using DEER. The distributions of distances for the intra-
spin labeled sites are shown in Table 3 (see appendix for detail of the distance 
distribution of each of the doubly labeled mutants).  
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Residue  # R (Å) σ (Å) Ca- Ca (Å)
Monomer A
Ca- Ca (Å)
Monomer B
NO-NO (Å)
Monomer A
NO-NO (Å)
Monomer B
12/88 22.5 9.1 23.5 22.5 30.3 31.9
15/88 23.5 8.8 20.6 20.6 24.8 20.6
16/88 24.5 9.7 23 23.4 31 36.6
32/85 47 11.7 30.6 35.4 22.8 39.2
35/85 34.6 10.8 32.8 36.9 30.3 38.9
36/89 30.7 9.9 30.8 32.4 30.6 33
58/103 18 10.3 7.2 - 15.8 -
 
 
Table 3: Intra-monomer distance between selected sites located in TM1/TM4, 
TM2/TM4, and TM3/TM4 determined by DEER. The grey shaded columns are the 
experimental average distance and the width of the distance distribution (σ). The rest of 
the four columns are the calculated distances from the crystal structure, Cα-Cα and the 
spin labeled probe (NO-NO) modeled onto the crystal structure for each of the two 
monomers (A and B). 
 
  
The average distances of the three chosen double mutant sites between TM1/ 
TM4 (Table 3) are not in agreement with the spin label modeled onto the crystal 
structure, especially for sites 12/88 and 16/88, which shows a distance of more than 30 Å. 
This suggests that the N-terminus of TM4 is closer to TM1 than is suggested by the 
crystal structure of the substrate bound-state. In Chapter V, we had mentioned that TM4 
is tilted relative to the membrane plane; therefore, the distances correlate with the 
accessibility data. 
As for the double mutants between TM2/TM4, since the distance distribution of 
the double mutant sites were similar to the corresponding single mutants (see appendix, 
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page 212), thus, we could not make a final conclusion. However, the distance distribution 
suggests that the TM2 helix is furthest away from the TM4 helix, while the TM3 helix is 
the closest to the TM4 helix.  
Overall, TM4 is further from the three transmembrane segments and may only 
contribute structurally as has been proposed for a homologue of EmrE, Hsmr, where 
TM4 is required for oligomerization (Poulsen, Rath, & Deber, 2009).  
 
Evaluating the Monomer in the Crystal Structure 
Several studies have used CW-EPR or pulse EPR techniques (McHaourab et al., 
1997; Rabenstein & Shin, 1995) to derive structural models. The distance constraints 
obtained from CW-EPR or DEER methods can be used to assess structure models, such 
as the crystal structure and the EM model of EmrE.   
Based on the sites examined in this Chapter, a number of observations can be 
made; The packing of the helices in the monomer was in agreement with both the crystal 
structure and the EM model, where TM1 and TM3 are between TM2 and TM4 (Y. J. 
Chen et al., 2007; Fleishman et al., 2006). This assignment of the helices suggests that the 
two monomers can form a dimer in an antiparallel orientation. Recent work has suggested 
that since conserved sites must face the core of the protein (Korkhov & Tate, 2008), the 
second monomer must be inverted to bring the conserved sites to face the center with 
similar interactions to the first monomer, forming a functional dimer. In contrast, 
published work using a tandem-EmrE where a linker connected the two monomers by a 
linker was compatible with parallel topology, and this construct had similar functional 
characteristics to the wild-type EmrE (Steiner-Mordoch et al., 2008). However, the 
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tandem-EmrE results do not rule out a dimer of dimer that is antiparallel. In addition, the 
crystal structure had observed a two fold symmetry axis relating two dimers but it was 
not shown (Y. J. Chen et al., 2007). These contradictions are still to be resolved.  
The EPR results describing the detailed packing of the helices within the 
monomer did not correlate well with the crystal structure. One of these reasons would be 
the difference in the detergent used by the crystal structure (Nonyl-β-D-glucoside) versus 
Dodecyl-β-D-maltoside used in this experimental work (see details in Chapter IV). The 
NG, having a shorter hydrocarbon chain length has an effect in destabilizing the 
hydrophobic transmembrane segments of EmrE.  Recent published work has proposed 
that different detergents can cause an increase in flexibility at similar sites within the 
same helix (Columbus et al., 2009). Thus, the use of different detergent micelles has an 
effect not only on helix-helix interactions but also on helix-micelle interactions. This 
could explain the difference in the packing of TM2 and TM3 with respect to TM1. 
Second, the crystal structure had published only the Cα trace of TPP+-bound EmrE. Thus, 
the modeled residues might also deviate from the real projection in the crystal structure. 
However, these changes are minor when comparing the distances for the selected 
residues of EmrE in solution with respect to the static crystal structure.  
The intra-monomer probe distances were in good agreement with the EPR 
spectral line shapes. For sites with a broadened spectral line shapes, such as 19/74 (Figure 
11), showed a distance of < 15 Å, while sites that had mobile spectral line shapes such as 
12/70 (see Table 2, and Figure 10) reflects a distance of > 25 Å. Yet, the broad 
distribution of distances observed may either be related to the asymmetry of the two 
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monomers within the EmrE dimer, or the flexibility and the dynamic contribution from 
the backbone fluctuation. This will be further clarified in the subsequent Chapter.  
 
Conclusion 
 In this chapter, site-directed spin labeling (SDSL), in combination with CW-EPR 
and pulse EPR methods, was used to investigate the orientation and packing of the 
helices within the EmrE monomer. The 34 double mutants selected were strategically 
chosen so as not to interfere with the packing of EmrE in the monomer or in the dimer. 
The data suggests that the packing and orientation of TM2 and TM3 with respect to TM1 
in the monomer deviates from the crystal structure. Thus, from the experimental results 
of the chosen sites of TM2 and TM3, both transmembrane segment need to be oriented 
counterclockwise to a certain degree with respect to TM1, which might in some cases 
support the static crystal structure. However, in other cases the average distance deviates 
greatly from the crystal structure even when rotating the transmembrane segments would 
not correspond to the crystal structure. Overall, the location of the transmembrane 
segments in the monomer supports both the crystal structure and EM model but does not 
support the packing interface between the transmembrane segments within the monomer.  
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CHAPTER  VIII 
 
 
PACKING OF EMRE MONOMERS IN THE DIMER. INSIGHT FROM 
LONG RANGE DISTANCE MEASUREMENTS BETWEEN SPIN 
LABELS 
 
 
Introduction 
Defining the structure and dynamics of EmrE is fundamental for the mechanistic 
description of its function. Although x-ray crystallography has yielded deep insights into 
the structure of proteins, constraints needed for growing crystals cannot provide dynamic 
information under physiological conditions.  In the case of EmrE, the orientation of the 
two monomers in the dimer has emerged as a focal point of contention. EmrE structures, 
determined from 2 and 3 dimensional crystals, provide compelling evidence supporting 
an antiparallel orientation of the monomers (Y. J. Chen et al., 2007; Tate et al., 2001). In 
addition, the sequence determinants of membrane topology, the arginine and lysine 
contents of EmrE loops (i.e. the K+R bias), do not favor a unique orientation in the 
membrane implying that EmrE could inserts with dual topology (Rapp et al., 2007). 
However, experiments designed to verify or alter the relative orientation of the monomers 
were inconclusive (McHaourab et al., 2008).   
In contrast, a body of biochemical data supports a parallel orientation of the 
dimer. These include the design and construction of functional EmrE chimeras where 
monomers are linked by short polar loops that are not favored energetically to cross the 
bilayer (Steiner-Mordoch et al., 2008). Furthermore, sites predicted to be on opposite 
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sides of the membranes in the antiparallel dimer model can be cross-linked without 
significant perturbation of transport (Soskine et al., 2002).  
In Chapter VI, double electron-electron resonance (DEER) was used to obtain 
distances for regions in TM3 in order to define conformational changes induced by TPP+ 
binding. Narrowing of the distance distribution and a decrease in the average distance 
was observed. The experiments demonstrated that careful analysis of the shape of the 
distance profile can provide detailed information regarding conformational sampling of 
the ensemble of structures.  
In this chapter, an extensive spin labeling EPR analysis in detergent micelle using 
DEER spectroscopy was carried out (Borbat et al., 2001; Borbat et al., 2007; Hubbell, 
Cafiso, & Altenbach, 2000; Jeschke et al., 2005). The experimental distances were 
compared to the Cα and the spin labeled probe modeled onto the crystal structure of the 
substrate bound-state of EmrE. The shape of the distance distributions reveal multiple 
conformations of EmrE due to motion of the backbone to which the nitroxide label is 
attached. Two questions are addressed in this chapter: the first is whether the EmrE dimer 
consists of antiparallel monomers and the second is the nature of the conformational 
changes induced by substrate binding.  
The crystal structure of the substrate bound-state of EmrE in detergent micelles 
(Y. J. Chen et al., 2007) provides a starting point to evaluate the conformational state of 
EmrE. The experimental work will evaluate not only the crystal structure of the substrate 
bound-state of EmrE in the mechanistic chain of events but also its deviation relative to 
the apo-state. 
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Experimental Methods 
Double Electron-Electron Resonance (DEER) 
The double cysteine mutants were made on a cysteine-less EmrE background. 
Purification and labeling were done as described in chapter III. The detergent samples for 
DEER measurements were concentrated to a final protein concentration 140-200 μM 
containing 30% glycerol (w/v). For the substrate bound-state of EmrE, a final 
concentration of 1 mM of TPP+ was added. All distance data were collected at 83°K (-
190°C) using four-pulse DEER protocol (Pannier et al., 2000). DEER signals were 
analyzed by Tikhonov regularization (Chiang et al., 2005) using DeerAnalysis 2008 
software to determine average distances (r) and distribution of distances P(r). 
 
Molecular Modeling  
Modeling of double-labeled mutants with MTSL is based on the crystal structure 
of the substrate bound-state of EmrE (PDB ID: 3B5D; (Chen et al., 2007). The dihedral 
angles (χ1, χ2, χ3) between the Cα of the spin labeled cysteine and the nitroxide ring were 
fixed. The disulfide-linked nitroxide side chain was estimated using the χ4χ5 model 
(Langen et al. 2000) where χ4 and χ5 were varied to explore conformational space. The 
relative distances between the two nitroxide radicals were calculated using the 
CalDihedral in-house program (see detail in Chapter VII, experimental methods).  
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Results and Discussion 
Distance Fingerprint of Antiparallel Packing 
The published crystal structure of EmrE in the substrate bound-state had only 
reported the Cα trace of the four α-helices (Y. J. Chen et al., 2007). Figure 1 show the Cα 
inter-subunit distance for each site that is resolved by the crystal structure (sites 6 to 102). 
An interesting pattern is observed in Figure 1. The sites with distances greater than 30 Å 
are located in the loops connecting each of the four TMSs and located on opposite side of 
the lipid bilayer in the crystal structure. For each TM helix, the sites of close distances are 
located near the center of the helices. 
Figure 1B shows the predicted distances between spin labels modeled onto the 
crystal structure of TPP+-bound EmrE. The modeled distances agree well in trend but not 
in magnitude with the Cα-Cα distances for sites located in TM2, TM3, and TM4. For 
TM1, the pattern is distorted for sites in the middle of the helix where the projection of 
the spin label leads to distances close to 30 Å. This reflects the tilt of the two helices 
relative to the membrane normal and the shorter separation between the helical axes.  
One caveat with this approach is that at buried sites, the spin labels are likely to 
have different orientations relative to the alpha carbon than predicted by the simple cone 
model used here. However, exact modeling of the spin label rotamers at sterically 
restricted sites has not been carried out and is beyond the scope of this dissertation. 
Therefore, the pattern of distances between the modeled spin labels will be compared to 
the experimental distances with emphasis on exposed sites in the TM helices and loops.  
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Figure 1: Calculated distances from the crystal structure. A) The calculated Cα-Cα 
distance between EmrE residues 6 to 102. B) The calculated inter-spin label nitroxide 
distances modeled onto the crystal structure for each residues from 6 to 102. The 
horizontal grey dotted lines show that distances above 30 Å are in the loop regions while 
those below 30 Å are within the transmembrane segments. 
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Distance Analysis of EmrE Structure in Detergent Micelles 
To test whether the experimental distances between the inter spin labeled sites are 
similar to those predicted by the crystal structure of the substrate bound-state, 59 different 
sites were chosen where the spin labels are predicted to be more than 20 Å apart. The 
chosen sites are from TM1 (6, 8, 9, 12, 13, 15, 16, 19, 20, 21, 22, 23, 25, 26, 27, 28, and 
29); from TM2 (31, 32, 33, 34, 35, 36, 38, 39, 42, 43, 46, 47, 52, 53, 54, 56, 57, and 58); 
from TM3 (59, 61, 62, 66, 67, 68, 69, 71, 73, 74, 76, 77, 78, 79, 81, 82, and 83); and from 
TM4 (85, 88, 89, 91, 99. 100, 102). Each of the 59 single cysteine mutants were spin 
labeled, and the distance between symmetry related pairs were measured using DEER. 
Data were analyzed to determine the average inter-spin label distances. 
The table in the appendix of the inter-spin label interaction (see appendix, pages 
213 and 214) summarizes distances and the distribution of distances for the spin label 
mutants in TM1, TM2, TM3 and TM4 determined in the apo-state and for some in the 
substrate bound-state. The differences in the average distance between the two states are 
very small, as will be shown in the next section. The distances that were collected were 
divided into two categories; the first consists of sites where single component distance 
distributions are observed, and the second consist of sites where multiple component 
distance distributions are observed. These two categories will be discussed separately 
below. 
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Single Component Distance Distributions 
 
From the 59 different sites that were chosen for distance measurements only 22 
sites showed single component distance distributions that can be compared to the 
calculated distance of the crystal structure (Figure 2).  
These sites are: for TM1 (6, 8, 9, 16, 20, 21, 22, 23, 27, and 29); for TM2 (32, 33, 
34, 38, 42 and 53); and for TM4 (82, 85, 88, 89, 99, and 102). In some sites the average 
distance of the TPP+ bound-state was measured for comparison with the apo-state (see 
Figure 2 and the tabel in the appendix, pages 213 and 214). The average distance between 
the two states did not change. Therefore, we will focus on the experimental data of the 
apo-state and compare it to the crystal structure of the TPP+ bound-state.  
All these residues are located at the N- or C-terminal regions in the crystal 
structure. When compared to the predicted distances, substantial deviations (up to 10 Å) 
are noted at some sites specifically in TM1. At sites 21, 22, and 27 where the spin label is 
involved in steric contacts and therefore its location relative to the Cα is not well defined, 
the distances are likely to deviate from the cone model. Hence, the packing of the side 
chain would possibly determine the orientation, and in turn the average distance and the 
distribution of distances (Alexander, Bortolus, Al-Mestarihi, McHaourab, & Meiler, 
2008).  
For the sites located in the N-terminal TM2 helix (sites 32-34, Figure 2B), the 
experimental distances and the calculated distances are similar.  
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Figure 2: Comparison of experimental distances to the crystal structure of TPP+ 
bound-state. The left column shows the ribbon diagram of each TM helices highlighted 
in blue and wheat for each monomer, for clarity. The chosen regions for distance 
measurements are highlighted in red, they are A) TM1 sites; 6, 8, 9, 16, 21, 22, 23, 27, 
and 29. B) TM2 sites; 32, 33, 34, 38, 42, and 53. C) TM4 sites; 82, 85, 88, 89, 99, and 
102. The sites in the second monomer are distinguished by asterisk. The right column is 
the inter-spin label experimental distance determined by DEER of the apo-state (black 
squares) and TPP+ bound-state (red squares). The vertical bars are the width of the 
distance distribution from fitting the experminetal data. Grey empty circle are the 
calculated distances by modeling the spin label onto the crystal structure at each position. 
The calculated Cα-Cα distances from the crystal structure are the grey filled circle.  
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However, moving towards the middle and the C-terminal the distances vary suggesting a 
change in the backbone packing. Site 53 that is located in the loop region connecting 
TM2 to TM3 shows a large distribution of distances suggesting that this part of the loop 
is flexible. 
At a number of sites in TM4, the distances deviate from the crystal structure, 
suggesting that the backbone of TM4 helices in the apo-state is further apart. The 
difference could also pertain to the packing of the helices in the dimer. The DEER data is 
in support of EPR accessibility (see Chapter VI) suggesting that TM4 may have a larger 
average tilt relative to the membrane normal than what is observed in the substrate-bound 
crystal structure.  
Overall, the experimental distances of specific regions of EmrE are in accordance 
with the modeled spin label onto the crystal structure for sites that are located only in N-
termini of TM2s, but not for TM1, C-termini of TM2s and TM4, suggesting a difference 
in the helical packing for certain regions. In all the single component distances that have 
been collected and shown in Figure 2, none were from sites located in TM3. TM3 are in 
the second category of distances, which show multi-component distance distributions. 
 
Multi-Modal Distance Distributions: Dynamics of TM3  
 
 The two questions that are crucial in understanding the structure of EmrE is; First,  
why do most of the data that were collected for distance measurements of EmrE have 
multiple component average distances and second, if the multiple distance components 
are a reflection of flexibility of the EmrE backbone, how are the distances affected when 
the substrate (TPP+) is bound?  
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Recent published work has shown that DEER distance distributions provide 
information about conformational ensemble and equilibria (Blackburn et al., 2009; 
Smirnova et al., 2007; Zou & McHaourab, 2009). Hence, the observation of two or more 
distance populations between symmetry related spin labels, indicative of minor and major 
spin populations in the spectroscopic ensemble. On the other hand, the wide distance 
distributions are indicative of flexibility or the sampling of different local conformations. 
In EmrE, 37 sites out of the 59 sites were collected for distance measurements and 
located in TM1, TM2, TM3 and TM4 (See appendix, for detail of the distance 
distributions) all showed multiple component distance distributions in the apo-state. In 
most of these cases the differences in the distances suggest that it does not arise from 
multiple conformations of the label. Rather, our model suggests that throughout the apo-
EmrE structure a constant motion of the backbone occurs. This conformational flexibility 
of apo-EmrE may have an important role in facilitating the binding of substrates to 
different sizes and structures.  
Consistent with the accessibility and mobility data described in Chapter VI, 
distance distributions of spin labels along TM3 suggest a highly flexible backbone. The 
multiple component distributions are illustrated in Figure 3 for site 77 and 78. Other sites 
were presented in Chapter VI, Figure 18 and the rest are in the appendix (pages 218 and 
219). These represent functionally relevant conformational equilibria that are supported 
by the effects of TPP+ binding. Sites located in TM3 (68, 69, 71, 73, and 74) and the loop 
region connecting TM3 to TM4 (76 to 79) show changes in the shape and width of the 
distance distributions. In some cases, such as site 71 and 76, there was also an increase in 
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Figure 3: DEER distance measurements of inter-probe residues of 77 and 78 located 
in TM3 with and without TPP+. A ribbon representation of the two subunits of EmrE is 
shown in grey and wheat. The TPP+ is shown in light cyan. The location of sites 77 and 
78 are represented by red sticks. The black dotted line shows the distance between the 
Cα-Cα for each site in the dimer. The distance distribution from the DEER experiments 
of the spin labeled site 77 (left) and78 (right) in the presence (red trace) and absence 
(black trace) of TPP+. 
 
 
The experimental distances are all measured in frozen solution which in principle 
captures all the conformations of the nitroxide at room temperature. Although, specific 
conformations at low temperature might be more favorable than others, the multiple 
distance components observed at most sites of EmrE suggest that there is a 
conformational equilibrium that adds complexity to the structural topology of EmrE. 
193 
 
Further work is needed to evaluate the complex distance distribution by collecting 
data using different microwave frequencies in the presence of other substrates. More 
importantly, the use of molecular modeling should provide a perspective on the nature of 
the conformational ensemble.  
 
Short Range Distance Analysis of the Dimer Interface 
 The asymmetry of the two monomers that form a dimer in the crystal structure 
shows that one side is further apart than the opposite side, which suggests the transporter 
is facing one side of the bilayer. Thus, choosing double mutants that are in close 
proximity at the dimer interface would elucidate the asymmetry. The chosen mutants 
were 21/48 between TM1 and TM2, and in the loop region connecting TM1 to TM2 they 
are: 22/53, 23/53, and 26/52 (Figure 4). 
 The inter-probe interaction at the dimer interface did not agree with the close 
proximity that is shown in the crystal structure. Since there is asymmetry in the crystal 
structure the spectral line shape should reveal multiple spin label populations that would 
suggest different conformational geometry in the packing of the interface, however, this 
was not observed.  
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Figure 4: Inter-probe interactions of TM1 and TM2 sites at the dimer interface. 
Sites A) 21/48, B) 22/53, and C) 23/53, and D) 26/52 are represented by red sticks on the 
ribbon diagram of the substrate-bound EmrE crystal structure. Each subunit is shown in 
grey and wheat. The CW-EPR spectra for each double spin label site are shown in blue 
trace. The corresponding sum of single mutants is shown in black trace. All spectra were 
recorded at room temperature with a scan width of 160 Gauss. 
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Figure 5: Inter-probe interactions of TM4 sites at the dimer interface. A) 89/101 and 
B) 93/100 are represented by red sticks on the ribbon diagram of the substrate-bound 
EmrE crystal structure. Each subunit is shown in grey and wheat. The CW-EPR spectra 
for each double spin label site are shown in blue trace. All spectra were recorded at room 
temperature with scan width of 200 Gauss with the exception of the spectra of sum of 
singles and 93/100 (top right panel of B) was recorded with a scan width of 160 Gauss. 
The grey trace spectral line shape (lower right panel of B) is the subunit exchange of 
93/100 with cysteine-less EmrE (WT*). 
 
To characterize the packing of TM4 at the dimer interface, pairs of spin labels 
were introduced at sites predicted to be in close proximity in the crystal structure. Figure 
5A and B shows two double spin lablel mutants located at position 93/100 and 89/101. In 
Chapter V the mobility data of the TM4 helix shows that symmetry related sites along 
TM4 are further apart than suggested in the crystal structure. Consistent with this result, 
the CW-EPR spectral line shape of site 89/101 does not show any broadening indicating 
that the spin labels are more than 20 Å apart.  The spectrum was similar to the sum of the 
corresponding single mutants.  
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Conversely, 93/100 (Figure 5B) showed a broadened spectral line shape, 
suggesting close proximity via inter-monomer or intra-monomer interactions. This unique 
mutant of 93/100 has similar intra- and inter-monomer distances of 15 Å in the crystal 
structure. The two interactions can be resolved using subunit exchange with unlabeled 
cysteine-less EmrE (WT*) (see detail of the method in Chapter III). If the broadening that 
is observed is due to inter-monomer interaction it would be expected that subunit 
exchange would lead to an increase in signal amplitude. The result reveals an intra-
monomer interaction of 93/100, where subunit exchange sample had similar spectral line 
shape to the double spin label site of 93/100. This confirms that TM4’s are further apart 
than suggested in the crystal structure.  
 
Conclusion 
 The main goal of this chapter is to compare distances between symmetry related 
spin labels in detergent micelles with the calculated distances from the structure of EmrE 
in the substrate bound-state. In most cases, the experimental distances did not agree in 
trend and magnitude with the Cα-Cα distances of the crystal structure, suggesting a 
difference in the backbone order.  
The overall consensus from the distance measurements shows the dynamic 
flexibility of the EmrE backbone in the apo-state. The dynamic flexibility is an important 
feature of EmrE that confers the ability to bind to a variety of structurally dissimilar 
substrates.  
In the substrate bound-state of EmrE, the C-termini of TM1 sites show an increase 
in average distance, suggesting that the C-terminal region of TM1 is moving further apart 
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upon the binding of the substrate. However, sites located in TM2 and TM3 shows very 
little change in average distances between the two intermediate states but a decrease in 
flexibility of the backbone. The decrease in flexibility of EmrE induced by TPP+ may 
initiate an intermediate for the vectorial translocation of the substrate across the 
membrane bilayer.  
In general, the crystal structure is a snap-shot of one of several intermediate states 
of EmrE due to its flexibility. Therefore, it is not unexpected that the experimental 
distances collected in solution would deviate from the static crystal structure.  
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CHAPTER  IX 
 
 
SUMMARY AND PERSPECTIVES 
 
 
The work presented in this dissertation addresses three fundamental questions 
relevant to the transport mechanism of EmrE: 
1. How can we reconcile the EPR data with the crystal structure of EmrE in the 
substrate bound-state? 
 
2. What conformational changes of EmrE are observed in the presence of TPP+, how 
does it compare with the apo-state EPR data, and with the crystal structure of the 
TPP+ bound-state? 
 
3. What is the topology of EmrE?  
 
The consensus antiporter mechanism (Figure 1) proposes that substrate in the 
cytoplasm would bind to unprotonated glutamate at position 14 (E14) of EmrE. A 
conformational change occurs causing the binding site to face the periplasm. In the 
periplasm the pH is more acidic, E14 becomes protonated and leads to the release of the 
substrate. 
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2H+
H+H+H+H+
TPP+E- H+ (protonated E14)E- (unprotonated E14)
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Proposed mechanism for transport by EmrE. The two asymmetric 
monomers are shown in blue and orange. E-H+ is the protonated glutamate residue at 
position 14. E- is the unprotonated glutamate residue. The approximate dimensions of the 
lipid bilayer are shown by the grey shading.  
 
 
Reconciling the EPR data of EmrE Apo-State with the Crystal Structure of the 
Substrate Bound-State  
 The published crystal structure reports that EmrE is an asymmetric dimer 
composed of four transmembrane helices / monomer packed in an antiparallel orientation 
(Y. J. Chen et al., 2007). The substrate is bound in the center of the first three helices 
from each monomer, while the fourth transmembrane helices are perpendicular to the 
membrane plane. In contrast, the distorted crystal structure of EmrE in the apo-state at pH 
4.0 shows that TM4 helices are extending away from the main body of the dimer (Y. J. 
Chen et al., 2007).  
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 The EPR data in the absence of substrate showed a deviation from the crystal 
structure of the substrate bound-EmrE for TM3, and TM4, whereas TM1 and TM2 had a 
similar arrangement at the dimer interface. Even though the buried environment of these 
sites hinders a quantitative comparison with the crystal structure, the focus was on 
whether the pattern of proximity agrees with the pairwise packing of helices in the crystal 
structure.  Distance and orientation are the critical factors in such assessment since in the 
simplest model, the labels project along the Cα-Cβ bond. The spin labels for TM1 at site 
14 are therefore expected to directly point towards each other thus rationalizing the 
broadened population. Site 18 shows dipolar coupling only in the apo-state and not in the 
substrate bound-state. This observation suggests that TPP+ binding involves local 
rearrangement. For TM2 the only difference between the EPR data and the crystal 
stucture is related to sites 31, 34, and 38. All 3 sites show accessibility to high 
concentration of oxygen indicative of a region facing the lipid bilayer. 
 The crystal structure of EmrE shows an antiparallel dimer, in which site 63 is 
located in the first turn of the N-termini of TM3s at the dimer interface, with a distance 
separation of 10 Å. However, the EPR data did not show any spin-spin interactions for 
this site.  The only two sites showing dipolar coupling were spin labeled sites 60 and 64. 
The C-terminal region of TM3 (73-76) was accessible to oxygen, suggesting a location 
within the lipid bilayer.  
The interaction of sites located in TM1 and TM3 within the monomer shows that 
sites 19/74, and 22/74 have strong dipolar contact but not 19/73, suggesting that site 74 is 
facing the lipid bilayer and in close contact to site 19 and 22 of TM1. In the crystal 
structure, site 74 is facing away from the lipid membrane, while site 73 is facing the lipid 
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bilayer and in close contact to site 19.  Overall, the deviation of TM3 topology between 
the crystal structure and the EPR data is related to the flexibility of the helix, thus, the 
crystal structure is perhaps showing one snap shot of several intermediates.  
Both the crystal structure of the substrate bound-state and the EM model had 
shown that TM4 is perpendicular to the membrane plane. However, the EPR accessibility 
data does not support a helix that is perpendicular to the lipid bilayer, since most of the 
sites facing the lipid bilayer have similar collision rates to oxygen without a gradient 
where the highest oxygen accessibility would be at the center of the TM segments. The 
EPR data in the native like environment (reconstituted EmrE in liposomes), under which 
TM4 helices are at a steep angle with respect to the membrane plane or a surface helix 
parallel to the membrane plane compared to the crystal structure of the TPP+-bound 
EmrE. The difference may well pertain to the flexibility of this region, thus, the static 
crystal structure is observing one conformation for TM4 while the EPR data represents an 
average over the ensemble of all conformation within the lipid bilayer.   
At a number of sites, the EPR lineshapes and DEER data suggest the presence of 
at least two distinct conformations of EmrE. One explanation of the EPR data is the 
asymmetric structure of the two monomers, specifically for residues located in TM3 and 
TM4. The second explanation is that the EmrE dimer has a parallel topology. This may 
explain why site 60 and 64 that are located at the N-terminus of TM3 showed spin-spin 
interaction. For these sites to be in close proximity in an antiparallel orientation of the 
EmrE dimer they must be located below the lipid-water interface.  
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Figure 2: Diagram of each transmembrane segment in the apo- and substrate 
bound-state. Each TMS in the dimer is shown as cylinder and viewed parallel to the 
membrane plane. The TMS in one monomer is colored in blue, and the other in orange. 
TPP+ is shown in orange sphere. The approximate dimensions of the lipid bilayer are 
shown by the grey shading.  
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As a result, the C-terminal region and the loop connecting TM3 to TM4 would be in the 
water phase. The antiparallel model, however, does not explain the high oxygen 
accessibility observed in this region.  
 
Predicted Model of Conformational Changes for each Helix Induced by TPP+ 
Binding 
 Figure 2 shows a model of the proposed changes observed for each helix upon 
TPP+ binding from the EPR data. TM1 sites facing the binding pocket such as sites 10, 14 
and 18 are in direct contact with TPP+. Site 10 increases steric contact with other sites in 
the region while site 18 loses its dipolar coupling involving local rearrangements upon 
the binding of the substrate. These changes in lineshape were also observed for sites in 
the C-terminus of TM1 (19, 21, and 22).  
 Along TM2, site 44 increases the dipolar coupling while site 40 loses its spin-spin 
contact upon the addition of the substrate. This observation resolves the crystal structure 
projection of site 40 where one of the labels is away from the dimer interface. The N-
terminus of TM2 increases in tilt when substrate binds reflected by an increase in O2 
accessibility for sites 30, 34, and 38. The differences between the EPR data and the 
crystal structure of the substrate bound-state are in TM3 and TM4. We predict, from the 
data upon substrate binding, site 64 at the N-terminus face one another at the dimer 
interface. This would explain the broadened spin populations observed in the spectral line 
shape. Changes are also observed along the full length of TM3, where there is a backbone 
rearrangement. We have proposed that the hinge between the N- and C-terminus of TM3 
is at position 65 and 67. Consequently, the region (68-78) shows a change not in the 
rotamer of the spin label but in backbone dynamics. The DEER data for the region (68-
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76) shows a decrease in the width of the distance distribution in the TPP+-bound EmrE, 
suggesting that the C-terminal region of TM3 has an overall backbone mobility that 
decreases upon substrate binding to EmrE.  
In the absence of substrate, TM4 showed substantial tilt relative to the membrane 
normal (see final model in Figure 2) as evident from the pattern of oxygen accessibility. 
The maximum values decrease towards the C-terminus and the helical periodicity is lost 
after residue 103 with no tertiary contact. The increase in Π (NiEDDA) beyond site 103 
suggests that this region of the helix is emerging out of the membrane. The region 104-
110 is not resolved in the crystal structure of the TPP+ bound-state may suggest a flexible 
backbone.   
 
Topology of EmrE 
 The data showed that the arrangement of the helices in each monomer was 
assigned similar to the crystal structure, where TM1 and TM3 were flanked by TM2 and 
TM4. The tertiary structure of the two monomers has been proposed previously to have 
only an inverted orientation within the membrane (Korkhov & Tate, 2008). This is 
because conserved residues such as site 14, 44, and 60 must point towards the center of 
the EmrE dimer to make specific interactions such as helix-helix and helix-substrate 
interactions. If the two monomers were parallel then each helix must be related by a 
translation, followed by a rotation of 180° about the individual helical axis to place each 
of the conserved sites in the center of the dimer. This causes the interface of the helices 
within each monomer to have different packing specificity, which to this day has never 
been seen with other membrane proteins.  
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 It is also important to realize that previous published work from our lab 
(McHaourab et al., 2008) emphasized that EmrE topology does not only depend on the  
K+R bias as has been proposed previously (Heijne, 1986) but also the helix-helix 
interaction and helix-membrane interaction that has an important role in the orientation of 
membrane proteins. The main disagreement in the topology of EmrE from our published 
data came from observing dipolar coupling along TM3 at position 60 and 75 that were 
interpreted as indicative of parallel packing of two TM3s at the dimer interface 
(McHaourab et al., 2008).  When the finding that spin labels at residue 64 have strong 
dipolar coupling, the data could be brought into closer agreement with an antiparallel 
model if the N-terminus of TM3 is located well below the membrane-water interface, 
placing site 60 and 64 in close proximity. 
 The flexibility of EmrE made it difficult to identify the exact topology of the two 
monomers of EmrE. A reason for the predicted models of each trasmembrane segments 
of EmrE in Figure 2 to be in an antiparallel topology was related to a double mutant 
22/56 (see chapter VII). The EPR spectral line shape showed the close proximity of these 
two sites can only arise at the dimer interface (inverted monomers) and not within the 
monomer, as was proven by subunit exchange. Furthermore, the persistence of second 
populations in the dipolar coupled spectra reveals conformations of EmrE with different 
packing interfaces.  However, the pattern of proximity along TM1 and TM2 suggest that 
one EmrE conformation is similar to the TPP+-bound crystal structure. Flexibility and 
dynamics are invoked to rationalize the discrepancy between EPR data along TM3 and its 
crystallographic conformation.  
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For future work, the topology of EmrE can be further investigated by comparing it 
to another SMR family of transporter such as EbrA and EbrB proteins that are 
significantly homologous to each other and to EmrE (Zhang et al., 2007). It has also been 
suggested that EbrA/B form an antiparallel topology (Kikukawa, Miyauchi, Araiso, 
Kamo, & Nara, 2007). Thus, the homologous protein may elucidate the topology of 
EmrE.  
 
Future work 
Substrate Translocation 
The thesis work gave detailed insight into the structure and dynamics of EmrE in 
the apo-state and the substrate bound-state. Future work is needed to investigate 
conformational changes using different substrates to elucidate the question of how cans a 
small membrane protein like EmrE extrude such a wide variety of substrates. 
Understanding the different conformational changes of EmrE require additional study of 
mechanism of transport. Previous work has shown that imposing an electrochemical 
gradient (ΔμH+) across the lipid bilayer causes the substrate to transport from one side of 
the membrane to the other (Gutman et al., 2003; Muth & Schuldiner, 2000; Rotem & 
Schuldiner, 2004). However, whilst the assays do demonstrate pumping of substrate, it 
was difficult to maintain a continuous pH gradient across a membrane due to the 
permeable nature of membranes to protons. Thus, a recent method have shown that the 
multidrug transporter can be co-reconstituted with a light driven proton pump 
bacteriorhodopsin (bR) into unilamellar vesicles (Basting, Lorch, Lehner, & Glaubitz, 
2008). Thus, illuminating bR would generate a stable pH gradient, which EmrE requires 
for substrate transport. Hence, the sites that showed single distance components upon 
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binding of TPP+ can be used to compare the distances between the same sites during 
substrate transport.  
 
Effect of Detergent 
The study where the crystal structure was determined using Nonyl-β-D-glucoside 
(NG) instead of Dodecyl-β-D-maltoside (β-DDM) to solubilize EmrE. Both detergents 
are non-ionic, but the hydrocarbon chain length of NG is shorter than β-DDM and may 
affect the conformation of the two monomers. In addition, it has been suggested that the 
detergents with the head group of the glucosides exhibit larger aggregation numbers and 
less spherical micelles compared to the maltosides for the same hydrocarbon chain 
length. Thus, the large head group of the maltosides as compared to the glucosides leads 
to stronger steric repulsion and, therefore, to smaller micelles (which, as a result, are 
more spherical) (Lipfert, Columbus, Chu, Lesley, & Doniach, 2007). Furthermore, a 
study has shown that extracting EmrE in NG detergent disrupts the oligomeric state of the 
protein (Soskine et al., 2006). Therefore, the differences in extraction of EmrE in our 
work and the crystal structure would have an effect in the inconsistencies observed in the 
packing of the helices of EmrE in the apo-state.  In addition, our work shows that the 
detergent samples had similar EPR spectral line shape to the liposome samples (data not 
shown), thus, it may be an important consideration for future work to examine different 
detergents for solubilizing EmrE that may decrease the dynamic fluctuation without 
perturbing the overall tertiary structure.  
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Effect of Lipid Composition 
Multidrug transporters bind to a variety of substrates. The flexibility in the 
transport protein binding pocket may be reflected in sensitivity to their surrounding 
lipids. Thus, lipid composition and global properties of the lipid bilayer play a key role in 
membranes, often modifying the function of membrane proteins. Recent work has shown 
that the lipid composition of EmrE reconstituted into liposomes modifies drug transport 
and that substrate translocation is dependent on in vitro lipid composition (Charalambous, 
Miller, Curnow, & Booth, 2008). This highlights the importance of investigating the 
influence of lipid environment on multidrug transport activity. Therefore, a long term 
goal is to learn the most efficient method for decreasing the resistance of specific 
substrates such as chemotherapeutic drugs that would have a major influence in 
successfully and selectively killing tumor cells.  
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APPENDIX 
 
INTRA-SPIN LABEL INTERACTIONS 
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Intra-spin distance distributions using CW-EPR. Spin labeled double mutant located 
between TM1/TM2 (blue trace), simulated spectra (black trace). 
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CW-EPR spectra of  the intra-spin mutants. Spin labeled double mutants with (red 
trace) and without (black trace) TPP+. 
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CW-EPR spectra of  the intra-spin mutants. Spin labeled double mutants with (red 
trace) and without (black trace) TPP+. 
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Intra-spin distance distributions using DEER. Spin labeled double mutants of sites 
located between TM1/TM4, TM2/TM4, and TM3/TM4 (blue trace). The blue arrow 
represents the average distance from the double mutants. The distance distribution of the 
corresponding single mutants (black and dotted trace, respectively) for comparison.  
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INTER-SPIN LABEL INTERACTIONS 
 
 
Experimental distance, Rav 
(Å) 
 
Mutants 
 
Location 
 
Apo 
 
TPP+ 
 
Calculated 
distance, 
Cα-Cα (Å) 
 
Calculated 
distance of the 
spin label (Å) 
3 TM1 35.5 ± 2.95    
4 TM1 35.6 ± 4.4    
5 TM1 46.7 ± 4.8    
6 TM1 40.3 ± 2.7 40.6 ± 2.9 30.2 34.31 
8 TM1 30 ± 2.1 31 ± 1.9 30.1 22.95 
9 TM1 41.8 ± 9.3  24.5 18.73 
12 TM1 33.1 ± 9.5 32.4 ± 11 25.1 37.69 
13 TM1 31.3 ± 6.8  20.4 19.48 
15 TM1 33.8 ± 12.5 32.2 ± 3.4 21.6 34.21 
16 TM1 35.1 ± 10.3  23.6 30.74 
19 TM1 33.6 ± 5.7 36.4 ± 6.3 25.3 34.94 
20 TM1 37.5 ± 2.8 39 ± 4.6 24.1 18.38 
21 TM1 18.1 ± 2.7 19.2 ± 3.8 20.8 10.25 
22 TM1 35.1 ± 4.9 36.3 ± 5.7 25.7 25.63 
23 TM1 41.9 ± 4.2  30.5 32.23 
25 Loop 1 44.3 ± 8.5 43.4 ± 6.6 31 32.41 
26 Loop 1 37.6 ± 10.4  32.8 31.1 
27 Loop 1 19.4 ± 4.7 20 ± 5.0 30.5 30.38 
28 Loop 1 33.9 ± 17.7  29.2 29.41 
29 Loop 1 43.9 ± 2.7  33 42.42 
31 TM2 34.8 ± 15.1  33 42.69 
32 TM2 40.8 ± 4.1  32 44.36 
33 TM2 25.3 ± 4.7 25 ± 5.7 26.8 33.72 
34 TM2 22.5 ± 5  22.4 24.31 
35 TM2 39.4 ± 10  25 21.43 
36 TM2 25.7± 18  24.4 30.92 
38 TM2 23.7 ± 7.8  16.7 23.92 
39 TM2 29.9 ± 15 29.4 ± 20 20.4 31.72 
42 TM2 29.6 ± 6.6 32.1 ± 5.1 17.5 29.81 
43 TM2 26.7 ± 18.4 26.2 ± 22.4 17.1 18.05 
46 TM2 31.5 ± 19.5 35.3 ± 5.2 22.3 27.24 
47 TM2 15 ± 27.5  18.9 4.8 
52 Loop 2 44.6 ± 5.4 42.9 ± 9.1 33.4 42.6 
53 Loop 2 43.9 ± 20 45 ±16.2 35.7 35.4 
54 Loop 2 35.8 ± 3  35.9 35.78 
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Table of the average distances and the distribution of distances for the inter-spin 
label mutants in detergent micelles. 
 
 
Experimental distance, Rav 
(Å) 
 
Mutants 
 
Location 
 
Apo 
 
TPP+ 
 
Calculated 
distance,  
Cα-Cα (Å) 
 
Calculated 
distance of the 
spin label (Å) 
56 Loop 2 29.8 ± 4  26.6 35.21 
57 Loop 2 28.3 ± 16.2 28.4 ± 11.8 23.9 20.3 
58 Loop 2 32.1 ± 14.8 32.6 ± 7.9 21.1 32.4 
59 TM3 15 ± 30  15.3 19.5 
61 TM3 22.7 ± 18  14.3 27.34 
62 TM3 29.7 ± 4.5  14.6 23.44 
66 TM3 35.4 ± 12.1 35.4 ± 1.0 16.6 19.77 
67 TM3 29.7± 15  12.7 16.3 
68 TM3 21.8 ± 3.4 23.4 ± 0.85 16.6 19.7 
69 TM3 24.5 ± 13.5 24.1 ± 13.1 22.8 29.12 
71 TM3 27.4 ± 14.6 30.2 ± 12.2 22 17.14 
73 TM3 35 ± 7.6 34.4 ± 5.2 29.2 29 
74 Loop 3 36 ± 10 37.2 ± 6.4 27.8 19.2 
76 Loop 3 31 ± 27 40.9 ± 7.5 36.6 31.64 
77 Loop 3 45 ± 12.4 51.3 ± 12.2 38.9 49.4 
78 Loop 3 46.5 ± 13.6 48.7 ± 12.4 40.7 40.1 
79 Loop 3 40.5 ± 10.2 39.7 ± 5.5 40.8 53.1 
81 Loop 3 37.2 ± 9.9 38.1 ± 9.9 34.2 36.2 
82 Loop 3 46.6 ± 6.5  35.7 34.86 
83 Loop 3 31.6 ± 15.9  34.6 28.59 
85 TM4 28.9 ±6.9  28.5 28.02 
88 TM4 31.7 ± 6.8  28.3 38.51 
89 TM4 23.6 ±3.1 24 ± 4 23 28.6 
91 TM4 27.8 ± 18.4  18.9 30.69 
95 TM4 14.4 ± 38.8  12.6 26.08 
97 TM4 31.1 ± 26.9 30 ± 24.7 5.5 14.2 
99 TM4 28 ± 6  14.2 21.7 
100 TM4 25.5 ± 8.8  14.1 6.1 
102 TM4 28 ± 5.0  18.1 21.3 
103 Loop 4 34.5 ± 5.9    
104 Loop 4 32.6 ± 7    
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Inter-spin distance distributions using DEER. Changes in the average distance and 
distribution of distance between symmetry related spin labels with (red trace) and without 
(black trace) TPP+. 
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